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2Abstract
Voltage gated sodium channels (VGSCs) play a key role in the initiation and propagation of
action potentials in neuronal cells. NaV1.8 is a Tetrodotoxin resistant VGSC expressed in
nociceptors and underlies the majority of sodium currents during action potentials. Many
studies have highlighted a key role of NaV1.8 in different pain pathways. Lipid rafts are
microdomains of the plasma membrane highly enriched in cholesterol and sphingolipids
characterised by unique physical features: a liquid ordered phase and the resistance to non-
ionic detergent at 4°C. Lipid rafts are thought to act as platforms on the membrane where
proteins and lipids can be compartmentalised and functionally clustered. In the present study
we investigated NaV1.8 sub-cellular localisation and explored the idea that it is associated with
lipid rafts in nociceptors. We hypothesised that lipid rafts on primary sensory neurons act as a
platform on the membrane where NaV1.8 can be trafficked and underlie action potentials
generation. We demonstrated that NaV1.8 is associated with lipid rafts along the sciatic nerve
ex vivo and in DRG neurons in vitro.  We also found that NaV1.8 is distributed in clusters along
the axons of DRG neurons in vitro and ex vivo. We investigated the functional meaning of
NaV1.8-raft association by studying action potential propagation in sensory neurons, in
response to mechanical and chemical stimulation, by calcium imaging. Disruption of the
association between NaV1.8 and lipid rafts in cultured sensory neurons, by methyl-beta-
cyclodextrin and 7-ketocholesterol, caused a reduction in the number of cells able to
propagate action potentials. In addition, lipid raft depletion caused a remarkable reduction in
the conduction velocity upon mechanical stimulation. These findings highlight the importance
of the association between NaV1.8 and lipid rafts in the conduction of action potentials and
could lead to new perspectives in the study of NaV1.8 trafficking and nociceptor excitability.
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Chapter 1: General Introduction
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1 Introduction
1.1 Pain and pain anatomical pathway
1.1.1 Pain: definition and types.
The ability of complex living organisms to detect noxious stimuli and to code the sensation of
pain is of fundamental importance. The feeling of pain serves as a protective mechanism
against potentially dangerous insults; it prevents or limits bodily harm and preserves physical
integrity. The experience of pain is the result of a complex interaction and integration of
different parts of the body which include neuronal and non-neuronal cells, the sensory
transducers, nerves, the spinal cord, and the brain. Also, at each level of the pain pathway,
multiple tuning mechanisms contribute to define the sensation of pain, which ultimately
occurs in the brain. Pain also affects the emotional dimension and this, in turn, can affect the
feeling of pain itself. Pain is defined as “an unpleasant sensory and emotional experience
associated with actual or potential tissue damage, or described in terms of such damage” (Wall
and Melzack, 2005). An unequivocal strict classification of different types of pain cannot be
made, since there are overlapping mechanisms behind the different conditions. Nevertheless,
pain can be broadly classified into different types according to several parameters which
include the cause, time course, modality, and region of the body from which it arises. By
considering the cause as a determinant, pain can be defined as nociceptive when it results
from a direct activation of the cells that are able to transduce the noxious insult. Minor
injuries, burns and infections can lead to an inflammatory state, characterised by
hypersensitivity towards noxious stimuli. This type of pain is referred to as inflammatory pain.
Neuropathic pain results from damage or a malfunction of the nervous system. Examples of
conditions that may be associated to neuropathic pain include trauma, diabetes, viral infection
and cancer (toxic effect of chemotherapy). From a temporal point of view, pain can be defined
as acute, which usually resolves when the noxious stimulus is no longer present, or chronic,
which can occur for years. The modality of pain, referring to intensity and description, can also
be used in its classification. In fact, there are several degrees of pain intensity (moderate to
severe) and it can be described, for example, as burning, stabbing, tingling, numbing, and
prickling. Pain becomes of clinical relevance when it loses its protective physiological role.
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There are many conditions and diseases where specific symptoms are accompanied by chronic
pain. In these conditions pain no longer serves as a defensive mechanism. Usually chronic pain
is characterised by hyperalgesia and allodynia. Hyperalgesia is defined as an increased
sensation of pain in response to a normally noxious stimulus, while allodynia is the perception
of pain in response to a normally non noxious stimulus. Chronic pain heavily affects the quality
of life and can aggravate the clinical condition, since chronic pain can be the cause of co-
morbidities like stress, anxiety, depression, and lack of sleep. Apart from pure clinical aspects,
social issues must be also considered, in terms of both social consequences for the patients
(e.g. inability or impairment to perform everyday activities) as well as costs for the health
systems. It is estimated that 1% of the UK population suffers from chronic pain. The different
types of pain can be managed clinically, albeit with different degrees of effectiveness.
Traditionally, acute nociceptive and inflammatory pain can be efficiently treated with
painkillers (e.g. paracetamol, NSAIDs). On the other hand, even if drugs (e.g. opioids, tricyclic
antidepressant, and pregabalin) can alleviate chronic pain in some patients, effective
treatments able to abolish severe ongoing pain are unavailable (O'Connor and Dworkin, 2009).
For this reason, a wide-spectrum approach is being carried out, from scientists to clinicians, in
an effort to understand the exact mechanisms behind untreatable pain, in order to tackle this
condition.
1.1.2 Pain anatomical pathway: nociceptors.
Sensory information from the limb and trunk is conveyed to the spinal cord by sensory
neurons, whose cell bodies are clustered in dorsal root ganglia (DRG) within the vertebral
column adjacent to the spinal cord. DRG neurons are pseudo-unipolar, with a single axon
arising from the cell body which bifurcates in two branches. The peripheral branches, bundled
in peripheral nerves, terminate in the target tissues (e.g. skin, viscera, muscle spindles) while
the central processes enter the spinal cord, through the spinal roots, and connect in the
superficial laminae of the grey matter (dorsal horns) inter-neurons or neurons projecting to
the brain (Fig. 1.1) (Kandel et al., 2000). This anatomical organization provides the base for the
transmission of stimuli from the peripheral and visceral tissues to the central nervous system.
Supra-threshold stimulation of the peripheral endings of these neurons triggers action
potentials that are propagated through the axons to the spinal cord.
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Fig. 1.1) Schematic organization of the sensory and motor systems. Sensory afferent system is
shown in red. Sensory neurons, whose cell bodies are contained in the dorsal root ganglia
(DRG), convey information from the periphery to the dorsal horn of the spinal cord. In the
spinal cord they connect inter-neurons (not shown) or neurons that project to the brain, which
ultimately processes and integrates the incoming information. The descending pathway is
shown in green. Efferent system is shown in blue. Neurons that control skeletal muscle
contraction have cell bodies in the ventral horns of the spinal cord, where they receive
information from the brain. Efferent axons project to the peripheral system through the
peripheral nerves.
DRG neurons are a heterogeneous population of cells and can be discriminated according to
different properties including morphology, extent of myelination/speed of conduction, and
sensory function. Also, DRG neurons can be classified according to the expression of specific
molecular markers, like structural protein, receptors, and ion-channels (Hunt and Mantyh,
2001). From a morphological point of view there are three classes of neurons. Related to this
parameter, DRG neurons are also divided according to their myelination state which, together
with the size of the axons, determines the speed of conduction. By considering the
aforementioned features, DRG neurons are classically defined as: Aα/β, Aδ and C fibre neurons
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(Lawson, 2002). Aα/β are large, heavily myelinated fibres, with an axonal diameter larger than
10 µm; they conduct action potentials at high speeds (30-100 m/sec). Aδ are medium size,
thinly myelinated neurons, with a diameter of 2 to 6 µm, and an intermediate conduction
velocity (12-30 m/sec). C fibres are small unmyelinated neurons, with axon diameters between
0.4 and 1.2 µm; these cells conduct action potentials at the lowest speed (0.5-2 m/sec). The
different dimensions are also mirrored at the level of the cell bodies, with large neurons having
a diameter smaller than 25 µm, medium neurons having a diameter between 25 µm and 32
µm and large neurons with a diameter greater than 32 µm (Lawson et al., 1984). In the skin,
even though the proportion can vary, their relative abundance is 20%, 10% and 70%,
respectively (Millan, 1999). Action potential propagation in myelinated neurons relies on the
effect of myelin and on the clustering of voltage gated sodium channels (VGSCs) in discrete
positions along the axons, the Nodes of Ranvier, which lack the myelin envelope (Cusdin et al.,
2008). Myelin wrap between the Nodes of Ranvier increases the resistance between the
cytoplasm and the extracellular space, preventing current leakage between the Nodes. It also
drastically reduces the capacitance of the axons, which contributes to the high speed of
conduction in myelinated axons. Clusters of VGSCs at the Node of Ranvier prevent the
depolarisation (which passively spreads between the nodes) from dying-out, by boosting
action potentials. Action potentials are only generated in the nodes and they propagate by
quickly “jumping” from node to node.  For this reason, action potentials are said to propagate
by saltatory conduction (from the Latin saltare, to jump) (Kandel et al., 2000). On the other
hand, unmyelinated fibres conduct depolarisations more slowly than myelinated fibres. In
contrast to the myelinated fibres, the action potentials are not propagated by saltatory
conduction in these fibres. Once the membrane has been depolarized beyond the VGSCs
activation threshold, an action potential is generated. This local depolarisation is spread
passively down the axon, causing the adjacent patch of membrane to reach the threshold for
generating an action potential. Ultimately, action potentials are propagated by continuous
conduction. In contrast to the myelinated fibres, events regulating VGSCs trafficking, their sub-
cellular localisation and the detailed mechanisms of action potential propagation in
unmyelinated axons are still unknown.
DRG neurons also exhibit differences from a functional point of view. Aα neurons carry
proprioception information from muscle spindles and the joints. Aβ neurons respond to light
touch and in normal condition they are not activated by noxious stimuli. DRG neurons that
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respond to noxious stimuli are called nociceptors, and they include the Aδ and C neurons. Both
neuron types end as free nerve endings in the peripheral tissue. Nociceptors typically respond
to stimuli of different nature (e.g. thermal, mechanical, and chemical), hence they are called
polymodal. As a very simplified rule, Aδ are responsible for the sharp, acute and spatially
localised pain while C fibres mediate the dull, long lasting, more diffused pain (Julius and
Basbaum, 2001). There are two types of Aδ neurons, with different sensitivity to thermal and
mechanical stimuli. Aδ type-I are present in both glabrous and hairy skin. They respond to
chemicals and high threshold mechanical stimuli (e.g. pinching of the skin). These cells are
weakly responsive to high intensity heat. Importantly, these cells can be sensitised, and in this
condition they will be also activated by thermal stimuli. Aδ type-II neurons are mostly present
in the hairy skin. Compared to type-I, they have higher and lower thresholds to mechanical and
thermal stimuli, respectively. These cells are thought to mediate the fast component of
noxious heat. C fibres are generally polymodal, even though some neurons responding to
unique stimuli have been described. C fibres respond to chemical, thermal and mechanical
noxious stimuli. There is also a class of C fibres named as silent nociceptors; in normal
conditions these neurons are not gated by noxious stimuli, but they become responsive when
sensitised. It must be noted that not all C and Aδ neurons are nociceptors; neurons responding
to non noxious stimuli have been discovered in these sub-groups and the functional
classification between Aβ, Aδ and C fibres must be considered dynamic. Indeed DRG neurons
can change their properties in inflammatory and chronic pain conditions (Gold and Gebhart,
2010).
DRG neurons can be grouped according to the expression of specific markers. Myelinated
neurons express the structural protein NF200, while unmyelinated C fibres are positive for
cytoskeletal protein Peripherin. C fibres can be further subdivided into two major groups,
peptidergic and non peptidergic. The first group expresses and releases neurotransmitters
Substance P and Calcitonin Gene Related Peptide (CGRP). These cells are trophic for Nerve
Growth Factor (NGF) and express its receptor TrkA. The non peptidergic population is trophic
for Glial Derived Neurotrophic Factor (GDNF) and expresses its receptor c-Ret and GFRα. Also,
it binds the Isolectin IB4 (glycoprotein isolated from Griffonia simplicifolia). Myelinated
neurons are trophic for Brain Derived Neurotrophic Factor (BDNF) and NT-3 and express their
cognate receptors TrkB and TrkC (Fig. 1.2).
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Fig. 1.2) Nociceptor sub-populations. The pie-chart shows a simplified representation of the
different sub-population of nociceptors. Marker molecules are also presented for each sub-
group.
DRG sub-populations differentially project into the spinal cord. The dorsal horn of the spinal
cord is organized into laminae with distinct anatomical and functional properties. C fibres
terminate in the superficial laminae. More specifically, peptidergic fibres connect spinal
neurons in lamina I and in the most superficial area of lamina II, while non peptidergic fibres
terminate more deeply in lamina II. Aδ fibres project to lamina I and deeper into lamina V.
Lamina V is also, with lamina IV and III, the area where Aβ fibres terminate to. Spinal neurons
in lamina V that receive inputs from nociceptors and non nociceptors cells are called Wide
Dynamic Range neurons. Myelinated neurons also terminate into the deeper area of lamina II,
enriched with spinal neurons expressing PKC (Basbaum et al., 2009). C fibres act on post-
synaptic neurons by releasing glutamate, which binds to post-synaptic α-amino-3-hydroxyl-5-
methyl-4-isoxazole-propionate (AMPA) and N-methyl D-aspartate (NMDA) receptors and elicits
excitatory post-synaptic potentials. If the noxious stimulus intensity is strong enough
Substance P will be also released; this neuropeptide binds to NK1 receptors and will contribute
to an augmented post-synaptic response (Woolf and Costigan, 1999).
Apart from transducing acute nociception, DRG neurons contribute to the development and/or
maintenance of hyperalgesia and allodynia in pain conditions. Indeed, during inflammatory
conditions pro-inflammatory compounds released in the site of trauma (e.g. Prostaglandin E2
(PGE2), NGF, Bradykinin, Histamine, Tumor Necrosis Factor alpha (TNFα) trigger intracellular
pathways that sensitise the nociceptors, by decreasing the threshold of activation and/or
increasing firing upon stimulation (Hucho and Levine, 2007). These effects are collectively
named as peripheral sensitization, and are distinguished from events that occur at the level of
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the spinal cord, termed central sensitization, which also contribute to hyperalgesia and
allodynia. The different mechanisms underlying peripheral and central sensitization are
reflected in the ultimate output: peripheral sensitization leads to heat and mechanical primary
hyperalgesia, while central sensitization contributes to mechanical secondary hyperalgesia
only (Ali et al., 1996; Richard A. Meyer, 2005). In neuropathic pain conditions (e.g. injury of
nervous system, diabetic neuropathy, HIV related neuropathy, post herpetic neuralgia) altered
nociceptor excitability contributes to the development and/or maintenance of chronic pain,
also characterized by hyperalgesia and allodynia (Sah et al., 2003). In fact, even though
changes in the central nervous system are important for the development of painful symptoms
in peripheral neuropathies, several evidence indicates that changes in the excitability of
primary nociceptive afferents are the single most crucial factor in the generation and
maintenance of chronic neuropathic pain (Arner et al., 1990; Gracely et al., 1992; Koltzenburg
et al., 1994; Ochoa and Yarnitsky, 1993; Rowbotham et al., 1995; Wall and Melzack, 2005).
Damaged nociceptors show aberrant excitability and firing properties which can be caused by
several factors such as: 1) lowered threshold of activation of the excitatory transducers, 2)
mislocalisation of mechano/heat/chemical transducers at the injured end or at the level of the
cell bodies and 3) altered distribution of voltage gated ion channels (Gold and Gebhart, 2010).
Because of these factors, nociceptors may fire more vigorously upon activation and may
develop the ability to generate ectopic discharges. This translates into an augmented or an
ongoing electric activity towards the central nervous system. In abnormal conditions Aδ fibres
have the tendency to fire at regular intervals at high frequency while C fibres fire in an
irregular fashion; usually C fibres develop abnormal firing patterns later than Aδ fibres. DRG
neurons, because of cellular insults (e.g. injury, metabolic imbalance, viral infection) and
consequential cell death, may release chemicals that, either directly or indirectly, affect
neighbouring uninjured fibres. It has been reported that these intact fibres can become
sensitised, fire irregularly and contribute to pain states (Ali et al., 1999). Nociceptors represent
an interesting subject for studies aiming at the identification of therapeutic targets, because
they gate the noxious stimuli and play a key role in the development and maintenance of
chronic pain states.
18
1.1.3 Pain anatomical pathway: Spinal cord and brain.
Spinal cord neurons are heterogeneous and their properties, together with the type of sensory
neurons they connect to, define the spinal cord output upon sensory neuron excitation. Spinal
cord neurons that receive inputs solely from nociceptors are found in the superficial laminae.
Another class of dorsal horn neurons only connect Aβ afferents and fire upon light touch
stimulation. Neurons that receive inputs from nociceptors and non nociceptors cells are called
Wide Dynamic Range neurons and reside in lamina V. Both excitatory (glutamatergic) and
inhibitory (GABAergic) inter-neurons in the dorsal horn add a further level of modulation in
spinal processing (D'Mello and Dickenson, 2008). Glial cells are also present in the spinal cord
and have been demonstrated to play an important role in pain states (Scholz and Woolf, 2007).
Dorsal horn neurons represent an important site of synaptic plasticity. The changes that occur
at the level of the spinal cord during pain states are referred to as central sensitisation.
Modulation of the synaptic strength between primary afferents and dorsal horn neurons is at
the foundation of hypersensitivity that accompanies pain states. High frequency firing of
nociceptors results in the engagement of NMDA receptors in the dorsal horn neurons, which
leads to increased intracellular calcium concentration. Calcium, by acting as an intracellular
messenger, activates pathways that determine an increased responsiveness of dorsal horn
neurons upon stimulation by afferent fibres. These changes are mainly due to post-
translational modification of channels, receptors and signaling proteins and/or to their
increased expression and trafficking to the membrane. Central sensitisation also accounts for
the secondary mechanical hyperalgesia that develops in the area surrounding an injury. In
normal conditions Aβ neurons activation would not normally engage pain transmission circuit.
Central sensitisation results in the recruitment of previously subliminal low-threshold Aβ fibre
inputs which elicit allodynia (Basbaum and Woolf, 1999).
Dorsal horns also represent the site where the major ascending pathways project from: the
spinothalamic and spinbulbar projections. Neurons of the spinothalamic tract directly project
to the thalamus and originate from different regions of the spinal cord: lamina I, laminae IV-V
and laminae VII-VIII. This anatomical pathway is the one most closely associated with pain,
temperature and itch sensation. The spinobulbar projection originates from the same regions
of the spinothalamic tract but the cells of origin are different. It terminates in the parabrachial
nucleus (PB), the periaqueductal grey (PAG) and the brain stem reticular formation (Hunt and
Mantyh, 2001). From the thalamus, PB and PAG the nociceptive information is conveyed to
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different regions of the brain. The current model proposes that there is not a distinct “pain”
area, rather there is a “brain matrix” of different areas which may be differently activated
during pain processing. These areas comprise the amygdala, the insula, the primary and
secondary somatosensory, insular, anterior cingulate, and prefrontal cortices (Tracey, 2007;
Tracey and Mantyh, 2007).
The brain exerts its influence, both facilitatory and inhibitory, on the dorsal horn nociceptive
information through the descending pathway. Neurons of this pathway originate in the
rostroventral medulla and act on the primary sensory afferents, interneurons and projecting
neurons of the spinal cord. The cellular population of the descending pathway is mixed and
consists of “on cells”, “off cells” and “neutral cells”. ”On cells” discharges just prior to the
occurrence of withdrawal from noxious stimuli, “off cells” stop firing just prior to a withdrawal
reflex “neutral cells” show no consistent changes in activity when withdrawal reflexes occur
(Millan, 2002).
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1.2 Voltage gated sodium channels: an overview
Voltage gated sodium channels (VGSCs) are necessary for the generation and propagation of
action potentials in the nervous system (Hille, 2001). This class of protein comprises nine
traditional isoforms (NaV1.1-9) plus an atypical channel (NaX) (Goldin et al., 2000). VGSCs are
highly homologous proteins with an amino acid identity greater than 50% and are thought to
have evolved from one common ancestor (Catterall et al., 2003).  VGSCs are composed of a
main α sub-unit, which associates to β sub-units. The peptide core of the α sub-unit has an
apparent molecular weight of approximately 220 kDa, which can considerably vary according
to isoform specific glycosylation states (Diss et al., 2004). The α sub-unit, once folded, forms
the ion passage pore and encodes the main electrophysiological properties:  voltage-
dependent activation, rapid inactivation and selective ion conductance. The crystal structure of
eukaryotic VGSCs is not available. Hence, the folding topology of VGSCs has been predicted
from the amino acid sequence, homology to other proteins, from the crystal structure of a
presumptive bacterial VGSC purified from Bacillus halodurans (Ren et al., 2001) and from the
structure (obtained by cryo-electron microscopy) of VGSC purified from Electrophorus
electricus electroplax (Sato et al., 2001). This analysis has revealed that the α sub-unit
comprises 4 homologous domains (DI-IV) each one comprising six transmembrane segments
(SI-VI). The intracellular portions comprise the N- and C-terminuses, plus three loops (Fig. 1.3).
VGSCs are gated by changes of the voltage across the membrane. They exist in three states:
closed, opened and inactivated. At rest, the probability of VGSCs to open is minimal, and they
are assumed to be in the closed state. VGSCs contain a voltage “sensor” domain. Upon
membrane depolarisation, a conformational change, due to a movement of the “sensor”
domain, leads to channel opening. At this stage, extracellular sodium ions are driven
intracellularly through the VGSCs and further depolarise the cell. The force behind this
migration is guaranteed by the sodium electrochemical gradient existing at the resting
membrane potential, which is far from the sodium reversal potential. Upon sodium ions influx
the cell is further depolarised and more VGSCs are engaged. This sodium flux encodes the
rising phase of action potentials. When the membrane potential reaches a value close to the
sodium reversal potential, VGSCs inactivate and neurons enter the refractory period (Errington
et al., 2005; Kandel et al., 2000).  Transmembrane segments S5-6 plus the linker regions (P-
loop) in each domain are thought to form the conductive pore (Catterall, 2001). It is believed
that the voltage “sensor” is the S4 transmembrane segment present into each domain (Fig.
21
1.3). Highly conserved positively charged amino acids (Lysine or Arginine) are found every
three positions in the S4 and organised in a linear array (Wood and Baker, 2001). The “sliding-
helix” model proposes that, upon membrane depolarisation, the S4 segment moves outwards
perpendicularly to the plane of the membrane in a rotating fashion, determining a
conformational change that opens the VGSCs (Catterall, 2010; DeCaen et al., 2009) . An
alternative model, still under investigation for sodium channels (paddle model), suggests that
the voltage sensor lies in a horizontal orientation, compared to the plane of the membrane,
and moves to a vertical position during voltage changes (Catterall, 2010; Long et al., 2005).The
fast inactivation mechanism, with kinetics in the order of milliseconds, relies on the
intracellular loop between domain III and IV, and particularly on the tri-peptide sequence IFM.
A slow inactivation mechanism is also known, with kinetic in the order of hundreds of
microseconds / seconds, but its molecular determinant are still not completely understood.
The “hinged-lid” mechanism is the current model to explain fast inactivation. The intracellular
loop between domain III and IV undergoes a movement which occludes the cytoplasmic side of
the sodium conducting pore and inactivate the channel. IFM residues are crucial for the
activity of the loop as well as the docking sites of the molecular lid, which have been found in
the S4-S5 linker regions of D-III and D-IV (Goldin, 2003). VGSCs are highly selective for sodium
ions. Mutagenesis experiments have revealed that each P-loop contributes to the selectivity
filter, formed by four amino acidic residues (DEKA) (Fig. 1.3) (Lipkind and Fozzard, 2008). These
residues create the favourable environment for sodium ions, but not other monovalent ions
(e.g. K+), to lose their hydration shell and enter the channel (Hille, 2001). VGSC are glycosylated
proteins. After the peptide synthesis, sugar residues (mostly Sialic acid and N-
acetylglucosamine) are linked to the peptide chain in the Golgi network. Glycosylation state
can differ between the isoforms and within the same isoform. Glycosylation has been found to
be developmentally regulated (for NaV1.9), to tune VGSCs biosynthesis/degradation,
membrane expression, electrophysiological properties and binding to other proteins (Denac et
al., 2000; Diss et al., 2004; Schmidt and Catterall, 1987). The putative glycosylation sites are in
the extracellular linkers (Fig. 1.3). VGSCs are post-translationally modified by kinases and
phosphatases. Typically the effect of phosphorylation is isoform specific and tunes trafficking
and electrophysiological properties of the α sub-unit. The sites of phosphorylation are within
the intracellular loops between domain I-II and III-IV; both cAMP dependent kinase PKA and
PKC have been demonstrated to phosphorylate the channels (Fig. 1.3) (Fitzgerald et al., 1999;
Gold et al., 1998). VGSCs have distinct electrophysiological and pharmacological properties. A
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widely used classification relies on their sensitivity to Tetrodotoxin (TTX). This toxin is isolated
from symbiotic bacteria of the puffer fish family Tetraodontidae. TTX blocks the channel by
binding to the external side of the pore and obstructs the ion pore. It is thought that TTX binds
to residues in the P-loops in a two step-mode. Firstly, residues EEDD are engaged, and then the
selectivity filter DEKA plays a role in stabilising the toxin-channel complex. TTX insensitivity is
conferred by a single mutation. TTX resistant (TTX-r) channels, lack the aromatic residue
(Phenylalanine or Tyrosine) in position 356 which is necessary for the toxin binding to the
DEKA motif, and are substituted with Serine (NaV1.8-9) or Cysteine (NaV1.5) (Sivilotti et al.,
1997) (Fig. 1.3). TTX sensitive (TTX-s) channels are blocked by nM concentration of TTX, while
TTX-r channels are blocked by µM concentration of TTX (Wood et al., 2004).
Figure 1.3) VGSC α sub-unit topology. The topology of the VGSCs α sub-unit is shown,
highlighting the main features.
VGSCs are distributed throughout the nervous system and serve different functions, according
to the intrinsic electrophysiological features, cellular background and developmental stage.
We shall focus on VGSCs that are mainly expressed in DRG neurons, and particularly on NaV1.8,
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since they represent the most relevant isoforms for the purpose of this thesis. Table 1.1
summarises the main features of the different isoforms.
Table 1.1. Main properties of VGSCs. Properties of VGSCs are summarised, focusing on their
role and expression in DRG neurons. Presence in DRG neurons, + = present, +++ = abundant.
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Name Main tissuedistribution
Presence in DRG neurons
(size)
TTX sensitivity
(IC50)
Main electrophysiological role in
DRG
NaV1.1 CNS + (Large) YES (6 nM) Unknown
NaV1.2 CNS + YES (12 nM)
May regulate frequency of firing in
injured neurons
NaV1.3 Embryonic +++ after axotomy YES (4 nM) Ectopic firing in injured neurons
NaV1.4
Skeletal
muscle - YES (5 nM) /
NaV1.5 Hearth - NO (1-2 µM) /
NaV1.6 CNS-PNS +++ (Large) YES (1 nM)
Action potential propagation in
myelinated fibres
NaV1.7 PNS +++ (Large and Small) YES (4 nM) Ramp currents
NaV1.8 PNS +++ (Small) NO (60 µM)
Action potential generation and
propagation
NaV1.9 PNS +++ (Small, IB4+) NO (40 µM) Setting resting membrane potential
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1.3 Voltage gated sodium channel NaV1.8
1.3.1 NaV1.8 electrophysiological properties and expression in DRG neurons.
NaV1.8 was identified in 1995 by a genetic screening of DRG transcripts by using a subtraction
library (Akopian et al., 1996; Akopian and Wood, 1995). The coding region of NaV1.8 comprises
27 exons and encodes for the main α sub-unit. NaV1.8 α sub-unit is composed of 1957 amino
acid residues with an apparent molecular weight of approximately 220 kDa (considering only
the peptide chain, and not post-translational modifications, such as glycosylation) (Souslova et
al., 1997). To date two splicing variants have been described in literature, one with the
absence of a glutamine residue in the first intracellular loop (Kerr et al., 2004) and one with a
duplication of exons 12-13-14 (coding part of domain II), which results to be up-regulated in
response to NGF (Akopian et al., 1999a). The functional role of these isoforms is unknown.
During development, NaV1.8 starts being expressed at E15, peaks at P7 and its expression in
the adult stabilises at P21 (Benn et al., 2001).
NaV1.8 is a TTX-r VGSC which underlies action potential (AP) generation in C-type neurons in
DRG. Studies conducted on NaV1.8 knock-out (KO) mice revealed that in these animals,
compared to controls, resting potential, input resistance, action potential threshold, and
current threshold of DRG neurons are unchanged. The striking difference was found in the
ability to generate APs. Small DRG neurons in NaV1.8 KO mice only generated graded
responses upon depolarising stimuli, in marked contrast with wild type cells where all-or-none
APs were generated. In neurons from NaV1.8 KO mice both the peak of the graded response
and the rate of depolarisation was found to be reduced, compared to wild type cells. Indeed, it
has been quantified that NaV1.8 underlies the majority of sodium influx (approximately 90%)
during the rising phase of APs, in small DRG neurons. NaV1.8 also determines the firing
properties of unmyelinated DRG neurons. It allows repetitive firing upon a sustained
stimulation. In neurons from KO animals an ongoing stimulation determined graded response
that adapted more quickly than in control cells, where APs firing at high frequency was
sustained (Fig. 1.4) (Renganathan et al., 2001).
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Figure 1.4) Electrophysiological properties of NaV1.8. Wild type NaV1.8 neurons  generate all-
or-none action potentials when stimulated with depolarizing currents (For  clarity,  traces
generated  by  0-,  20-,  40-,  60-,  70-, 80-, 90-, 100-, 110-, 150-, and 250-pA current  injection
only  are  shown) . NaV1.8 KO neurons generate smaller graded responses. Wild type NaV1.8
neurons also produce sustained repetitive firing in response to depolarizing stimuli of 150 pA.
NaV1.8 KO neurons fail to sustain high-frequency ﬁring. Adapted from Renganathan et al. 2001.
NaV1.8 displays different electrophysiological properties, compared to TTX-s channels
expressed in DRG neurons; this shapes the excitability of the cells where it is expressed. In fact,
in small DRG neurons TTX-r currents mediated by NaV1.8 are kinetically slower than TTX-s
currents in terms of time to peak and to decay. Also, the peak of the I-V relationship, the mid-
point of the normalized conductance curve and the mid-point of the steady-state inactivation
curve is significantly more depolarized than the curves of TTX-s currents (Fig. 1.5).
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Figure 1.5) Electrophysiological differences between NaV1.8 mediated TTX-r currents and
TTX-s currents. A) Representative traces of TTX-r and TTX-s currents. B) The relationship
between peak current amplitude and test potential (I-V curve) for TTX-r and TTX-s currents. C)
The relationship between g/gmax and test potential of TTX-r and TTX-s currents (voltage
dependence of activation). D) Steady state inactivation curves for TTX-r and TTX-s currents
(voltage dependence of steady-state inactivation). Circles are TTX-s currents, triangles are TTX-
r currents. Adapted from Elliott et al. 1993.
TTX-r channels also recover from fast inactivation more rapidly than TTX-s channels. These
feature confers DRG cells expressing NaV1.8 the ability to fire action potential when
depolarised (when TTX-s are inactivated) and to sustain high frequency firing (Elliott and
Elliott, 1993).
A comparison between rat and human NaV1.8 electrophysiological properties has been made.
It was found that activation curves were similar and that the human isoform displayed more
hyperpolarised voltage-dependence than the rat channel, faster development of inactivation,
slower recovery from the fast component of inactivation, and faster recovery from the slow
inactivation. It is not clear yet if these differences are due to intrinsic differences of the α sub-
units, or to indirect modulation of other factors (the electrophysiological properties were
analysed in a heterologous background) (Browne et al., 2009).
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Different VGSCs isoforms contribute to APs electrogenesis in nociceptors. NaV1.8 underlies the
vast majority of sodium conductance, both at the beginning and during the upstroke of APs,
with very little contribution from TTX-s channels, such as NaV1.7. NaV1.7 activates at voltages
close to the resting membrane potential, displays fast activating and inactivating currents
(Klugbauer et al., 1995). Because of its electrophysiological properties it yields to ramp
currents in response to small depolarisations (Cummins et al., 1998). In general TTX-s channels,
even though they activate earlier than NaV1.8, are only active during the first phase of APs
(Blair and Bean, 2002). The other TTX-r channel expressed in DRG neurons, NaV1.9, does not
contribute to APs; indeed, this channel displays very slow activation and inactivation kinetics.
In addition, it has a large overlap between the activation and steady-state inactivation curves,
centred at voltage values close to the resting membrane potential. It encodes a persistent
current and its contribution in nociceptor excitability is to set the resting membrane potential
and to enhance sub-threshold depolarisations. Hence, the current model for AP electrogenesis
in nociceptors is that NaV1.7 encodes ramp currents (boosts sub-threshold stimuli) to
depolarise the cell to an extent sufficient to recruit NaV1.8, which generate the APs (Rush et
al., 2007).
NaV1.8 in the nervous system is only expressed in the PNS in DRG neurons. Recent evidence
showed that cardiomyocyte also express this channel (Chambers et al., 2010). Because of its
restricted expression pattern, a lot of efforts have been put into the characterisation of the
neurons expressing this channel. NaV1.8 is in the majority of small diameter neurons and in a
small proportion of medium and large size neurons. Most importantly, virtually the entire
neuronal population positive for NaV1.8 expression (89% of C-fibres, 93% of Aδ, 64% of Aα/β)
displays nociceptor-like properties (broad APs and large overshoots).  It was also found, in
agreement with NaV1.8 role in AP electrogenesis, that there is a positive correlation between
NaV1.8 expression and large AP overshoots in the cells expressing the channel (Djouhri et al.,
2003a). Within the C-fibre population, NaV1.8 is expressed in both IB4+ and IB4- cells (Fang et
al., 2005). These cells have unique electric properties: strongly IB4+ cells have longer AP
durations and rise times, slower conduction velocities and more negative resting membrane
potentials than IB4- cells. NaV1.8 contributes to these differences. Indeed, it was demonstrated
that in IB4+ cells, compared to IB4- cells, NaV1.8 enters the slow inactivation state more rapidly
and recovers from it more slowly. This translates into differences in excitability, between IB4+
and IB4- cells, with the latter being able to sustain repetitive firing and to undergo less
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adaptation upon a continuous depolarising stimulation, compared to the IB4+ population (Choi
et al., 2007).
1.3.2. NaV1.8 and pain pathways.
All the VGSCs isoforms expressed in DRG neurons have been shown to play a role in pain
pathways (Benarroch, 2007; Dib-Hajj et al., 2010; Ekberg and Adams, 2006; Lai et al., 2004;
Momin and Wood, 2008; Rogers et al., 2006; Wood and Baker, 2001). For the purpose of this
thesis this section will mainly focus on the role of NaV1.8. The evidence that NaV1.8 expression
is restricted to nociceptors and that it is the major determinant for APs generation in these
cells hints to a role of NaV1.8 in pain pathways. Indeed there is a vast amount of literature
demonstrating how NaV1.8 plays a role in nociception. This role has emerged from the
characterisation of NaV1.8 in pain conditions, from electrophysiological and pharmacological
studies, and from the studies carried out in NaV1.8 KO animals. KO mice are viable, have similar
cell profiles as wild-type animals (WT) and show a complete absence of TTX-r currents. NaV1.8
KO mice have been tested for acute pain behaviours. It was found that NaV1.8 absence
resulted in an increased latency of paw withdrawal and tail flick following the exposure of
radiant noxious thermal stimuli. Also, pain threshold to acute mechanical stimuli (tail
pressure), but not to graded Von Frey filament stimulation, was markedly increased in KO
animals. Inflammatory condition was also investigated and it was found that in KO animals
Carrageenan induced thermal hyperalgesia was delayed compared to WT animals (Akopian et
al., 1999b). By studying WDR neurons response to peripheral stimulation it has emerged that
NaV1.8 KO mice show stimulus-dependent deficits in spinal neuronal activity. The interesting
aspect of this experimental model is that it exploits anesthetised animals and supra-threshold
stimuli can be delivered. In this set-up NaV1.8 KO mice displayed less electric activity in WDR
neurons upon mechanical stimulation (but not thermal) of the hind paw, both in the noxious
and non-noxious range with Von Frey filaments. Brushing, acute mechanical stimuli (pinching)
and noxious cold also led to less excitability of WDR neurons (Matthews et al., 2006). NaV1.8
role in inflammatory pain has also been explored. In inflammatory conditions (CFA and
Carrageenan models) NaV1.8 is up-regulated in DRG neurons (Lai et al., 2004). NGF systemic
injection in mice is linked to the development of thermal hyperalgesia. In this model NaV1.8 KO
mice show a clear reduction of thermal sensitivity, compared to WT animals. In the same set of
experiments, neuropathic pain behaviours following partial ligation of the sciatic nerve were
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analysed. NaV1.8 KO developed mechanical allodynia like WT animals and showed a partial
analgesia to thermal stimuli at early time points (Kerr et al., 2001). In vivo PGE2 dermal
injection produces a robust mechanical hyperalgesia and NaV1.8 KO animals displayed
decreased TTX-r currents and attenuated hypersensitivity (Khasar et al., 1998). In models of
neuropathic pain NaV1.8 transcript is down-regulated. Indeed upon axotomy or nerve ligation,
NaV1.8 is down-regulated by at least 50% at the level of DRG cell bodies in rodents (Okuse et
al., 1997) and in humans (Coward et al., 2000). These results suggested that NaV1.8 does not
take part in hypersensitivity that accompanies chronic pain models. In fact reports argued
against a role of this channel in the development or maintenance of neuropathic pain. For
example, Nassar et al. demonstrated that double KO animals for NaV1.8 and NaV1.7 developed
neuropathic pain and mechanical allodynia normally. On the other hand, acute pain thresholds
following noxious mechanical stimuli and radiant heat noxious stimuli were increased;
spontaneous pain following formalin injection was also markedly reduced in double KO mice
(Nassar et al., 2005). The ablation in mice of cells expressing NaV1.8 did not impede thermal
and mechanical allodynia from developing in neuropathic pain models. On the contrary,
inflammatory hypersensitivity was reduced in these mice, compared to wild-type, in CFA and
Formalin models. In addition, acute nociception was impaired upon presentation of noxious
mechanical stimuli and noxious cold (Abrahamsen et al., 2008). On the other hand, other
reports directly pointed to a role of NaV1.8 in neuropathic pain. Sodium channels are necessary
for the generation of ectopic firing in neuromas (Matzner and Devor, 1994) that contributes to
trigger chronic pain and associated hypersensitivity (Gracely et al., 1992; Rizzo et al., 1996;
Wall and Melzack, 2005). In agreement with this finding, a therapeutic approach to treat
neuropathic pain is the administration of Lidocaine, a sodium channel blocker (Mao and Chen,
2000; O'Connor and Dworkin, 2009; Wall and Melzack, 2005). NaV1.8, even though its
expression is down-regulated in DRG cell bodies, accumulates at the site of injury upon chronic
constriction injury (CCI) or axotomy (Novakovic et al., 1998). Interestingly, its presence is
necessary for the generation of ectopic firing in the nerve. Indeed, upon neuroma formation in
control mice, A- and C-fibres spontaneously fire, with C-fibres firing at higher frequency. In
NaV1.8 KO the ectopic discharge is completely absent (Roza et al., 2003). Notably,
redistribution of NaV1.8 in the peripheral nerves has also been described in humans with
hyperalgesic and allodynic conditions resulting from brachial plexus injury (Coward et al.,
2000). Further evidence of a role for NaV1.8 in chronic pain conditions in human comes from a
study where it was shown that NaV1.8 is up-regulated within the axons of painful neuromas
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(Black et al., 2008). It has also been observed that spinal nerve ligation (SNL) leads to an
increase of NaV1.8 along the uninjured C-fibres of the sciatic nerve, where it supports
increased TTX-r AP conduction (Gold et al., 2003). Notably, oligodeoxynucleotide mediated
down-regulation of  NaV1.8 in L4, L5 and L6 DRG completely reversed tactile allodynia and
thermal hyperalgesia in a model of chronic pain (L5/L6 spinal nerve ligation) (Lai et al., 2002)
and prevented them from developing in a model of chronic inflammatory pain (Porreca et al.,
1999). Other evidence for a role of NaV1.8 in neuropathic pain comes from studies carried out
with a specific inhibitor for this channel. Administration of this compound in vivo was reported
to have profound effects on the excitability of DRG neurons and pain behaviour in several
models of neuropathic pain. In fact, spontaneous activity of WDR neurons and firing upon
mechanical stimulation was reduced in the presence of the inhibitor. Also, it attenuated
mechanical and cold allodynia in SNL and CCI models and decreased thermal hyperalgesia in an
inflammatory model (Jarvis et al., 2007; Joshi et al., 2009). Another report showed that cone
snails µO-Conotoxin MrVIB inhibits NaV1.8, blocks action potential propagation in C fibres of
the sciatic nerve and has an analgesic effect in pain models (Bulaj et al., 2006). Recently, it has
been found that lesion of motor neurons only (leaving DRG neurons uninjured) triggers
neuropathic pain-like behaviour. It has been found that in this model NaV1.8 and its currents
are up-regulated in DRG neurons (both small and medium size), and that this increase is
dependent on the increase of TNFα after nerve injury (He et al., 2010). Given these evidence in
now clear that NaV1.8 plays an undisputed role in inflammatory and acute pain and the
potential discrepancies about NaV1.8 role in neuropathic pain conditions have been suggested
to arise from 1) different species used (rats vs. mice), 2) differences in pain models (e.g.
axotomy, SNL, CCI), 3) outcome testing modalities (spontaneous pain, thermal vs. mechanical
stimuli), 4) time course (initiation of neuropathic pain vs. maintenance), and 5) potential
compensatory effect in KO mice, which may hide or lead to underestimation of NaV1.8
influence in neuropathic pain models. Indeed, NaV1.8 KO mice show a robust up-regulation of
TTX-s channel NaV1.7 (Akopian et al., 1999b). Notably, NaV1.8 plays a fundamental role in the
cold. Indeed, this is the only channel able to fire APs at low temperature. When nociceptors
are progressively cooled the voltage-dependent slow inactivation of TTX-s channels is
enhanced, while NaV1.8 inactivation properties are temperature independent (Zimmermann et
al., 2007). Overall, the amount of literature to date demonstrates the NaV1.8 plays a key role in
different pain modalities.
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1.3.3 NaV1.8 sensitisation mechanisms.
NaV1.8 has been shown to be the target of several signaling pathways, which usually result in
its enhanced activity and nociceptors peripheral sensitisation. This phenomenon contributes to
pain related hypersensitivity. PGE2 is a pro-inflammatory compound which is released in the
site of injury from mast cells, where it contributes to vasodilation. Several enzymes are
involved in its biosynthesis and they include the COX enzymes (the target of NSAIDs). PGE2
sensitises the nociceptors by modulating NaV1.8 currents. Indeed, PGE2 by acting on its GPCR
EP2 determines an increase of NaV1.8 mediated currents and alters its electrophysiological
properties by shifting the activation curve and the steady-state inactivation curve to more
hyperpolarised potentials (England et al., 1996). This effect is mediated by cAMP-PKA
dependent phosphorylation of the channel in its second intracellular loop (Fitzgerald et al.,
1999). While PKA activation potentiates NaV1.8 currents, it has an inhibitory action towards
other VGSCs (e.g. NaV1.7 and NaV1.9) (Kakimura et al., 2010; Vijayaragavan et al., 2004a). PGE2
also leads to increased trafficking of NaV1.8 to the membrane (Liu et al., 2010). Adenosine and
Serotonin have been reported to have similar effects on NaV1.8, which are mediated by PKA
dependent phosphorylation (Gold et al., 1996b). NaV1.8 is also a target of PKCε. PKCε
dependent phosphorylation determines NaV1.8 increased currents and a shift of the activation
and steady-state inactivation curves in a hyperpolarizing direction (Gold et al., 1998; Khasar et
al., 1999). Upstream signaling molecules activating PKCε include neuropeptide Substance P,
which has been shown to act in an autocrine way on DRG neurons through GPCR NK1 (Cang et
al., 2009), and Bradykinin. Bradykinin is a nonapeptide pro-inflammatory agent released in the
site of injury. It signals through GPCRs receptors B1 and B2. Activation of these receptors leads
to activation of PKC (through phospholipase Cβ) and sensitisation of NaV1.8 (Gold and Gebhart,
2010; Gold et al., 1996b). Furthermore, PKCε is downstream of NGF receptor TrkA (Okuse,
2007). It has been shown that NaV1.8 is also a target of p38 MAPK. Hudmon at al.
demonstrated that p38 MAPK and NaV1.8 are expressed in the same DRG neurons. P38 MAPK
is activated in inflammatory conditions and increases NaV1.8 currents in DRG neurons (without
affecting the electrophysiological properties) by phosphorylating two serine residues, different
from residues targeted by the PKA pathway, in its first intracellular loop (Hudmon et al., 2008).
A recent study has investigated the potential involvement of local translation on NaV1.8
protein changes in a model on neuropathic pain. Upon sciatic nerve entrapment it has been
found that compound action potential and NaV1.8 immuno-reactivity increased in the treated
nerve. Concomitant with these ﬁndings, NaV1.8  mRNA  level  was  up-regulated  in  the  sciatic
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nerve  but remained unchanged in the DRG. The authors propose that speciﬁc and enhanced
transport of NaV1.8 mRNA into the axons may account for this up-regulation and that local
mRNA accumulation could contribute to increased axonal NaV1.8 protein levels (Thakor et al.,
2009). NaV1.8 has also been found to be modulated by endogenous miRNA (Zhao et al., 2010).
1.3.4 Trafficking of NaV1.8.
The determinants of NaV1.8 trafficking and localisation in DRG neurons have been unknown for
a long period. The first study that identified a regulatory trafficking mechanism for NaV1.8 was
conducted by Okuse et al. It was found that Annexin II light chain sub-unit p11 is necessary for
the functional expression of TTX-r currents mediated by NaV1.8 (Okuse et al., 2002). The role of
p11 in NaV1.8 trafficking will be discussed in more details in Chapter 2 (see section 2.1.5).
Together with p11, other proteins have been found to regulate NaV1.8 association with the
membrane. PDZD2 is a scaffolding protein containing the PDZ motif. It interacts with the
second intracellular loop of NaV1.8. This association correlates with increased TTX-r currents,
compared to a scenario where NaV1.8 PDZD2 interaction is impaired. It is not known yet if
PDZD2 is important for the trafficking of the channel to the membrane or for its retention on it
(Shao et al., 2009). Contactin, a GPI anchored cell adhesion molecule, has been found to
regulate NaV1.8 currents. In Contactin KO mice NaV1.8 mediated currents are reduced in small
diameter neurons (Rush et al., 2005). In addition, Calmodulin has been found to bind to the C-
terminus of NaV1.8 in a calcium independent manner. It is hypothesised that Calmodulin
binding results in the stabilisation of the channel into the membrane, by masking sites on the
C-terminus that would act as endocytosis signal (Choi et al., 2006). Related to the endocytic
pathway, CAP-1 (Clathrin associated protein-1) specifically binds the C-terminus of NaV1.8. It
may act as a bridging element with Clathrin and may regulate the rate of removal of the
channel from the membrane by endocytosis (Liu et al., 2005). NaV1.8 contains also a PY motif
(LPXY) in the C-terminus which acts as a docking site for the Ubiquitin ligase Nedd4-2. It is
proposed that the interaction of Nedd4-2 to NaV1.8 promotes its removal from the membrane
and proteasomal degradation (Fotia et al., 2004). More recently, it has been found that NaV1.8
contains an endoplasmic reticulum (ER) retention motif RXR (495RRR497) in the first
intracellular loop. It is thought that the β3 sub-unit participates in the forward trafficking of
the channel by binding to this motif. The binding event would mask the retention motif and
promotes the translocation of NaV1.8 to the membrane (Zhang et al., 2008). Furthermore,
33
transmembrane segments from each domain act as retention signal in the ER, and the
association of transmembrane acidic residues with Calnexin determines the recruitment of
NaV1.8 into the endocytic pathway, leading to decreased membrane expression (Li et al.,
2010). A β3 sub-unit independent mechanism has also been described. It has been
demonstrated that PGE2 directly promotes surface expression of NaV1.8 in a dose-dependent
manner and that it is dependent of the PKA phosphorylation on the first intracellular loop (Liu
et al., 2010).
The studies presented above have shed light on the dynamics regulating NaV1.8 trafficking
(Swanwick et al., 2010c). Nevertheless, NaV1.8 precise sub-cellular localisation remains
obscure. Indeed, evidence suggests NaV1.8 presence along the axons (Gold et al., 2003),
peripheral terminals (Black and Waxman, 2002; Brock et al., 1998; Persson et al., 2010) and
dorsal horn afferent endings (Amaya et al., 2000) but the exact sub-cellular distribution of this
channel in vivo and in vitro has not yet been thoroughly investigated. Neuronal excitability is
shaped by the cohort of ion channels expressed and by their localisation within the neurons.
The knowledge of where NaV1.8 is localised within nociceptors would open new perspectives
in the comprehension of the excitability of these cell.
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1.4 Voltage gated sodium channel β sub-units
VGSCs β sub-units are single transmembrane proteins with a V-set immunoglobulin loop in
their extracellular domain, homologous to neuronal cell adhesion molecules (NCAM). Four
genes have been identified coding for the isoforms NaVβ1-4, with an approximate molecular
weight of 36 kDa. NaVβ1-3 associate with the α sub-unit non-covalently, while NaVβ2-4 are
covalently bridged through a disulfide bond. The site of interaction with the α sub-unit has
been proposed to be in the extracellular portion. The IgG loop seems to be important for the
binding to other proteins of the extracellular matrix (Tenascin-C-R, Neurofascin, NrCAM) or
other transmembrane proteins exposed by adjacent cells (Cusdin et al., 2008). β sub-units
regulate cell adhesion, trafficking and are required to express the full native
electrophysiological properties of the α sub-unit. These effects depend on many factors
including, isoform specificity, cellular background, developmental stage (Isom, 2001). With
regards to NaV1.8, it has been found that β3 sub-unit promotes trafficking of the channel
towards the membrane, by masking an ER retention motif present on NaV1.8 (Zhang et al.,
2008). Interestingly, β3 sub-unit is up-regulated in small diameter neurons upon nerve
axotomy (Takahashi et al., 2003), CCI (Shah et al., 2000) and, in medium size neurons, in
diabetic neuropathy models (Shah et al., 2001). Thus, the β3 sub-unit mediated NaV1.8 release
from the ER could also account for increased excitability in pain states due to additional NaV1.8
being transported to the cell membrane. In heterologous system it has been found that β sub-
units and their specific combination have an effect on the electrophysiological properties of
NaV1.8. In particular, β1 alone or in combination with other β sub-units determines an increase
in TTX-r current amplitudes, accelerates the kinetics of decay, and negatively shifts the steady-
state curves. On the other hand β2, alone and in combination with β1, shifts the steady-state
inactivation curve to more depolarized potentials (Vijayaragavan et al., 2004b). It has been
reported that in Xenopus oocytes β3 caused a hyperpolarizing shift in the threshold of
activation of NaV1.8, and a threefold increase in the peak current amplitude when compared
with NaV1.8 expressed alone (Shah et al., 2000).
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1.5 Lipid rafts
1.5.1 Lipid rafts: a historical overview.
Originally cellular membranes were described as a two dimensional fluid mosaic where all
lipids and proteins  randomly diffuse (Singer and Nicolson, 1972). This model has been
extensively developed over the decades. To date, the current vision describes the cellular
membrane as a heterogeneous environment, characterized by a lateral organization, with a
liquid disordered (Ld) phase and a liquid ordered (Lo) phase, which differ in the composition of
lipids and proteins, in the extent of lipids packing, degree of order and mobility of the
constituents. The domains of the plasma-membrane characterized by Lo phase are called lipid
rafts (Coskun and Simons, 2010). The existence of lipid rafts was proposed following the
observation that in polarized epithelial cells the apical and basolateral portions of the
membrane exhibit marked differences in terms of lipid species, particularly with
glycosphingolipids highly enriched in the apical portion (van Meer and Simons, 1988). The first
definition of rafts was suggested after the discovery that GPI-anchored proteins, confined in
the apical membrane, could be recovered from the portion of membrane that was not lysed by
non-ionic detergents at 4°C. This detergent-resistant membrane (DRM) was found to be
enriched with glycosphingolipids and excluded proteins from the basolateral membrane
(Brown and Rose, 1992). Concomitant with this, it was discovered that the physical base of the
lipid Lo phase and resistance of these domains to lysis is the abundance of sphingolipids (with
saturated fatty acid chains) and cholesterol (Schroeder et al., 1994). Since then the scientific
interest towards lipid rafts has been constantly growing, as more than 3500 publications
demonstrate, and the features of these domains have been analysed in details. To date, lipid
rafts are defined as “dynamic, nanoscale, sterol–sphingolipids enriched, ordered assemblies of
proteins and lipids, in which the metastable raft resting state can be stimulated to coalesce
into larger, more stable raft domains by specific lipid–lipid, protein–lipid and protein–protein
oligomerising interactions” (Coskun and Simons, 2010; Pike, 2006; Simons and Gerl, 2010).
1.5.2 Lipid rafts: lipid content and Lo phase.
Lipid rafts are highly enriched in phospholipids with saturated fatty acid chains, sphingolipids,
and cholesterol. A lipid analysis of rafts has revealed that cholesterol and sphingolipids are five
times more concentrated in rafts than in the bulk membrane. Rafts also contain more
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glycosphingolipids, such as cerebrosides and gangliosides. On the other hand,
glycerophospholipids, including the major membrane phospholipids, phosphatidylcholine and
phosphatidylethanolamine, comprise less than 30 % of raft lipids (compared to approximately
60 % in non raft membranes) (Pike, 2003, 2004). Membrane lipids are amphipathic molecules,
meaning that they contain one hydrophilic and one hydrophobic moiety. Glycerophospholipids
are glycerol based phospholipids. The hydrophilic head comprises the phosphate group with its
negative charges plus the substituent (which may be polar) and faces the intracellular and
extracellular side of the cells. The hydrophobic portion contains diacylglycerol, with saturated
and/or unsaturated (one or more C=C bond) acid chains of various lengths. Sphingolipids
derive from the amino-alcohol sphingosine. Usually sphingosine is linked to an acyl group, like
a saturated fatty acid (ceramide). Differently from glycerophospholipids, sphingolipids have
longer and fully saturated fatty acid chains. According to the nature of the polar head,
sphingolipids can be classified into different sub-groups. Sphingomyelin has a phosphocholine
group, glycosphingolipids have sugar group/s and gangliosides are glycosphingolipids with
terminal sialic acids. Cholesterol is the most abundant non polar lipid on the cell membrane. It
is characterized by a rigid hydrophobic planar structure and a hydrophilic hydroxyl group (Fig.
1.6) (van Meer et al., 2008).
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Figure 1.6) Membrane lipids. The figure shows a schematic representation of membrane
lipids, and their name according to the different substituents, plus the structure of
phosphatidylcholine, sphingomyelin, glycosphingolipids and cholesterol. Adapted from Fantini
et al. 2000.
According to physical studies on membrane lipids, mixtures of lipids can adopt different
phases: gel like (Lg), Ld and Lo. The Lg and Ld phase represent the two extremes of a spectrum of
possible conformations. In the Lg phase lipids are in a crystalline solid state while in the Ld
phase lipids exist in a fluid state (Hancock, 2006). The Lgdoes not exist in biological membranes
(Veatch, 2008) and the bulk membrane is in the Ld phase. The Lo phase represents an
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intermediate state, which co-exists in live cells with the Ld phase, and is characteristic of lipid
rafts (Ahmed et al., 1997). The co-existence of different lipid phases and the ability of rafts to
cluster at physiological temperatures was clearly demonstrated in plasma membrane spheres
by Lingwood et al. (Lingwood et al., 2008). The parameters that describe the phase of
membrane lipids are the configurational order (trans vs. gauche isomerisation of the C-C bonds
in the acyl chains), translational order (the position of a lipid in the by-layer, e.g. lateral
motility) and rotational order (rotation of a lipid around its axis, perpendicular to the plane of
the membrane). It has been estimated that rafts have a high configurational order (high
trans/gauche ratio), similar to the Lg phase. Compared to the Ld, the Lo rafts have a moderately
higher translational order, with the translational diffusion coefficient estimated to be two
times lower (in the order of 10-8 cm2/sec, compared to 10-11 cm2/sec of the Lg phase) (Simons
and Vaz, 2004).
The high abundance of sphingolipids and cholesterol in lipid rafts is at the base of their Lo
phase. These molecules work in concert and determine the physical properties of rafts. In fact,
sphingolipids, compared to the unsaturated chains of glycerophospholipids enriched in the
bulk membrane, have long saturated acyl chains that interact through hydrophobic interaction
and allow tight packing of the lipids in rafts. In addition, sphingolipids differ from
glycerophospholipids because they have both donor (the hydroxyl group) and acceptor groups
(the amide group) in the polar heads which can be engaged in H-bonds (Rietveld and Simons,
1998). Glycosphingolipids can extend the formation of H-bonds also to their sugar residues
(Brown, 1998). These features allow an extensive network of H-bonds which stabilizes the
sphingolipids aggregates. Cholesterol preferentially intercalates with its planar sterol plane
between the saturated long chains of sphingolipids, rather than between the unsaturated
phospholipids with kinks in their chains. Because of its intercalating activity it further promotes
the Lo phase by constraining the fatty acid chains of neighbouring sphingolipids in a trans
(linear) conformation. Also, it impedes the formation of Lg phase (van der Goot and Harder,
2001). When cholesterol is embedded within the sphingolipids it is partially shielded from the
extracellular environment by the polar heads of the sphingolipids and is thought to interact
with these through an H-bond, between its hydroxyl group and sphingolipids’ amide group
(Cebecauer et al., 2009; Simons and Vaz, 2004).
The combined effect of sphingolipids and cholesterol enrichment in rafts is that these domains
are thicker, more densely packed and less fluid than the bulk membrane. These physical
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features confer lipid rafts the ability to resist to non-ionic detergent lysis at 4°C. In fact it is
proposed that in this condition the lipid-lipid interaction is stronger than the lipid-detergent
interaction, therefore the creation of lipid-detergent micelles is energetically unfavourable
(Brown and Rose, 1992; London and Brown, 2000). Lipid rafts yields to DRMs upon lysis with a
detergent. DRMs, because of their high lipid-protein ratio and low density, can be separated
from the rest of solubilised membranes by floatation on a sucrose density gradient, after
detergent extraction. Detergent extraction has become the gold standard to purify them and
to test if a protein is raft or non raft associated.
1.5.3 Lipid rafts: biological roles.
Lipid rafts have been traditionally investigated in epithelial and immune cells; concomitant
with the growing body of evidence showing that rafts are implicated in many biological roles,
more cell types have been investigated. We shall concentrate our introduction on neuronal
cells, since the focus of this thesis is on this cell type. Lipid rafts have been implicated in many
biological processes; the core role of rafts is to act as hubs on the cellular membrane where
proteins can be sorted and functionally localized. In other words, rafts tune the spatial and
temporal organization of proteins on the membrane. Rafts have been proposed to exert their
function via multiple ways, which can overlap. In particular, rafts have been shown to 1)
facilitate/impede the association of protein involved in given signaling pathways, 2) allow the
formation and/or stabilization of protein clusters on the neuronal membrane, 3) act as sorting
signals for cellular trafficking, regulating both forward trafficking and endocytosis rate, 4)
modify the intrinsic properties of certain proteins (e.g. electrophysiological features of ion
channels) (Allen et al., 2007; Golub et al., 2004). For the purpose of this introduction, examples
of how rafts modulate neuronal functions will be described.
1.5.4 Lipid rafts and cell signaling.
With regards to the nervous system, rafts have been implicated in the modulation of cell
signaling. A notable example to show how rafts laterally modulate cell signaling by allowing
interactions between partner proteins is given by RET signaling. GDNF binds to RET and to GPI
anchored co-receptor GFRα1. It has been discovered that RET associates with raft upon GDNF
binding, and that raft associated GFRα1 is responsible for this translocation. Notably, this
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dynamic association between RET and rafts is physiologically important. In fact, mis-targeting
of RET, due to the presence of modified GFRα1 (soluble or transmembrane anchored forms) or
raft disruption by cholesterol depletion, abolishes intracellular signaling without affecting the
formation of the GDNF-RET-GFRα1 complex. It has been proposed that the detrimental effect
of non-raft targeting of RET is due to the lack of association between RET and raft associated
effectors, such as Src and PI3K kinases. The absence of association between RET and rafts is
reflected in ineffective neuronal differentiation and survival (Tansey et al., 2000). Another
group further explored the importance of rafts in GDNF signaling. RET shuttling between raft
and non raft portions determines how different intracellular pathways are recruited. In non
raft portions RET associates with SHC while in rafts it associates with raft associated FRS2
(Paratcha et al., 2001). These studies exemplify how rafts can influence cellular signaling by
spatially organising different proteins. Also, NGF receptor p75NTR translocates to lipid rafts
upon phosphorylation. It has been found that, in neurons not expressing TrkA, NGF promotes
p75NTRmediated PKA intracellular activation. PKA in turn, phosphorylate p75NTR determining its
recruitment to lipid rafts. In these microdomains p75NTR inactivates raft resident Rho (Higuchi
et al., 2003). Lipid rafts are also necessary for NCAM mediated neurite outgrowth. Disruption
of NCAM association with rafts, by mutating its palmitoylation domain or by depleting
cholesterol which leads to raft disassembly, abolishes the activation of NCAM target kinases
and completely blocks neurite outgrowth (Niethammer et al., 2002). Related to studies
focusing on pain, there is an interesting study showing that rafts are involved in pain pathways
in vivo. It was found that PGE2 induced hyperalgesia is mediated by Integrin sub-units α1, α3,
β1 while epinephrine induced hyperalgesia depends on α5, β1. α1 Integrin sub-unit is found in
lipid rafts in vivo, and raft disruption reduced PGE2 induced mechanical hyperalgesia, without
affecting epinephrine mediated hypersensitivity. The authors propose that lipid rafts play an
essential role in facilitating the interaction of Integrins with second messenger elements
(Adenylyl cyclase/cAMP/PKA) that mediate PGE2 induced hyperalgesia (Dina et al., 2005).
Apart from these examples, many other signaling pathways are modulated by rafts and include
immune synapse formation and T-cells activation (Luo et al., 2008; Magee et al., 2002), IgE-
FcεRI signaling (Sheets et al., 1999), and eNOS signaling (Patel and Insel, 2009). The common
scheme is that receptors in rafts may behave in three ways: 1) receptor is stably associated
with rafts and ligand activates the receptor in rafts, 2) individual receptors with weak raft
affinity could oligomerise on ligand binding, and this would lead to an increased residency time
in rafts, 3) activated receptors could recruit proteins residing in different rafts and promote
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protein cross-linking and raft coalescence. The formation of large stable rafts would allow the
concentration of signaling proteins (and exclusion of not related proteins) (Simons and
Toomre, 2000). Rafts also regulate cell processes on a spatial scale. Proteins regulating cell
adhesion, axonal extension and cell motility are found to be raft associated and their activity is
tuned by such association. For example, Integrin signaling relates to raft distribution and to
small GTP-binding protein Rac activity. It was demonstrated that Integrin engagement leads to
the accumulation of rafts at the cell surface, which determines cell polarisation and
stabilisation of Rac within lipid rafts on the cell membrane. Furthermore, in the absence of
surface rafts, Rac fails  to  associate  with  the  plasma  membrane  and  to activate  the
downstream   effector  of  Integrins  FAK (del Pozo et al., 2004). It is also proposed that small
rafts, upon certain signals, coalesce into larger and more stable platforms. The functional
meaning of this clustering is to promote/enhance cell signaling by bringing in close vicinity
partners proteins. In addition, larger rafts would provide a signal on the membrane to polarise
the cell and to feed-back protein/raft clustering (Golub et al., 2004). A remarkable example is
given by the polarised distribution of receptors/rafts in the growth cone of axons, which is at
the base of chemotaxis. Guirland et al. showed that rafts selectively mediate the growth cone
guidance (but not growth cone outgrowth) in concert with BDNF, Netrin-1 and Sema3A. Upon
presentation of the chemical stimuli rafts and rafts-associated protein asymmetrically
distribute and polarise the growth cone, posing the base for axon steering (Guirland et al.,
2004). Lipid raft domains also spatially organize specific G proteins on the membrane. This
regulated partitioning between lipid rafts and bulk membrane could facilitate or prevent G
proteins interactions with their receptors and/or effectors, resulting in either the abolition or
the promotion of cell signaling. It has been found that  G proteins can be stably associated with
rafts or undergo a stimulus-dependent segregation (Allen et al., 2007).
1.5.5 Lipid rafts and protein clustering.
Lipid rafts are important for efficient clustering of several classes of proteins. It has been found
that lipid rafts are necessary for the efficient clustering of Acetylcholine Receptors (AChRs) at
the level of the neuromuscular junction. Motor nerves trigger muscle contraction through the
neuromuscular junction, a specialised synapse which connects neurons and skeletal muscles.
AChRs bind to endogenous acetylcholine and allow movement of cations, which depolarise the
post-synaptic cells. AChRs determine an excitatory post-synaptic potential in neurons and a
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muscle contraction in the case of myofibres. A hallmark of the neuromuscular junction is the
clustering of AChRs in the post-synaptic membrane, which is needed for the correct
functioning of the synapses. Lipid rafts play a role in clustering the AChRs. It has been found
that lipid rafts act as a platform that allows the dynamic molecular interactions between
AChRs and their binding partners (Pato et al., 2008; Zhu et al., 2006). Pato and others
proposed that AChR is targeted to micro-rafts on the cell surface with MuSK, a tyrosine kinase
receptor, and binding to Agrin, a large extracellular proteoglycan, leads to MuSK
phosphorylation. Activated micro-rafts subsequently recruit downstream MuSK effector Cdc42
as well as the Actin-nucleation factors N-WASP and Arp2/3. The activation of these factors
drives the coalescence of micro-rafts, via Actin-based movements, and leads to the formation
of stable AChR macro-clusters. Importantly, integrity of rafts is crucial for the maintenance of
AChR clusters (Willmann et al., 2006). Rafts also participate in the clustering of AChRs in
neuronal somatic spines, as in ciliary neurons (Bruses et al., 2001). It has also been found that
hippocampal neurons contain lipid rafts in the dendritic tree and they are crucial for a normal
morphology and for the maintenance of the correct number of dendritic spines. In addition, a
portion of AMPA receptors localises in these domains, and the stability of rafts is important for
the stabilisation of AMPA receptor clusters on the membrane. In fact lipid raft depletion leads
to a reduction of AMPA receptor molecules on the membrane (Hering et al., 2003).
Interestingly, a few studies have also shed light on a potential role for lipid rafts in the
stabilisation of potassium channels at the paranodes along myelinated axons in vivo. The
paranodes flank the nodes of Ranvier and are rich with clustered Shaker type potassium
channels. A complex feedback between glial cells and neurons is the key for the development
of the correct morphology of nodes and paranodes (Poliak and Peles, 2003) and lipid rafts are
thought to participate in the maintenance of such structures (Schafer et al., 2004). It has been
revealed, for example, that many paranode-associated proteins are clustered with lipid rafts in
this region (Ogawa and Rasband, 2009). In addition, the paranodal junctions in mice lacking the
β1, 4-N-acetylgalactosaminyltransferase, a key enzyme in the synthesis of gangliosides, have
an altered composition of lipid rafts, display an abnormal morphology and mislocalisation of
Kv1.2 (Susuki et al., 2007).
43
1.5.6 Lipid rafts and membrane excitability.
Lipid rafts have been shown to shape neuronal excitability. Ion channels, which determine the
cell’s electric properties, have been demonstrated to partition into lipid rafts. The effect of
rafts on membrane excitability is mediated by their influence on proteins trafficking and/or on
the intrinsic electrophysiological properties of the ion channels themselves (Pristera and
Okuse, 2011). Proteins from different classes have been described to reside in lipid rafts. For
example, Sodium/Potassium-ATPase pump, which plays the main role in setting the resting
membrane potential, is distributed in clusters on the cell membrane of cerebellar granule cells.
It also partitions in Brij-98 detergent-resistant membranes suggesting that it is localised in lipid
rafts. The physiological meaning of the association between Sodium/Potassium-ATPase pumps
and lipid rafts has not yet been investigated (Dalskov et al., 2005). Although the precise rafts
targeting mechanism of the Sodium/Potassium-ATPase pumps is unknown, the authors
speculated that the pumps themselves recruit the surrounding membrane lipids and thus
function as a core for rafts formation. Hartmann et al. provided a good example of how rafts
modulate ion channel trafficking and contribute to determine cell excitability. Chloride co-
transporters Potassium-Chloride (KCC2) and Sodium-Potassium-2Chloride (NKCC1) regulate
Chloride concentration across the plasma membrane (Delpire, 2000). KCC2 and NKCC1 show
different patterns of raft association in mature brain neurons: NKCC1 is enriched in lipid rafts
while KCC2 is distributed both in lipid rafts and in the non-lipid raft fractions. This dual
segregation seems to have a functional role as disruption of lipid rafts alters the transport
activity of these proteins. In fact, raft disruption has opposite effects on the transporters, with
KCC2 being potentiated and NKCC1 becoming less active. Raft disassembly also leads to a re-
distribution of the transporters into larger clusters at the level of the plasma membrane
(Hartmann et al., 2009). This study clearly shows how protein function can be modulated by
sorting the proteins between the lipid raft microdomains and the bulk membrane. In addition,
another study demonstrated that KCC2 associates with lipid rafts in clusters in hippocampal
neurons and that this association appears to be dependent on the integrity of lipid rafts and on
the phosphorylation of KCC2, which occurs at Tyr-1087 (Watanabe et al., 2009). Several ligand
gated ion channels have been found in neuronal lipid rafts. A few studies have demonstrated
the role of the association of NMDA receptors with lipid rafts, and how this association is
dynamically regulated. The partition of NMDA receptors between the post synaptic density
and lipid rafts has been found to be developmentally regulated in the brain: the amount of
both NR2A and NR2B subunits increases postnatally (during the first three weeks), with NR2A
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rapidly associating with lipid rafts after birth and with NR2B gradually being transported to
lipid rafts over three weeks (Besshoh et al., 2007). Interestingly, the partitioning of NMDA
receptors is regulated during memory formation as shown by Delint-Ramirez et al., who
demonstrated that NR1, NR2A and NR2B subunits quickly move to lipid rafts during the
learning of a spatial task (Delint-Ramirez et al., 2008). It is proposed that NMDA receptors
trafficking between the post-synaptic density and lipid rafts may be mediated by the
association between the intracellular portion of NR2 subunits and the scaffolding protein PSD-
95, which contains the PDZ domain (Delint-Ramirez et al., 2010). AMPA receptors have also
been described to associate with rafts and a few groups have highlighted a role for lipid rafts in
AMPA receptor functional sorting. Hippocampal neurons contain lipid rafts in the dendritic
tree and a portion of AMPA receptors localises in these domains. Importantly, the stability of
rafts is crucial for the stabilisation of AMPA receptor clusters on the membrane. In fact, lipid
raft disruption determines a reduction of AMPA receptor molecules on the membrane, both in
basal and AMPA stimulated neurons, due to their engagement into the endocytic pathway
(Hering et al., 2003). Hou at al. found that AMPA receptors association with rafts is modulated
by NMDA receptors. This finding provides a regulatory loop between the two receptors, which
segregate to lipid rafts. When NMDA receptors are activated, more AMPA receptors are
trafficked to the lipid rafts and this effect is mediated by the nitric oxide synthase pathway.
The integrity of lipid rafts is important for the correct insertion of the AMPA receptors into the
membrane. Indeed this group showed that lipid raft disruption reduces the amount of AMPA
receptors on the membrane; In contrast to the other study, this effect was found to be
determined by a reduction in the rate of translocation of the molecules to the membrane,
rather than an increased rate of endocytosis (Hou et al., 2008). Of particular interest for pain
pathways, there is the evidence that serotonin receptor 5-HT3, P2X3, ASIC, TrpV1 and TrpM8
partition into rafts. Serotonin receptor 5-HT3 is widely distributed in the nervous system
(Barnes et al., 2009) and when expressed in a heterologous system it is trafficked to lipid rafts
(Eisensamer et al., 2005). This association has been demonstrated to regulate the receptor’s
activity. Indeed, cholesterol depletion and raft disruption leads to reduction of the serotonin
induced currents and to an alteration of the channel’s kinetics. Interestingly, raft disruption
only alters the native properties of the channel, and leaves serotonin-mediated currents
unaffected in the presence of antidepressant drugs (Nothdurfter et al., 2010).  P2X3 is a
nucleotide gated ion channel expressed in primary sensory neurons where it is thought to
sense tissue damage, by binding to Adenosine-5'-triphosphate (ATP) released by
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necrotic/apoptotic cells. Its association with rafts has been analysed in different tissues and
cell types, and P2X3 has been shown to partition into raft domains in cerebellar granule
neurons and DRG neurons, but the biological meaning of this partition is yet to be determined
(Vacca et al., 2004). ASIC3 is a cation channel gated by low pH, and localises at nerve terminals
where it is thought to act as a transducer of acidosis. It has been implicated in pain perception
and may play a role in mechanosensation (Alvarez de la Rosa et al., 2002). It has been found
that both ASIC3 and PSD-95 associate with lipid rafts, and either the disruption of rafts or the
mistargeting of PSD-95, by mutating its palmitoylation domain, alters the properties of ASIC3
(Eshcol et al., 2008). TrpV1 is expressed in the peripheral nervous system in DRG and
trigeminal ganglia. It is a polymodal receptor involved in the transduction of noxious heat and
can be activated by the endogenous lipid anandamide, pH lower than 5.9 and capsaicin, the
component that confers chilli peppers their hot taste. Interestingly, it has been found that in
DRG neurons cholesterol, an essential component of lipid rafts, is needed for the correct
functioning and trafficking of the channel. Cholesterol depleted DRG neurons display less
TrpV1 trafficked to the membrane and both capsaicin and protons evoke smaller currents,
when compared to control neurons (Liu et al., 2006). The functional interaction between
TrpV1 and lipid rafts has been further investigated in trigeminal ganglia neurons. In these cells,
upon raft depletion, capsaicin induced calcium fluxes were markedly reduced, when compared
to untreated trigeminal ganglia neurons (Szoke et al., 2010). TrpM8, like TrpV1, contributes to
the transduction of thermal stimuli. TrpM8, unlike TrpV1, shows higher ion permeability at
temperatures lower than 25°C and is activated by substances like menthol and icilin, which
produce a sensation of cold. TrpM8 also associates with and is modulated by lipid rafts. In
particular, TrpM8 co-segregate with Flotillin-1 in the lipid raft fractions of mouse DRG and HEK
cells. Lipid raft disruption increases the responsiveness of TrpM8 to menthol and cooling
stimuli, suggesting that lipid rafts have an inhibitory role towards this channel. Interestingly
the trafficking of the channel is unaffected in cholesterol depleted cells, suggesting the lipid
rafts directly modulate the gating properties of the channel rather than its amount on the
membrane. In fact, when the electrophysiological properties of the channel in raft depleted
cells were analysed it was found that TrpM8 temperature activation threshold was shifted to
warmer temperatures, and the voltage dependence of activation shifted to a less positive
value (Morenilla-Palao et al., 2009). Members of the voltage gated potassium channels are
also raft associated. KV2.1 is expressed in the brain and localises preferentially to the dendritic
compartment of neurons (Lim et al., 2000). KV2.1 is mostly associated with planar lipid rafts
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and rafts directly modulate its electrophysiological features. Depletion of membrane
cholesterol disrupts KV2.1-raft association and shifts its steady state inactivation curve towards
more hyperpolarised values without altering its current density and activation kinetics
(Martens et al., 2000). It has been proposed that the Kv2.1-raft complex facilitates the
interaction between Kv2.1 and signaling molecules such as kinases. The authors also
conjectured that the transmembrane regions of Kv2.1 may contain the information that
determines lipid rafts association per se (Scheiffele et al., 1997). In another report, Kv1.4 and
Kv4.2 were examined. The former is localised in axons and contribute to action potential
repolarisation (Debanne et al., 1997), while the latter is confined to the soma and dendrites
where it contributes to set the excitability of the postsynaptic compartments (Hoffman and
Johnston, 1998). Kv1.4, Kv4.2 and the scaffolding protein PSD-95 were all found in lipid rafts in
rat brain membranes. Although both channels (in a heterologous system) have the ability to
traffic to lipid rafts in the absence of PSD-95, co-expression of PSD-95 further promoted
forward trafficking of Kv1.4 and its association with lipid rafts but it did not affect the
trafficking of Kv4.2. In addition, the PDZ binding motif present in both channels seems to play a
key role in the channel trafficking, since its deletion leads to a robust decrease in rafts
association (Wong and Schlichter, 2004).
1.5.7 Lipid raft targeting mechanisms.
Several mechanisms have been shown to determine raft targeting (Brown, 2006; Levental et
al., 2010) (Fig. 1.7). Proteins can be targeted to rafts by directly binding cholesterol, which is
highly enriched in these microdomains. The most notable case is given by the Caveolin group,
which directly binds cholesterol buried in the plasma membrane and promotes the formation
of caveola-type lipid rafts (Parton and Simons, 2007). Proteins in the extracellular side usually
bind to raft domains by a glycophosphatidylinositol (GPI) anchor. GPI is post-translationally
attached to the C-terminus of proteins and consists of an oligosaccharide core with a
phosphatidylinositol group, with the latter carrying two saturated fatty acid chains that
intercalates the sphingolipids present in rafts (Michael AJ Ferguson, 2009). Proteins targeting
rafts via GPI include receptors GFRα1, adhesion protein NCAM-120, Thy-1 and F3/Contactin
(Tsui-Pierchala et al., 2002). Intracellular proteins target rafts by the addition of fatty acid
moieties to the peptide chain; in fact, it is believed that the addition of saturated fatty acid
chains increases the affinity of the proteins carrying such modification for the Lo environment.
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The most common modifications are palmitoylation and N-myristoylation. Palmitoylation is the
reversible post-translational addition of palmitate to Cysteine residues, while myristoylation is
a co-translational irreversible addition of a myristate to the N-terminus (Bijlmakers and Marsh,
2003; Boutin, 1997). Proteins targeting rafts via these motifs include lipid rafts marker
Flotillins, Src-family protein kinases (Fyn, Lck, Lyn), MAP kinases, RAS family of small GTPase
and G proteins (Tsui-Pierchala et al., 2002). On the other hand, acylation with unsaturated
fatty acid chain (e.g. farnesylation) most likely determines a non-raft association (Levental et
al., 2010). Proteins can also directly bind rafts without fatty acid modifications. The most
notable example is transmembrane protein Haemagglutinin (HA). It was reported that amino
acidic residues in the transmembrane segment were sufficient to target HA to rafts (Takeda et
al., 2003). Some proteins are targeted to rafts in an indirect way, by binding to proteins that
reside in rafts (Pike, 2004). The mechanisms described above have been found to promote raft
partitioning, but they may not be sufficient for this process, pointing to the fact that other
factors may contribute to traffic proteins to lipid rafts.
Figure 1.7) Lipid rafts and raft targeting signals. The figure shows a schematic representation
of a lipid raft platform, with proteins partitioning to this domain through different ways. Non
raft portion of the membrane and non raft protein are also shown. L0 = Liquid ordered, Ld =
Liquid disordered.
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1.6 Aims
Our hypothesis is that lipid rafts may act as platforms in the cell membrane of primary sensory
neurons where NaV1.8 can be trafficked and functionally expressed.
The aims of this study are to:
1) Investigate the sub-cellular localisation of NaV1.8 in DRG neurons.
2) Investigate the association between NaV1.8 and lipid rafts.
3) Investigate the association between NaV1.8 and other proteins (raft markers and proteins
involved in pain pathways).
4) Interfere with raft integrity and to explore the functional meaning of the association
between NaV1.8 and lipid rafts.
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Chapter 2: Investigation of the sub-cellular
localisation of NaV1.8 and its association
with lipid rafts in DRG neurons
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2.1 Introduction
2.1.1 Synopsis.
The methodology to study lipid rafts and the proteins that we have investigated together with
NaV1.8 in our study will be introduced in the introduction of this chapter.  NaV1.8 partitioning
into lipid rafts and its relationship with other molecules will be described and discussed. In the
general introduction we have highlighted the known mechanisms and unknown issues about
NaV1.8 trafficking and cellular distribution (See section 1.3.4). In the present chapter the
results focusing on NaV1.8 sub-cellular localisation will be also presented and discussed.
2.1.2 Lipid raft methods of study.
Detergent extraction, combined with ultracentrifugation in a density gradient, is the most
widely used technique to study lipid rafts and raft associated proteins (Allen et al., 2007;
Coskun and Simons, 2010; Golub et al., 2004; Hancock, 2006; Simons and Ikonen, 1997; Simons
and Toomre, 2000). Lipid rafts, due to their physical properties, can be extracted from the bulk
membrane with non-ionic detergent (e.g. TritonX-100) at 4°C. Usually, the cells or tissue of
interest are lysed with a non-ionic detergent in the cold; since rafts are resistant to lysis,
compared to the bulk membrane, they are spared from the detergent action. Therefore, the
membranes obtained with this method are defined detergent resistant membranes (DRMs). To
separate DRMs from the lysed membranes a gradient ultracentrifugation is carried out. DRMs,
because of their light density, float away from the solubilised portion and can be recovered
from the top of the density gradient. The recovered fraction can be analysed by western
blotting to determine if the protein of interest partitions or not with lipid rafts. Even though
detergent extraction is the gold standard to study raft association caution must be taken when
interpreting the results. The lipid and protein analysis carried on DRMs strongly suggests that
this fraction represents lipid rafts on live cells (Brown and Rose, 1992; Schroeder et al., 1994;
Simons and Gerl, 2010). Nevertheless, reports show that potential artefacts due to detergent
extraction could lead to misinterpretation of protein-raft association. In fact, weak raft
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associations could be disrupted by the detergent extraction. Also, the notion that different
detergents may lead, for certain proteins, to equivocal results supports the hypothesis that
rafts are heterogeneous (Pike, 2004), but also does not rule out that detergent-dependent
artifacts could be created (Magee and Parmryd, 2003). This evidence led during the early
period of the lipid raft field to mixed results and inconsistencies. Another point of strong
debate was the inability to visualise intact small rafts in live cells. The small size and the
dynamic nature of small rafts were proposed to be in the range of 20-50 nm. This size is below
the detection limit of light microscopy (200 nm) which is determined by light diffraction (Shaw,
2006). Also, the mechanisms of raft biosynthesis were not investigated and they are still not
fully understood. The current view proposes that rafts are most abundant on the plasma
membrane and they may originate in the late Golgi network, where the enzymes to synthesise
sphingolipids are present. The absence of cholesterol in the ER, and its gradual enrichment
along the exocytosis pathway support this hypothesis (Simons and Toomre, 2000; van Meer et
al., 2008). Another unclear aspect is how the outer leaflet of rafts (enriched in sphingolipids
and cholesterol) communicates with the inner leaflet (enriched in cholesterol but lacking
sphingolipids). It has been proposed that the long chains of the sphingolipids in the outer
leaflet interdigitate with the inner part and bridge the two components; also, transmembrane
proteins are hypothesised to serve communication between inner and outer leaflet.
Nevertheless, strong experimental data supporting this hypothesis are still missing (Munro,
2003). These initial uncertainties and a technical impasse, led to controversies in the raft field.
With the introduction of new methods of study, apart from the detergent extraction, and the
development of powerful imaging techniques more features about the detailed nature of lipid
rafts have been explained and all the initial uncertainties have been challenged. A fundamental
advantage in the study of lipid rafts was the discovery that cross-linking of the small highly
dynamic rafts leads to their patching and direct visualisation (Hammond et al., 2005; Owen et
al., 2007). Both protein patching (Friedrichson and Kurzchalia, 1998; Harder et al., 1998) and
lipid patching (Janes et al., 1999) have been demonstrated to determine raft coalescence in
live cells. This method gives the advantage of analysing, by microscopy based techniques, the
degree of association between rafts and the protein of interest, over the limit of microscopy
resolution. Also, it gives important information on the spatial distribution of rafts and proteins.
Notably, this process is known to be of physiological relevance in nature. In fact, in activated T-
cells small dynamic rafts are clustered into an ordered stable platform, which is necessary for
the correct cell signaling and creation of the immunological synapse (Harder and Sangani,
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2009; Kabouridis, 2006). Also, the clustering of AchR at the neuro-muscular junction is
mediated by the coalescence of small rafts into a stable platform (Pato et al., 2008).
Furthermore, stimulation of EphrinB1 leads to the formation of large raft-patches that are
thought to act as multiprotein signaling platform downstream of EphrinB1 (Bruckner et al.,
1999). It has also been described that rafts coalesce during HIV-virus budding from the host
cells (Fantini et al., 2002; Simons and Gerl, 2010). Recent studies, by exploiting cutting edge
microscopy techniques, have revealed rafts existence in live cells (Day and Kenworthy, 2009;
Duggan et al., 2008). These techniques involve Förster (fluorescence) resonance energy
transfer (FRET) (Varma and Mayor, 1998), fluorescence lifetime imaging (FLIM) (Hofman et al.,
2009; Hofman et al., 2008), Atomic force microscopy (AFM) (Nicolini et al., 2006; Yuan et al.,
2002), fluorescence correlation spectroscopy (FCS) (Bacia et al., 2004; Lasserre et al., 2008),
stimulated emission depletion (STED) (Eggeling et al., 2009), far-field fluorescence nanoscopy,
single molecule tracking (Drbal et al., 2007) super resolution microscopy (van Zanten et al.,
2009) and electron microscopy (Prior et al., 2003). The common feature of these techniques is
that they overcome the resolution limit set by the physic nature of light and allow investigation
of rafts at a molecular level. Another way to assess lipid rafts’ nature in live cells is to combine
microscopy with fluorescent probes, whose spectral properties are dependent on the
surrounding lipid phase. LAURDAN (6-acyl-2-dimethylamino-napthalene) represents the classic
dye used for this purpose. LAURDAN is a ratiometric dye which shows a 50 nm blue shift of its
emission spectra upon the transition between Ld to Lo phase. This behaviour has been
attributed to differential penetrability of water molecules in the lipid phases, which affects the
dissipation of energy from excited LAURDAN and its emission spectra (Gaus et al., 2006). By
using LAURDAN it was found, for example, that phase separation of lipids occurs in live cells
and that cholesterol dependent Lo domains are enriched in the filopodia of macrophages,
positive for raft marker Caveolin-1 (Gaus et al., 2003). The major drawback of this dye is that it
is excited in the UV range, which is toxic for the cells. 4-Di-ANEPPDHQ (amino-naphthyl-
ethenyl-pyridinium) represents a newer dye with improved characteristics. Similarly to
LAURDAN, it readily partitions into the membrane of cells and shifts its emission spectra upon
phase transition. Importantly, it has novel interesting features, compared to LAURDAN. It can
be efficiently excited by blue light, has a greater signal/noise ratio, has low cellular toxicity and
can be used both in single photon microscopy as wells as with two-photons and FLIM (Jin et al.,
2006; Owen et al., 2007). This dye proved to give a high contrast in the analysis of phase
separation in live cells (Owen et al., 2007). A different approach in the study of lipid rafts
53
consists in interfering with raft stability and to assess the behaviour of the protein
hypothesised to reside in these domains. This approach will be introduced in more detail in the
next chapter (see section 3.1.2). Recently, advantages in lipid mass spectrometry (Shevchenko
and Simons, 2010) and mathematical modeling supported by physical studies (Richardson et
al., 2007) are contributing to understand fundamental properties of protein rafts. The data
collected from all these approaches gave us a more detailed view of lipid rafts and raft
associated proteins.
In conclusion, the strategy to study lipid rafts and raft associated proteins is based on
complementary techniques. The recovery of a certain protein from the DRMs can be
considered as a strong indicator of raft association but it must be supported by other data. For
example, powerful methods to investigate protein-raft association are provided by microscopy
based techniques such as phase sensitive dyes, induction of raft patching and high-resolution
microscopy. Approaches to interfere with raft stability, which lead to the dissociation of the
protein of interest from rafts, should be also considered. Moreover, functional assays,
performed to understand the physiological meaning of protein-raft association, must be
carried out.
2.1.3 Planar and Caveola type lipid rafts.
Lipid rafts are heterogeneous (Hancock, 2006; Pike, 2004). A planar form and a caveola-type
lipid raft have been described. The former lacks a distinguishable morphological feature while
the latter is a flask shaped invagination of the membrane (50-100 nm diameter) which can be
readily observed with electron microscopy (Parton and Simons, 2007). Protein markers for
these different rafts are Flotillins (Bickel et al., 1997; Stuermer and Plattner, 2005) and
Caveolins (Parton and Simons, 2007), respectively.
Two Flotillin isoforms, with a predicted molecular weight of 49 kDa, have been described:
Flotillin-1 (Reggie-2) and Flotillin-2 (Reggie-1). They are widely expressed in the adult organism
(even though a detailed tissue expression map is missing) (Langhorst et al., 2005). With regards
to the nervous system, they co-localise in non-caveola type rafts in neurons (Lang et al., 1998;
Stuermer and Plattner, 2005). It has been reported that they can exist as homo-hetero-
oligomers, where the presence of Flotillin-2 is required for the stability of Flotillin-1 (Solis et al.,
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2007). They co-localise along the processes of DRG neurons in micro-clusters (approximately
2.5 µm2) and are associated with GPI-anchored proteins (Thy-1 and CAM F3) in stable raft
platforms (Lang et al., 1998). These microdomains (raft platforms) can be efficiently visualised
by confocal microscopy and electron-microscopy with gold particles (Kokubo et al., 2003;
Stuermer and Plattner, 2005). Flotillins lack a transmembrane segment and are juxtaposed to
the intracellular side of the plasma membrane, with both N- and C-terminus facing the
intracellular space. They target lipid rafts by acylation via a Golgi independent pathway;
Flotillin-1 is palmitoylated (Morrow et al., 2002), while Flotillin-2 is both myristoylated and
palmitoylated (Langhorst et al., 2005). Due to the paucity of data from KO animals, the exact
functions of Flotillin are still unknown but their widespread expression suggests they may be
implicated in several biological processes. Flotillins co-localise and co-immunoprecipitate with
Src kinases and are thought to be implicated in signal transduction (Stuermer et al., 2001).
They have been described to control cytoskeletal dynamics by forming signaling raft platforms
on the plasma membrane. They are crucial for a balanced and controlled cytoskeletal
remodelling, which occurs during neuronal differentiation. Indeed, Flotillins are necessary for
the recruitment of adaptor proteins to the membrane and the engagement of signaling
pathways which determine Actin remodelling in neuronal cells (Langhorst et al., 2008).  Also,
they are up-regulated during axon regeneration (Schulte et al., 1997). Flotillin-1 and
membrane rafts have been demonstrated to be necessary for efficient development and
branching of hippocampal neurons. It has been proposed that it associates with membrane
rafts and acts as a nucleation site for other proteins. The formation of a multi-protein complex
on the membrane (including Actin and Exocysts) drives the events of branching and neurite
elongation (Swanwick et al., 2010a). Furthermore, Swanwick et al. showed that the NMDA
receptor subunit NR2B binds to lipid raft markers Flotillin-1 and Flotillin-2, while NR2A binds
only to Flotillin-1 (Swanwick et al., 2009). This group also demonstrated that in the
hippocampus Flotillin-1 drives the formation of glutamatergic synapses, co-localises with
synaptic NMDA receptors, and regulates the excitability of hippocampal neurons by tuning the
firing frequency of these synapses (Swanwick et al., 2010b). Flotillin-1 seems also to define a
clathrin-independent endocytic pathway (Glebov et al., 2006).
Four Caveolin isoforms have been discovered: Caveolin-1 (α and β), -2 and -3. Caveolin-1β
results from an internal translation and lacks thirty-one amino acid residues, compared to
Caveolin-1α. Caveolin-1 and -2 are ubiquitously expressed, with the highest level observed in
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adipocytes, endothelial cells, smooth muscle cells and pneumocytes. Caveolin-3 is a muscle
specific isoform (Williams and Lisanti, 2004). In the nervous system Caveolin-1 and -2 mRNA
have been detected in the peripheral nervous system, in the spinal cord and in several parts of
the brain (with the highest expression in the subthalamic nucleus and substantia nigra).
Galbiati et al. described the presence of Cavolin-1 and -2 in DRG neurons. Both isoforms were
detected in the insoluble fraction of cultured DRG neurons. Imaging techniques were
employed to analyse the sub-cellular localisation of Caveolin-1 and -2. It was found that both
proteins are present on the entire surface of DRG neurons and caveola-like structures were
identified by electron microscopy (Galbiati et al., 1998). Caveolin-2 has also been found in
cortical neurons where it defines rafts involved in dendritogenesis (Takemoto-Kimura et al.,
2007). Caveolin-1 expression in neurons has been proven to be dynamic. In hippocampal
neurons Caveolin-1 is expressed in a punctuate fashion and glutamate stimulation of these
neurons, via AMPA receptors, increases Caveolin-1 expression in a time and concentration
dependent manner (Bu et al., 2003). Caveolins predicted size is 23 kDa. Caveolin-1 and -2 are
thought to form hetero-oligomers (up to 16 units) in caveolae and Caveolin-1 is necessary for
Caveolin-2 expression and membrane targeting. The predicted topology of Caveolins indicates
that these proteins have a highly hydrophobic stretch which is buried into the membrane. For
this reason Caveolins are thought to assume a hairpin structure, with both N- and C-terminus
in the intracellular environment. Caveolins are the structural determinant of caveola-type lipid
rafts and heterologous expression of Caveolins is sufficient to drive the formation of caveolae
(Lipardi et al., 1998). Caveolin-1 and -3 KO mice lack distinguishable caveolae and have
impaired endothelial nitric oxide synthase (eNos) and Calcium signaling in the cardiovascular
system (Drab et al., 2001; Galbiati et al., 2001). Caveolin-2 KO mice do not show apparent loss
of caveolae but are characterised by abnormal lung morphology and exercise intolerance
(Razani et al., 2002). Caveolins directly bind cholesterol (1-2 molecules) and are palmitoylated.
As expected, caveolae are enriched in cholesterol and sphingolipids and cholesterol depletion
leads to their disruption (Parton and Simons, 2007). In line with rafts’ role in biological
processes, caveolae and Caveolins have been implicated in signal transduction, protein
clustering and trafficking (Stern and Mermelstein, 2010). They are thought to
compartmentalise and concentrate signaling molecules. It has been proposed, for example,
that Caveolin-1 modulates the ERα-mGluR1/5 pathway in hippocampal neurons by facilitating
the interaction between these proteins (Boulware et al., 2007). Caveolins also scaffolds and
coordinates protein complexes involved in NMDA receptor signaling and it has been
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demonstrated that such interaction is necessary for NMDA receptor mediated neuronal
protection from ischemic cell death (Head et al., 2008). In addition, various classes of signaling
molecules, including G-protein subunits, receptor and non-receptor tyrosine kinases, eNos,
and small GTPases have been found associated with Caveolins (Williams and Lisanti, 2004).
Caveolins also modulate trans-endocytosis and define a Clathrin independent pathway, but its
regulation is still poorly understood (Cohen et al., 2004; Shmuel et al., 2007).
2.1.4 Nerve Growth Factor and TrkA.
NGF is a neurotrophic factor of the family of neurotrophin, which includes BDNF,
Neurotrophin-3 and Neurotrophin-4/5 (Kandel et al., 2000). It was discovered more than fifty
years ago as the molecule responsible for the survival and differentiation of neurons in the
peripheral nervous system (Levi-Montalcini, 1987). NGF is a 13 kDa protein which exists as a
homo-dimer. The active form is the result of a proteolytic cleavage of a precursor which is
expressed by different cell types (Sofroniew et al., 2001). NGF has pleiotropic functions ranging
from a role in differentiation, cell survival, regulation of gene expression, sensitization and
regeneration. NGF acts through two receptors: the low affinity p75 and the high affinity TrkA.
TrkA is a 87 kDa transmembrane tyrosine kinase (Sofroniew et al., 2001). TrkA is mostly
expressed in CGRP positive, IB4 negative, DRG neurons which account for approximately 40%
of the total DRG neuronal population (Averill et al., 1995), and it has been demonstrated the
TrkA expressing DRG neurons are nociceptors (Fang et al., 2005). NGF-TrkA signaling plays a
key role in many biological processes. In fact, during development NGF is crucial for
differentiation and survival of primary sensory neurons. Mice lacking NGF or TrkA lack
unmyelinated small diameter neurons and display hypoalgesia (Wall and Melzack, 2005). NGF,
through TrkA, acts also in adult animals and on DRG neurons in vitro. In adult animals it is not
necessary for cell survival but promotes neurite outgrowth in cultured DRG neurons (Lindsay,
1988). Upon nerve injury NGF is expressed by non-neuronal cells in the site of injury. NGF in
this case has a neuroprotective role, by decreasing apoptosis, promoting regeneration and
correct nerve targeting (Petruska and Mendell, 2004). On the other hand, NGF is also a pro-
nociceptive factor. It modulates DRG neurons excitability upon trauma and in pain states and
determines thermal and mechanical allodynia when injected intradermally (Gould et al., 2000;
Kerr et al., 2001). NGF acts directly on TrkA expressing neurons and sensitise them through the
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activation of intracellular pathways. It has been found that NGF increases TrpV1 mediated
currents through PLC activation, by determining the removal of tonic inhibition maintained by
phosphatidylinositol 4-5-bisphosphate (Chuang et al., 2001), and by increasing its trafficking to
the membrane (Zhang et al., 2005). It has been proposed that NGF, via the ceramide pathway,
also determines an increase of NaV1.8 TTX-r mediated currents (Zhang et al., 2002). NGF, by
acting on non-neuronal cells (e.g. mast cells), triggers the release of pro-inflammatory
compounds from these cells and indirectly sensitises nociceptors (Wall and Melzack, 2005).
TrkA mediates NGF effects by homo-dimerising, by auto-phosphorylating and by
phosphorylating target proteins. The intracellular pathways that are engaged are multiple and
include cAMP-PKA, PLC-PKC, MAPK p38, RAS and ERK1/2 (Sofroniew et al., 2001). TrkA-NGF
complex can also undergo endocytosis, be trafficked and trigger signaling at the level of soma
(Zweifel et al., 2005). NGF also modulates nociceptor excitability by regulating gene expression
of several classes of proteins including neuropeptides (e.g. Substance P) and molecular
transducers (e.g. TrpV1) (Okuse, 2007; Petruska and Mendell, 2004). In relationship to NaV1.8,
basal NGF expression in adult animals is necessary to maintain the channel’s tonic expression
in nociceptors (Fjell et al., 1999b). NaV1.8 expression is up-regulated in vivo during
inflammatory conditions (CFA, Carrageenan) (Lai et al., 2004), when elevated concentrations of
NGF are circulating (Donnerer et al., 1992), and NGF increases NaV1.8 expression in vitro (Black
et al., 1997; Fjell et al., 1999a). TrkA represents a protein of particular interest in studies
focusing on NaV1.8 and pain pathways because it mediates NGF effects on NaV1.8 and because
NGF-TrkA signaling shapes nociceptors phenotype.
2.1.5 Annexin II light chain S100A10 (p11).
Annexins are a large group of proteins (Annexin I-XI, XIII) characterised by two common
features: the presence of a conserved annexin domain and the ability to bind negatively
charged phospholipids in a Calcium dependent manner. Annexins, by virtue of their ability to
bind phospholipids, are involved in several biological processes, including vesicle trafficking,
scaffolding of membrane proteins and exo- endocytosis. Annexins exist as a hetero-tetramer of
two heavy chains plus two light chains (Seaton and Dedman, 1998). The complex Annexin II-
S100A10 (p11) shows unusual features compared to the other members of the Annexin family.
P11 has two EF hand motif which carries two deletions and mutations, which make the
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Calcium binding site non functional. Indeed, this mutation makes Annexin II-p11 constantly
locked in an “active” state related to the binding of its target proteins (Rescher and Gerke,
2008). Notably, Annexin II-p11 is acylated at its N-terminus and localises in lipid rafts
(Babiychuk and Draeger, 2000; Gerke and Moss, 2002; Oliferenko et al., 1999; Rescher and
Gerke, 2004). Since p11 only exists in an active state, modulation of Annexin II-p11 dynamics in
trafficking proteins to the membrane may be regulated by Annexin II-p11 interaction. It has
been found that PKC, by phosphorylating Annexin II modulates its affinity for p11 (Rescher and
Gerke, 2008). During a yeast two-hybrid genetic screening it was found that p11 binds to the
N-terminus of NaV1.8 (Malik-Hall et al., 2003). Virtually all DRG neurons expressing NaV1.8 are
positive for p11 expression. Importantly, p11 promotes NaV1.8 localisation onto the
membrane. In CHO cells (heterologous system where exogenous NaV1.8 currents are
undetectable) co-expression of p11 with NaV1.8 is sufficient to promote channel insertion and
detection of TTX-r currents. Furthermore, in DRG neurons antisense treatment for p11 induces
a loss of NaV1.8 currents (Okuse et al., 2002). P11 expression is up-regulated by NGF in DRG
neurons. It has been suggested that NGF increases NaV1.8 mediated TTX-r currents by
increasing p11 amount and by promoting forward trafficking of the channel into the
membrane (Okuse, 2007; Okuse et al., 2002). P11 binding is specific for NaV1.8 and occurs
between NaV1.8 residues 74-13 and p11 residues 33-78 (Poon et al., 2004). Consistent with the
role of NaV1.8 in pain pathways and p11 key role in trafficking it to the membrane, p11
conditional KO mice display deficits in pain behaviours. When p11 is ablated in nociceptors
only, total NaV1.8 expression is not affected, but there is a marked decrease of membrane
bound NaV1.8 in DRG neurons; this also correlates with a 50% reduction of TTX-r currents.
These mice display deficits in WDR neurons activity upon presentation of mechanical and
thermal stimuli. Furthermore, an increase in pain threshold following a mechanic stimulus
(Randall-Selitto test) was observed. Deletion of p11 from nociceptors also reduced mechanical
allodynia following L5 spinal nerve injury (Foulkes et al., 2006). The well documented effect of
p11 on NaV1.8 makes this auxiliary protein an interesting target for studies focusing on the
trafficking and cellular localisation of NaV1.8.
59
2.1.6 Aims.
The studies presented in this chapter were aimed at the investigation in vivo and ex vivo of the
association between NaV1.8 and lipid rafts in DRG neurons, with biochemistry and imaging
techniques. As we outlined in the introduction, there is a paucity of data about NaV1.8
localisation within DRG neurons. Therefore we also investigated NaV1.8 sub-cellular
localisation in vitro and ex vivo. In addition, the localisation of NaV1.8 in DRG neurons was
analysed in relation to other proteins of interest (TrkA, Flotillin-1, and Caveolin-2).
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2.2 Materials and Methods
2.2.1 Detergent resistant membranes (DRMs) preparation and purification.
Cervical, thoracic, lumbar DRGs and sciatic nerves were extracted from female Wistar rats (6
weeks old; 150 grams) and homogenized, by using a glass pestle and mortar, in solution B (150
mM NaCl, 5mM dithiothreitol (DTT), 5mM EDTA, 25 mM Tris-HCl pH 7.4) supplemented with
1:1000 protease inhibitor cocktail set III (Merck). The homogenate was centrifuged at 3600
rpm for 10’ at 4°C to pellet chromatin, the supernatant recovered and adjusted with 10%
Triton X-100 (Sigma) in Solution B to give a final concentration of 1% Triton X-100. When DRG
cultures were used as the initial source, cells were recovered by scraping the cells in solution D
(Solution B with 1% Triton X-100). DRMs were prepared by incubating the samples 30’ on ice.
The lysate was mixed with 60% OptiPrep® (Iodixanol; Sigma) to obtain a final concentration
40% OptiPrep® (100 l OptiPrep® and 50 l sample). 120 l of the 40% fraction was layered
with 360 l of 30% OptiPrep® in solution D and 120 l of solution D in a 5/16 x 1 3/8 inch
Beckman ultracentrifuge tube (Fig. 2.1). All the described procedures were carried out on ice in
a cold room at 4°C with pre-cooled solutions. Following layers preparation, samples were
centrifuged at 36000 rpm at 4°C for 4.5 hrs in a Beckman Optima MAX ultracentrifuge with a
fixed angle TLA 120.1 rotor. After centrifugation the whole gradient was recovered from the
tubes by collecting nine fractions (66.6 µl each). Fractions were stored at -20°C.
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Figure 2.1) Schematic diagram of DRMs preparation. The diagram shows the steps involved in
DRMs extraction.
2.2.2 Western blotting and dot blotting.
Fractions recovered from ultracentrifugation were mixed with 5X Laemmli buffer (10% SDS,
50% glycerol, 20% β-mercaptoethanol, 0.01% bromphenol blue, 0.312 M Tris-HCl, pH 6.8) in
the presence of 20 mM and incubated 45’ at room temperature (R.T.). Equal volumes were
subjected to SDS-PAGE at constant voltage (80 V for migration through the stacking gel, 100 V
for migration through the resolving gel) till the proteins of interest were efficiently separated.
In particular, for the detection of NaV1.8 150 μl of sample (112.5 μl of each fraction recovered
from the ultracentrifugation step plus 37.5 μl 5X Laemmli buffer) were loaded in each well of
the gel. For the detection of all other protein 25 μl of sample (20 μl of each fraction recovered
from the ultracentrifugation step plus 5 μl 5X Laemmli buffer) were loaded in each well of the
gel. For the detection of NaV1.8, a large electrophoresis apparatus (Bio-rad) was used in
combination with an 8% poly-acrylamide gel. For other proteins, small electrophoresis
apparatus (Bio-rad) and 12% poly-acrylamide gels were used.
After electrophoresis proteins were transferred onto Polyvinylidene fluoride (PVDF)
membrane (Amersham) using either a wet system (for the detection of Transferrin receptor
and Flotillin-1; 2.5 hours at 200 mA) (Bio-rad) or the iBlotTM (Invitrogen) dry method (for the
detection of NaV1.8; Program 3; 9 mins transfer period). Non specific sites were blocked with
5% dried fat-free milk dissolved in phosphate buffered saline (PBS) supplemented with 0.1%
Tween-20 (Sigma) (PBS-T) over-night (o.n.) at 4°C. After washes (1x15’, 2x5’) in PBS-T
membranes were incubated with the following primary antibodies: rabbit anti NaV1.8 (from
K.Okuse), mouse anti Flotillin-1 (DB Biosciences), mouse anti Transferrin receptor (Zymed;
Invitrogen). All antibodies were used 1:1000 for 1 hr at R.T. Following washes (1x15’, 2x5’) the
membranes were incubated with the appropriate secondary antibodies conjugated to
Horseradish Peroxidase (HRP), with the following conditions: anti-rabbit IgG-HRP (Dako) 1:200
1 hr at R.T., anti-mouse IgG-HRP (Dako) 1:1000 1 hr at R.T. Antibodies were diluted in 10% goat
serum (GS) in PBS-T.
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For dot blot analysis, 1 l of each layer recovered from the centrifugation step was applied to a
nitrocellulose membrane (0.45 μm; Amersham) and dried at R.T. Non specific interactions
were blocked by incubating the membranes with 5% Bovine Serum Albumin (BSA) diluted in
PBS for 1 hr at R.T. Membrane was probed with biotinylated Cholera toxin sub-unit B (CTB;
Invitrogen) at a final concentration of 0.1 µg/ml in PBS for 20’ and, after three washes, was
incubated with HRP conjugated Streptavidin (Dako) diluted 1:10,000 in PBS for 20’.
All membranes were washed (1x15’, 2x5’) before developing chemiluminescence with the
enhanced chemiluminescence western blotting detection system kit (Applichem).
Chemiluminescence was detected with Fujifilm LAS-3000 Imaging System and images stored as
8 bit TIFF files. Signal intensities were quantified using freeware image analysis software
ImageJ (http://rsbweb.nih.gov/ij/).
When needed membranes were stripped and re-probed with the appropriate antibody. In
particular, membranes were incubated in stripping buffer (2% SDS, 100 mM β-
mercaptoethanol added fresh, 50 mM Tris-HCl, pH 6.8) at 50 °C for 30’ with gentle shaking in a
sealed box. Membranes were subsequently thoroughly washed in PBS-T (3x15’) and blocked
overnight in 5% dried fat-free milk dissolved in PBS-T.
2.2.3 DRG culture.
Female Wistar rats (6 weeks old; 150 grams) were culled by CO2 asphyxiation. DRGs (40-50 per
dissection) were harvested and placed in cold sterile Dulbecco’s Modified Eagle Medium
(DMEM) (GIBCO; Invitrogen). Excess of dorsal roots and spinal nerves were trimmed under a
stereo microscope with micro-dissection Vannas scissors (Fine science tool). After a quick wash
in DMEM, DRGs were incubated with 0.125% Collagenase XI (Sigma) and 0.1 mg/ml DNase II
(Sigma) in DMEM for 90’ at 37°C. After enzymatic digestion, DRGs were triturated with a cut 1
ml tip until a cloudy cell suspension was obtained (approximately 15 strokes). Cells were spun
down, resuspended in pre-warmed DMEM and filtered through a 70 µm mesh (BD
Biosciences). DRG neurons were recovered by using BSA (PAA) cushions. 1 ml BSA cushions
were prepared to a final concentration of 10% BSA in DMEM. Filtered cell suspension was
divided in 1 ml aliquots, gently overlaid on top of the cushions and spun for 8’ at 700 rpm.
After the centrifugation debris were aspirated from the interphase and DRG neurons
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recovered from the pellet. DRG neurons were pooled and washed in pre-warmed DMEM. Cells
were plated on 13 mm glass coverslips coated with poly-L-Lysine and Laminin in complete
media (DMEM, 10% fetal bovine serum (FBS), Penicillin/Streptomycin (1:100; Sigma), NGF (50
ng/ml; Peprotech) and Aphidicolin (10 µM; Sigma). Cell yield was calculated by counting cell
number of an aliquot of the cell suspension in a Neubauer hemocytometer. 10000 and 15000
cells per coverslips were plated for immunofluorescence and biochemistry purposes,
respectively. Cells were incubated in a 95% air/5% CO2 humidified incubator. Media was
changed every two days with pre-warmed complete media. Prior to plating, glass coverslips
were treated with 0.1 mg/ml poly-L-Lysine (Sigma) for 2 hours at R.T. After three washes with
deionised distilled water they were incubated with 10 µg/ml Laminin (Invitrogen) in DMEM for
90’ at R.T.
2.2.4 ND7/23 cell culture.
ND7/23 clone (Wood et al., 1990) was cultured in DMEM with 10% FBS in 10 cm diameter
dishes. The cell line was trypsinised and sub-cultured at a 90% confluence. When transfection
was needed, 15,000 cells were seeded onto poly-L-Lys covered glass coverslips the day before
transfection.
2.2.5 Ganglioside GM1 staining.
DRG neurons were quickly washed with sterile PBS and incubated with 1 µg/ml biotinylated
CTB (Invitrogen, Molecular Probes) in PBS for 20’ at R.T. CTB specifically binds to ganglioside
GM1 (Merritt et al., 1994; Schon and Freire, 1989) which is a marker of lipid rafts (Hammond
et al., 2005; Harder et al., 1998; Janes et al., 1999; Yuan et al., 2002). After three washes with
PBS, DRG neurons were incubated with 1:1000 Streptavidin-488 (Invitrogen) for 20’ at R.T.
Cells were washed three times in PBS, fixed with 4% paraformaldehyde (PFA) (Sigma) in PBS
for 10’ at R.T. and processed for immunofluorescence if needed.
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2.2.6 Immunofluorescence on cultured DRG neurons.
DRG neurons were washed in PBS three times and fixed with 4% PFA for 10’ at R.T.  Following
washes in PBS (3 x 10’ each) DRG neurons were incubated with primary antibodies. All the
antibodies (Table 2.1) were diluted in 10% GS for 1 hour at R.T. After washes (3 x 10’ each),
cells were incubated with fluorescently labeled secondary antibodies or Streptavidin (Table
2.1), diluted in 10% GS for 1 hour at R.T. in the dark. Absence of background fluorescence was
shown by omitting the primary antibodies (Fig. 2.2).
Figure 2.2) Secondary antibodies testing.  The images show the immunofluorescence carried
out with secondary antibodies only. Scale bar is 20 µm.
When nuclear counterstain was needed, cells were incubated with Hoechst 33342 (Invitrogen)
diluted 1:10000 in PBS for 10’ at R.T. After washes (3 x 10’ each) cells were quickly rinsed twice
in deionised water and coverslips were mounted on glass slides with anti fade agent AF1
(Citifluor LTD) and sealed with nail varnish. If storage was needed samples were left at 4°C in
the dark (or -20°C for long term storage). Samples were analysed on a widefield Nikon 80i
microscope and pictures acquired with an ultrahigh-quality digital Nikon DXM1200F camera
controlled with LUCIA G software. Post-acquisition processing was carried out with Adobe
Photoshop 7.
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Table 2.1. Antibody used for immunofluorescence. M=mouse, R=rabbit, C=chicken,
FITC=Fluorescein isothiocyanate, TRITC=tetramethylrhodamine isothiocyanate.
Antibody DilutionCultured DRG
Dilution
Teased sciatic nerve Company Note
α NaV1.8 1:200 1:100 K.Okuse
Before first use
spun down 5’
13k rpm at 4°C
α p11 1:100 - Neuromics -
α TrkA 1:100 - BDBiosciences Biotinylated
α Peripherin 1:200 1:100 Chemicon -
α NF200 1:500 - Chemicon -
αM-FITC 1:200 1:100 Dako -
αM-TRITC 1:1000 - Dako -
αR-TRITC 1:1000 1:100 Dako -
αC-TRITC 1:200 - Dako -
Streptavidin-
488 1:200 - Invitrogen -
Antibody anti NaV1.8 has already been validated and widely described in literature (Djouhri et
al., 2003a; Fang et al., 2005; Malik-Hall et al., 2003; Okuse et al., 1997; Okuse et al., 2002;
Stirling et al., 2005). We further confirmed the specificity of the antibody against NaV1.8. We
exploited the features of the DRG-like neuro-blastoma cell line ND7/23 (Wood et al., 1990).
ND7/23 cells express TTX-s channels, display TTX-s currents and lack NaV1.8 (John et al., 2004;
Leffler et al., 2007). We transfected ND7/23 cells with plasmid encoding GFP, NaV1.8 or NaV1.8-
Dronpa (construct with fluorescent protein Dronpa fused to the C-terminus of NaV1.8). We
delivered 1 µg total plasmid DNA with LipofectamineTM 2000 (Invitrogen), following
manufacturer’s instruction. Twenty-four hours after transfection, ND7/23 cells were processed
for immunofluorescence by using anti NaV1.8 antibody (Fig. 2.3). Non transfected cells and
ND7/23 cells expressing GFP did not display any immunoreactivity for NaV1.8, showing that
antibody anti NaV1.8 does not bind to TTX-s VGSCs expressed by ND7/23. ND7/23 transfected
with plasmids expressing GFP and NaV1.8 (in a ratio 1:9) showed immunoreactivity for NaV1.8.
Also, all the cells expressing the fusion protein NaV1.8-Dronpa were positive for
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immunoreactivity against NaV1.8. These results show that the antibody we use to detect
NaV1.8 is specific for this channel and does not cross-react with other VGSCs.
Figure 2.3) Anti NaV1.8 antibody testing.  ND7/23 cells have been transfected with plasmid
expressing GFP, NaV1.8 and NaV1.8-Dronpa. Control cells have not been transfected. The
images show the immunofluorescence for NaV1.8 in fixed ND7/23 cells. Only NaV1.8 and
NaV1.8-Dronpa transfected cells display immunoreactivity for NaV1.8. The insets show the
magnification of cells expressing NaV1.8 and NaV1.8-Dronpa positive for NaV1.8
immunoreactivity.
2.2.7 Electroporation of DRG neurons.
Exogenous DNA was delivered into DRG neurons by electroporation with NeonTM transfection
system (Invitrogen). Electroporation was carried out before plating the cells. DRG neurons
were prepared as described above (see section 2.2.3). The cell suspension was washed in 4 mls
of sterile PBS (Gibco; Invitrogen) and spun down. The pellet was resuspended in 27 µl buffer R
(Invitrogen) plus 3 µl of plasmid DNA. DNA was prepared by using Plasmid Midi Kit (Qiagen)
and used at a final concentration higher than 1 µg/µl and with a 260/280 nm reading not lower
than 1.8. The electroporation chamber was filled with 3 ml of buffer E. The cell suspension was
aspirated in a 10 µl gold tip and the electric pulses delivered (2 pulses, 1200 volts, 20 msec).
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For electroporation purposes, 200,000 cells were electroporated in four rounds of
electroporation. Gold tips were used for three times and electroporation chambers ten times
before being discarded. After the electric pulses neurons were quickly plated in pre-warmed
DMEM with 10% FBS without antibiotics. Two hours after plating, NGF was added to the cells.
The day after plating, media was replaced with complete DMEM and media changed every two
days. Expression of the exogenous constructs was monitored daily by fluorescence microscopy.
2.2.8 Plasmids.
NaV1.8 cDNA with a mutated stop codon (TGA → KpnI site) was sub-cloned from expression
vector pRK7-NaV1.8 (K. Okuse) by using unique HindIII and KpnI restriction sites into pDsRed2-
N1 (Clontech). NaV1.8 cDNA was cloned upstream of DsRed2 sequence to generate an in-frame
fusion product (NaV1.8-DsRed2). Flotillin-1 cDNA was amplified from a DRG neuron expression
library (K. Okuse). EcoRI site was introduced upstream of the starting codon and NotI was used
to replace TGA stop codon. Flotillin-1 cDNA was cloned into pDG1-MN1 vector (Amalgaam;
MBL) in frame with cDNA coding for CoralHueTM Dronpa-Green to generate a Flotillin-1 C-
terminus fusion product (Flotillin-1-Dronpa). Caveolin-2 cDNA was amplified from rat
adipocytes. EcoRI and HindIII sites were introduced upstream of the starting codon and to
eliminate the TGA stop codon, respectively. Caveolin-2 cDNA was cloned into pDG1-MN1
vector by using EcoRI and HindIII restriction sites. The cDNA was cloned in frame with Dronpa
cDNA to generate a C-terminus fusion product (Caveolin-2-Dronpa) (gift from S. Shepherd). All
the coding regions described above are specific for rat (Rattus norvegicus).
2.2.9 Teased fibre preparation from sciatic nerve and immunofluorescence.
Sciatic nerves  were harvested and placed on top of a 2% gelatin (Sigma) coated glass coverslip.
Under a stereomicroscope nerve fascicles were freed from the epineurium by pulling them
with fine tips tweezers (Fine science tools). The fascicles were dissociated in fibre bundles and
single fibres by gently pulling them with forceps. The sciatic nerve fibres were washed in PBS
and fixed in 4% PFA. After washes (3x10’) fibres were permeabilised with 0.1% Triton X-100 in
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PBS 10’ at R.T. Following washes, samples were blocked in 10% GS in PBS for 30’ at R.T. and
incubated with primary antibodies (Table 2.1) diluted in 10% GS/PBS for 2 hrs at R.T. After
washes with PBS samples were incubated with fluorescently labelled secondary antibodies
(Table 2.1)  diluted in 10% GS in PBS for 1 hour at R.T. Samples were mounted in anti fading
agent AF1 (Citifluor LTD) on glass slides, sealed with nail varnish and analysed under the
microscope (same equipment as for DRG culture immunofluorescence).
2.2.10 Statistical analysis.
Data were computed and analysed with OriginPro 8.5 software (Originlab Corporation). For the
comparison of the degree of colocalization between endogenous NaV1.8 and Flotillin1-Dronpa
and Caveolin2-Dronpa Fisher’s exact test was used. Data are expressed as mean ± SEM. P value
< 0.05 was considered statistically significant.
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2.3 Results
Investigation of NaV1.8 association with lipid rafts by biochemical techniques.
Lipid rafts, due to their biophysical features, are resistant to non-ionic detergents at 4°C. This
property is exploited to separate them from the soluble portion of the membrane (non-lipid
raft). After the detergent treatment, the membrane lysate, which includes intact lipid rafts and
solubilised membrane, is centrifuged in a density gradient; lipid rafts, because of their light
density, float towards the top of the gradient, where they can be recovered. We asked if
NaV1.8 associates with lipid rafts, therefore we analysed its partition between lipid rafts and
the soluble fraction from three different sources: DRG cell body (tissue), sciatic nerve (tissue)
and cultured DRG neurons. The following sections will describe the results from these
experiments.
2.3.1 NaV1.8 association with lipid rafts in DRG neurons ex vivo.
In adult animals NaV1.8 is mostly expressed in DRGs (Akopian et al., 1996). Anatomically DRGs
contain the cell bodies of sensory neurons and a small proportion of axons which originates
from these cells and project to the dorsal horn (through the dorsal root) and to the peripheral
tissues (through spinal nerves). We sought to investigate NaV1.8 partition between lipid rafts
and the soluble fraction in this tissue. We first assessed if our protocol allows us to efficiently
separate lipid rafts from the soluble membrane. In our study, we used a protein and a lipid
marker, Flotillin-1 and ganglioside GM1 (GM1) respectively, to define the floating, low density,
raft fraction. In our preparation, we have found that Flotillin-1 is present as two pools: one
associated with the bottom fractions (lanes 7, 8 and 9) and one associated with the top
fractions (lanes 2, 3 and 4) (Fig. 2.4 A, B). GM1 is highly enriched in the top fraction (lanes 2
and 3) and a minor amount is associated with the soluble fraction. To define the non-lipid raft
portion of the membrane we used Transferrin Receptor, which is widely used as a non-raft
marker (Harder et al., 1998). Transferrin receptor was only found in the bottom fractions (7, 8
and 9). Given the distribution of these markers, we defined fractions 2 and 3 as the lipid raft
fraction and fraction 7, 8 and 9 as the soluble portion of the membrane (Fig. 2.4 A, B). Blots in
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Fig. 2.4 represent n=1 experiment. This result indicates that we can efficiently separate lipid
rafts from the bulk membrane by using DRGs as a source.
Figure 2.4) Lipid raft separation from DRGs ex vivo. A) Fractions from a density gradient were
analysed by western blotting (Flotillin-1, Transferrin Receptor) and dot blotting (GM1) to test
the separation of lipid rafts from the soluble portion. Different fractions are labelled from 1 to
9, with 1 being the top fraction and 9 the bottom fraction. M is the protein ladder. B) Shows
the bands intesity of the different markers, plotted against the fraction number, of the blots
shown in A.
We next analysed how NaV1.8 partitions between lipid rafts and the soluble fraction in DRGs.
For this purpose, we probed with an antibody against NaV1.8 the same sample used for the raft
preparation presented above. We have found that NaV1.8 was present in lane 8, and only by
extending the acquisition exposure time (and saturating NaV1.8 signal in the lower fraction), a
minor amount of NaV1.8 could be detected in the lipid raft fraction (Fig. 2.5 A, B). Blots in Fig.
A
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2.5 represent n=1 experiment. This data indicates that in fresh DRGs the the great majority of
NaV1.8 does not associate with lipid rafts, and is restricted to the soluble fraction.
Figure 2.5) NaV1.8 is mostly associated with the non lipid raft fraction in fresh DRGs. A) Same
fractions as in Fig. 2.4 were analysed by western blotting with an antibody against NaV1.8.
Different fractions are labelled from 1 to 9, with 1 being the top fraction and 9 the bottom
fraction. M is the protein ladder. The two blots represent the same membrane, with different
exposure times. B) Shows the bands intesity from the membrane labelled as “NaV1.8 long
exposure”, plotted against the fraction number, of the blot shown in A.
2.3.2 NaV1.8 association with lipid rafts in sciatic nerve ex vivo.
Sciatic nerve is a spinal nerve which contains the axons of sensory and motor neurons, whose
cell bodies are located in the DRGs and ventral horn of the spinal cord, respectively. Since
NaV1.8 is localised in the unmyelinated axons of the sciatic nerve (Gold et al., 2003) and Fig.
2.14 (see section 2.3.5), we tested if NaV1.8 associates with lipid rafts in the sciatic nerve. We
A
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defined the raft compartment in the sciatic nerve with the same markers we used for the DRG
cell bodies. In this preparation we found that raft marker Flotillin-1 is present in the bottom
(lanes 8 and 9) and in the floating fractions (lanes 2, 3 and 4). GM1 is concentrated in the top
fractions (2, 3 and 4), while Transferrin Receptor is excluded from the buoyant rafts and
enriched in the soluble fraction (lanes 8 and 9) (Fig. 2.6 A, B). According to these profiles we
defined the raft fraction the one recovered from lanes 2, 3 and 4. Blots in Fig. 2.6 are
representative of at least n=2 experiments.
Figure 2.6) Lipid raft separation from sciatic nerve ex vivo. A) Fractions from a density
gradient were analysed by western blotting (Flotillin-1, Transferrin Receptor) and dot blotting
(GM1) to test the separation of lipid rafts from the soluble portion. Different fractions are
labelled from 1 to 9, with 1 being the top fraction and 9 the bottom fraction. M is protein
ladder. B) Shows the bands intesity of the different markers, plotted against the fraction
number, of the blots shown in A.
We next evaluated NaV1.8 partitioning on this preparation and found a completely opposite
finding compared to NaV1.8 distribution in DRG neurons cell bodies. Remarkably, in the sciatic
A
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nerve NaV1.8 was only found in the raft fraction (lanes 2 and 3) and no NaV1.8 was associated
with the soluble fraction (Fig. 2.7 A, B). Interestingly, NaV1.8 was present as slightly different
sizes (Fig. 2.7 A). The predicted sizes of these bands (as determined by Rf measures) were 222
kDa, 201 kDa (in lane 2) and 247 kDa (band in lane 3). Blot in Fig. 2.7 is representative of n=2
experiments.
Figure 2.7) NaV1.8 is only associated with the lipid raft fraction in the sciatic nerve. A) Same
fractions as in Fig. 2.6 were analysed by western blotting with an antibody against NaV1.8.
Different fractions are labelled from 1 to 9, with 1 being the top fraction and 9 the bottom
fraction. M is protein ladder. B) Shows the bands intesity of NaV1.8 bands, plotted against the
fraction number, of the blot shown in A.
2.3.3 NaV1.8 association with lipid rafts in DRG neurons in vitro.
DRG neurons can be dissociated and cultured in vitro. In this condition they are able to extend
neurites from the cell bodies. Similarly to what we did for DRGs and sciatic nerve ex vivo, we
separated lipid rafts from 15000 DRG neurons maintained for two days in vitro (DIV). From this
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source we found that the majority of Flotillin-1 was recovered from the low density fractions
(lanes 2 and 3). GM1 associated with top (lanes 2 and 3 ) and bottom fractions (lanes 7, 8 and
9). Transferrin receptor, as expected, did not diplay raft-like properties and was retained in the
soluble fraction (lanes 7, 8 and 9) (Fig. 2.8 A, B). Blots in Fig. 2.8 are representative of at least
n=2 experiments. These data clearly shows that cultured DRG neurons, similarly to DRG
neurons in vivo, contain DRMs which can be extracted from the soluble fraction. Hence, from
plated DRG neurons, by density gradient, lipid rafts were defined by floating fractions 2 and 3.
Figure 2.8) Lipid raft separation from DRG neurons in vitro. A) Fractions from a density
gradient were analysed by western blotting (Flotillin-1, Transferrin Receptor) and dot blotting
(GM1) to test the separation of lipid rafts from the soluble portion. Different fractions are
labelled from 1 to 9, with 1 being the top fraction and 9 the bottom fraction. M is protein
ladder. B) Shows the bands intesity of the different markers, plotted against the fraction
number, of the blots shown in A.
A
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DRG neurons, when plated, express functional NaV1.8 (Fjell et al., 1999a). We investigated
NaV1.8 association with rafts after 2 DIV. At this stage both cell bodies and axons are present in
culture (see section 2.3.4, Fig. 2.10). We probed the same sample as in Fig. 2.8 with the
antibody against NaV1.8 and found that in this condition NaV1.8 was clearly associated both
with the lipid raft (lane 2) and the non lipid raft (lane 8) fractions (Fig. 2.9 A, B). Blot in Fig. 2.9
is representative of n=2 experiments. The predicted sizes of these bands (as determined by Rf
measures) were 226 kDa (band lane2), 246 kDa and 285 kDa (bands in lane 8).
Figure 2.9) NaV1.8 is associated with the lipid raft fraction and the soluble fraction in DRG
neurons in vitro. A) Same fractions as in Fig. 2.8 were analysed by western blotting with an
antibody against NaV1.8. Different fractions are labelled from 1 to 9, with 1 being the top
fraction and 9 the bottom fraction. M is protein marker. B) Shows the bands intesity of NaV1.8
bands, plotted against the fraction number, of the blot shown in A.
A)
B)
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Investigation of NaV1.8 sub-cellular localisation and association with lipid rafts by imaging
techniques.
We further explored NaV1.8 association with lipid rafts by using microscopy techniques. We
first determined the sub-cellular localisation of NaV1.8 in DRG neurons and then correlated it
to the localisation of lipid rafts, by visualising GM1. Also, we analysed the localisation of other
protein of interests: p11, TrkA, Flotillin-1 and Caveolin-2.
2.3.4 NaV1.8 sub-cellular localisation in vitro.
We first analysed the sub-cellular distribution of NaV1.8 in DRG neurons in vitro by
immunocytochemistry. DRG neurons, once plated, exhibit the remarkable feature to extend
neurites from the cell body, if growth factors are supplemented. The great majority of NaV1.8
is known to be expressed in small diameter neurons. Nevertheless, a small percentage of
medium and large diameter neurons have been found to express the channel (Djouhri et al.,
2003a). After 2 DIV, DRG neurons already show an extensive neurite outgrowth and we found
that NaV1.8 displays a dual pattern of localisation. In small diameter neurons (< 25 µm), most
likely to be nociceptors, NaV1.8 is found both at the level of the cell body and along the
neurites in a clustered fashion (Mean length of the clusters ± SEM = 3.56 ± 0.37 μm; n=3; Total
clusters counted = 255; Fig. 2.10 A, B). In large diameter neurons (> 25 µm), NaV1.8 localises at
the cell body and along the neurites as large patches or in an evenly distributed fashion (Mean
length of the patches ± SEM = 11.76 ± 1.55 μm; n=3; Total clusters counted = 194; Fig. 2.10 C,
D). We also analysed the sub-cellular distribution of NaV1.8 after 4 DIV. Similarly to what we
found after 2 DIV, NaV1.8 clusters on the neurites of small diameter neurons (Fig. 2.11 A, B),
and show an even distribution along the neurites of large diameter neurons (Fig. 2.11 C, D).
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Figure 2.10) Sub-cellular localisation of NaV1.8 in DRG neurons at 2DIV. A) Endogenous
NaV1.8 is localised at the cell soma and in clusters along the neurites of a small diameter
neuron. B) Same neuron as in A is shown here, superimposed on the phase contrast image to
show the cell soma and the full extent of neurites. C) Endogenous NaV1.8 is localised at the cell
soma of a large diameter neuron. NaV1.8 is distributed along the neurites in large patches. D)
Same neuron as in C is shown here, superimposed on the phase contrast image to show the
cell soma and the full extent of neurites. Scale bars are 20 µm.
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Figure 2.11) Sub-cellular localisation of NaV1.8 in DRG neurons at 4DIV. A) Endogenous
NaV1.8 is localised at the cell soma and in clusters along the neurites of a small diameter
neuron. B) Same neuron as in A is shown here, superimposed on the phase contrast image to
show the cell soma and the full extent of neurites. C) Endogenous NaV1.8 is localised at the cell
soma of a large diameter neuron. NaV1.8 is distributed along the neurites in large patches. D)
Same neuron as in C is shown here, superimposed on the phase contrast image to show the
cell soma and the full extent of neurites. Scale bars are 20 µm.
D
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To further confirm NaV1.8 sub-cellular distribution we performed a double
immunocytochemistry between NaV1.8, Peripherin and NF200 after 2DIV. Peripherin is a
cytoskeletal protein, specifically a sub-unit of class III intermediate filaments, and is widely
used as a marker for small diameter, unmyelinated fibres (Goldstein et al., 1991). In contrast,
NF200, which is a sub-unit of intermediate filaments IV, is a common marker of large diameter
neurons (Perry et al., 1991). Similarly to what we found previously, in small diameter neurons,
expressing Peripherin, NaV1.8 is localised along the neurites in distinguishable puncta (Fig. 2.12
A, B, C). On the other hand, in large diameter neurons, expressing NF200, NaV1.8 is evenly
distributed along the neurites (Fig. 2.12 D, E, F).
Figure 2.12) Sub-cellular localisation of NaV1.8 in small and large diameter DRG neurons. A)
In small diameter neurons, positive for Peripherin, NaV1.8 is localised at the cell soma and in
clusters along the neurites. B) Same neuron as in A is shown here, with Peripherin signal
omitted. C) Same neuron as in A is shown here, superimposed on the phase contrast image. D)
In large diameter neurons, expressing NF200, endogenous NaV1.8 is localised at the cell soma
and distributed along the neurites in large patches. E) Same neuron as in D is shown here, with
NF200 omitted, to highlight the even distribution of  NaV1.8 along the neurites. F) Same
neuron as in D is shown here, superimposed on the phase contrast image. Scale bars are 20
µm.
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2.3.5 NaV1.8 sub-cellular localisation ex vivo.
We thought to investigate NaV1.8 distribution along the axons of small diameter, unmyelinated
fibres ex-vivo. The sciatic nerve contains a heterogenous mix of axons which originate from
different sources: DRG neurons and motor neurons. NaV1.8 is mostly expressed in
unmyelinated fibres originating from the DRG neurons. Myelinated fibres can be easily
identified by their morphology (myelin envelope and nodes of Ranvier) in a preparation of
teased sciatic nerve fibres. On the other hand, small unmyelinated fibres due to their small
dimension and lack of myelin show a low contrast in white light illumination. We have
devoleped a protocol to separate and visualise unmyelinated axons in the sciatic nerve. In our
preparation, both myelinated and unmyelinated fibres are present. In phase contrast,
myelinated fibres are identified as large axons (Fig. 2.13 A, *) with nodes of Ranvier (Fig.2.13
A, arrow heads), while unmyelinated axons are smaller fibres which display a low contrast.
When the preparation is processed by immunofluorescence against peripherin (Fig. 2.12 B),
bundles of unmyelinated fibres (Fig. 2.13 C, #)  and single axons (Fig.2.13 C, arrow) can be
readily identified.
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Figure 2.13) Visualisation of small diameter fibres ex vivo. A) Shows a preparation of teased
fibres from sciatic nerve, imaged by phase contrast.  Large myelinated fibres (*) with nodes of
Ranvier (arrow heads) are present with unmyelinated fibres, associated in bundles (#) and as
single axons (arrow). B) Shows the Peripherin positive, unmyelinated fibres, present in the
sample. C) Phase contrast image and immunofluorescence against Peripherin are merged in
this image to show unmyelinated axons present as a bundle (#) and as single axons (arrow).
Framed area are also shown at higher magnification. Scale bars are 20 µm.
Since this method allowed us to efficiently separate and visualise unmyelinated fibres, we used
this technique to investigate NaV1.8 distribution along these fibres ex vivo. In small diameter
fibres, identified both by morphology (Fig. 2.14 A, arrow) and by the expression of peripherin
(Fig. 2.14 D), NaV1.8 showed a clustered distribution (Fig. 2.14 B, E), similar to what we found
in an in vitro preparation.
Figure 2.14) Visualisation of NaV1.8 clusters along small diameter fibres ex vivo. A) Shows a
preparation of teased fibres from sciatic nerve. Arrow indicates a small diamater fibre,
identified by morpholgy. B) Shows NaV1.8 immunoreactivy along the unmyelinated axons,
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distributed in clusters. C) Shows the phase contrast image and the immunofluorescence
superimposed. D) Shows a preparation of teased fibres from sciatic nerve. Small diamater
fibre, in this case, is identified by Peripherin staining. E) Shows NaV1.8 immunoreactivy along
the unmyelinated axons, distributed in clusters. C) Shows the Peripherin and NaV1.8
immunofluorescences superimposed. Scale bars are 20 µm.
2.3.6 Ganglioside GM1 visualisation and NaV1.8 immuno-localisation in vitro.
GM1 ganglioside is highly enriched in lipid rafts and is considered a standard marker of these
micro-domains (Harder et al., 1998). To investigate the association between NaV1.8 and lipid
rafts in vitro we have visualised GM1 and localised NaV1.8 by immunocytochemistry. CTB is a
pentameric protein which directly binds GM1 on the cell surface. We used biotinylated CTB
and a fluorescent derivate of Streptavidin to visualise GM1 on the neuronal plasmamembrane.
We found that 77.3% ± 4.4 of DRG neurons expressed GM1 ganglioside. Also, we found that
54.6% ± 8.0 of DRG neurons expressed GM1 ganglioside are positive for NaV1.8
immunoreactivity and that 82.3% ± 12.2 of DRG neurons that expressed NaV1.8 were positive
for GM1 ganglioside labelling. At the sub-cellular level we have found that GM1 is present as
puncta on the cell surface of the cell body and along the axons of DRG neurons after 2 DIV (Fig.
2.15 A, B, C). Absence of background staining due to Streptavidin-488 was demonstrated by
performing the staining with omission of CTB (Fig. 2.15 D). At the level of the cell bodies
NaV1.8 and GM1, did not show a clear co-localisation. At high magnification is possible to
distinguish clear puncta for GM1, but NaV1.8 immunoreactivity is evenly distributed and
occasionally aggregates in brighter patches (Fig. 2.15 A). However, along the neurites, GM1
and NaV1.8 show an interesting pattern of association. We found that the great majority of
NaV1.8 clusters co-localised with clusters of GM1 (Fig. 2.15 B, C, arrows), but not all GM1
clusters were positive for NaV1.8 (84.6% ± 3.6 of NaV1.8 clusters positive for GM1 from eleven
different neurons; Total number of clusters = 182). Even though some of the clusters were
associated with knobs along the axons, it is worth to note that both the clusters for NaV1.8 and
GM1 could be readily visualised in portions of the neurites with a linear morphology in the
absence of knobs, varicosities, growth cones and branches (Fig. 2.15 C).
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Figure 2.15) Association between NaV1.8 and GM1 along the neurites of DRG neurons. A) At
the level ot the cell body NaV1.8 and GM1 do not show clear co-localisation. The framed area is
shown at higher magnification. B) Along the neurites the clusters of NaV1.8 co-localise with
GM1. The framed area is shown at higher magnification; Two neurites crossing each other are
imaged. Regions of co-localisation between NaV1.8 and GM1 are indicated by arrows. C) A
linear neurite is shown, with clusters of NaV1.8 co-localising with GM1 indicated by arrows. D)
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shows that Streptavidin-488 does not bind to the cells (identified by staining nuclei with
Hoechst). Scale bars are 20 µm.
We also studied the pattern of association between NaV1.8 and GM1 in small and large
diameter neurons. Small neurons showed, along the axons, co-localisation between the
clusters of NaV1.8 and GM1 (Fig. 2.16 A, arrows); in large diameter neurons, even though
occasional co-localisation occured, this association was less evident (Fig. 2.16 B, dashed
arrow).
Figure 2.16) Different degree of association between NaV1.8 and GM1 along the neurites in
small and large diameter neurons. A) GM1 and NaV1.8 co-localise in a small diameter neuron.
The framed area is magnified to show regions of co-localisation indicated by arrows. B) GM1
and NaV1.8 are do not co-localise in a large diameter neuron. The framed area is magnified to
show a region lacking co-localisation indicated by a dashed arrow. Scale bars are 20 µm.
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2.3.7 Ganglioside GM1 visualisation and NaV1.8-DsRed2 in vitro.
The techniques involved so far to localise endogenous NaV1.8 have been based on a specific
antibody against this channel and on fixed cells. We sought to confirm NaV1.8 sub-cellular
localisation and association with lipid rafts by using a fluorescent version of NaV1.8. We cloned
the fluorescent tag DsRed2 to the C-terminus of NaV1.8. DsRed2 is a red fluorescent protein,
derived from the coral reef Discosoma Striata. By mean of microporation we delivered
exogenous DNA into the DRG neurons and monitored DsRed2 fluorescence. Primary neurons,
and in particular DRG neurons, are notoriously hard cells to transfect. We achieved around
20% transfection efficiency with DsRed2 alone, whose expression was readily observed one
day after transfection (Fig. 2.17 A, B). DsRed2 didn’t show any clear sign of sub-cellular
targeting/compartmentalisation and was evenly distributed in the cell cytoplasm along the
neurites (Fig. 2.17 B).
Figure 2.17) DsRed2 expression in live DRG neurons. A) Shows a low magnification image of
live DRG neurons expressing red fluorescent protein DsRed2. The fluorescent signal is merged
with the phase contrast image to visualise the transfection efficiency B) Shows DsRed2
fluorescence only; the framed region is magnified and shows a neuron expressing DsRed2,
which is evenly distributed along the axons. Scale bar is 100 µm.
A) B)
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NaV1.8-DsRed2 proved to be a challenging construct to be delivered and/or expressed.
Nevertheless, we managed to express it in a few neurons, in separate independent
experiments, and to monitor NaV1.8-DsRed2 sub-cellular localisation by live cell imaging.
Remarkably, we found that NaV1.8-DsRed2 showed a clustered localisation in live cells along
the axons, similar to what we described by using antibody based technique on fixed cells (Fig.
2.18 A, arrows). At the level of the cell body, NaV1.8-DsRed2 was highly accumulated
intracellularly (Fig. 2.18 A, arrow head), most likely in the endoplasmic reticulum which is
known to contain the majority of the channel in the neurons expressing it (Djouhri et al.,
2003a; Okuse et al., 2002; Zhang et al., 2008).
A
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)
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Figure 2.18) NaV1.8-DsRed2 is clustered along the axons of live DRG neurons. A) Shows
NaV1.8-DsRed2 distributed in clusters (arrows) along the neurite of a neuron. B) The
fluorescence image is superimposed on the phase contrast image, to show the integrity of the
cell process. C) The discontinous distribution of NaV1.8-DsRed2 along the axons has been
mapped by quantifying pixels intesity along the neurite by using ImageJ software. The pixels
quantified are represented in the inset as a yellow line superimposed on the cell process.
Clusters are represented as peaks of fluorescence in the intesity fluoresce plot. Scale bar is 20
µm.
C
)
A) B)
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We also used NaV1.8-DsRed2 construct to further investigate the co-localisation of NaV1.8 with
lipid rafts along the neurites. We have electroporated the DRG neurons with the plasmid
expressing NaV1.8-DsRed2 and have performed the CTB staining to visualise the GM1. We have
found that the clusters of NaV1.8-DsRed2 co-localised with GM1 (Fig. 2.19), confirming the
previous finding, and showing that the addition of a fluorescent tag to NaV1.8 neither disrupts
its ability to cluster nor to co-localise with GM1.
Figure 2.19) NaV1.8-DsRed2 co-localises with GM1 along the neurites of cultured DRG
neurons. The co-localisation between NaV1.8-DsRed2 and GM1 is shown as a yellow signal in
the merged picture.  Scale bars is 20 µm.
2.3.8 Effect of NGF on the association between NaV1.8 and GM1 in vitro.
NGF is a pleiotropic cytokine involved in several biological processes. Specifically related to
sensory neurons, it is a crucial factor for cell survival. In fact, in the absence of NGF DRG
neurons expressing TrkA and p75 undergo apoptosis. It also promotes axonal regeneration and
neurite outgrowth in vitro (Lindsay and Harmar, 1989). NGF modulates NaV1.8
electrophysiological properite in the short term, through the PKCε pathway, and in the long
term by increasing its expression (Okuse, 2007). Given the multiple roles of NGF we asked
whether it also regulates the pattern of association between NaV1.8 and lipid rafts. We
cultured 5000 DRG neurons in the presence of 50 ng/ml NGF or without NGF plus an antibody
against NGF, to minimise the effect of circulating NGF released from non neuronal cells. After 2
DIV we found, as expected, that the absolute number of neuronal cells was reduced in the
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sample without NGF (total count of neuronal cells, based on morphology, from 40 random
fields of view per sample = 322 neurons in NGF treated samples, 181 neurons in samples
without NGF). Also, the percentage of small diameter neurons, identified by Peripherin
staining, was reduced in the samples without NGF (from 40 random fields of view per sample:
66.1% Peripherin positive neurons in NGF treated sample vs. 45.3% Peripherin positive
neurons in samples without NGF). In addition, NGF treated sample showed extensive neurite
outgrowth, while the depletion of NGF determined a less developed neurite network (Fig. 2.20
A). In the population of cells, which still presented neurites and expressed NaV1.8 after the
depletion of NGF, the association between NaV1.8 and lipid raft was impaired. In control cells,
along the neurites, NaV1.8 and GM1 co-localised; On the contrary, in the samples without NGF,
NaV1.8 and GM1 did not show a clear co-localisation (Fig. 2.20 B).
Figure 2.20) Effect of NGF on the association between NaV1.8 and GM1. A) Peripherin stained
neurons are shown (note that the saturated cell body is due to allow visualisation of the
neurites). Neuron treated with NGF shows longer neurites than neurons not treated with NGF.
B) In NGF treated samples NaV1.8 and GM1 co-localise on the neurites, while in samples
depleted from NGF, the association between NaV1.8 and GM1 was not evident. Framed region
A
)
B
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are magnified to show co-localisation (arrows) and lack of co-localisation (dashed arrow). Scale
bars are 20 µm.
2.3.9 NaV1.8 and TrkA immuno-localisation in vitro.
TrkA is a transmembrane tyrosine kinase receptor, which binds to NGF. TrkA is expressed in
DRG neurons and has been reported to translocate into lipid rafts when it binds to NGF, to
initiate intracellular pathways (Limpert et al., 2007). One of the well established roles of lipid
rafts is to act as platforms on the membrane, where they regulate the physical association
between signaling proteins and their targets. Since, 1) we found that NaV1.8 co-localises with
lipid raft marker GM1, 2) NaV1.8 is known to be modulated by NGF, through TrkA (Okuse,
2007), and 3) TrkA itself partitions to lipid rafts (Limpert et al., 2007), we studied the
distribution of these proteins in DRG neurons. We used immunocytochemistry after 2DIV, to
visualise the proteins of interest. For the purpose of this analysis we focused our interest on
cells that were both expressing NaV1.8 and TrkA. We have found that TrkA was distributed on
the cell body and along the neurites, and that a high percentage of NaV1.8 clusters co-localised
with TrkA (85.2% ± 8.6 of NaV1.8 clusters positive for TrkA from four different neurons; Total
number of clusters = 67) (Fig. 2.21 A, B, arrows).
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Figure 2.21) Co-localisation between NaV1.8 and TrkA. A) Shows a neuron expressing both
NaV1.8 and TrkA. The framed region is magnified to show co-localisation between the proteins
(arrows). B) Shows another example of co-localisation between NaV1.8 clusters and TrkA along
a neurite. The framed region is magnified to show co-localisation between the proteins
(arrows). Scale bars are 20 µm.
2.3.10 NaV1.8, Flotillin-1-Dronpa and Caveolin-2-Dronpa in vitro.
Lipid rafts are heterogenous microdomains. Traditionally, we can refer to two distinct types of
rafts: planar and caveola-type. Planar lipid rafts lack a distinguishable morphology, while
caveola-type are identified as 50-100 nm diameters flask shaped invagination of the cell
membrane, which can be observed by electronic microscopy. Apart from morphological
features, planar lipid rafts and caveola-type can be distinguished by protein markers. Flotillin-1
has been shown to be enriched in planar lipid rafts (Langhorst et al., 2005), while Caveolin-2 is
present in caveola-type lipid rafts (Parton and Simons, 2007). Since valid antibodies against
these proteins for immunocytochemistry are unvailable, we created fluorescent forms of
Flotillin-1 and Caveolin-2. We delivered the constructs into DRG neurons to monitor their
expression and localisation, related to endogenous NaV1.8. We tagged the C-terminus of
Flotillin-1 and Caveolin-2 with Dronpa. Dronpa is a photochromic protein derived from GFP.
Similarly to GFP, it emits fluorescence in the green region of the electromagnetic spectrum
when excited with blue light, and compared to GFP it is brigher and shows the ability to
undergo rounds of activation and de-activation (Ando et al., 2004; Wilmann et al., 2006). We
found that Flotillin-1-Dronpa is localised both in the soma and along the neurites. This
construct was evenly distributed, with brighter puncta of fluorescence along the axons (Fig.
B)
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2.22 A, arrowheads). Interestingly, when we correlated the signal of Flotillin-1-Dronpa to the
localisation of endogenous NaV1.8 (visualised by immunocytochemistry), we found that a high
percentage of NaV1.8 clusters co-localises with the brigher spots of Flotillin-1-Dronpa along the
axons (Fig. 2.22 A, B, arrows) (70.8% of NaV1.8 clusters positive for Flotillin-1-Dronpa; Total
number of clusters counted = 24).
Figure 2.22) Co-localisation between Flotillin-1-Dronpa and NaV1.8. A) Shows a neuron
expressing Flotillin-1-Dronpa. The framed are is magnified to highlight the brighter patches of
A
)
B
)
A)
B)
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Flotillin-1-Dronpa (arrowheads). The same magnified area is show in the merged image, to
show co-localisation with endogenous NaV1.8 clusters (arrows). B) Shows another example of
co-localisation (arrows) between NaV1.8 and patches of Flotillin-1-Dronpa characterised by
high fluorescence along a neurite. Scale bars are 20 µm.
Caveolin-2-Dronpa showed a distinct clustered organisation along the neurites (Fig. 2.23 A, B),
even though a small percentage of neurons characterised by a very high expression of the
construct displayed Caveolin-2-Dronpa distributed along the entire length of the neurite (Fig.
2.23 C). In neurons with a clustered distribution of Caveolin-2-Dronpa we found that few of
NaV1.8 clusters were associated with Caveolin-2-Dronpa puncta, with the majority being
excluded from it (29.4% of NaV1.8 clusters positive for Caveolin-2-Dronpa, Total number of
clusters counted = 43) (Fig. 2.23 B). In conclusion, endogenous Nav1.8 showed a higher
percentage of co-localisation with Flotillin-1-Dronpa, compared to Caveolin-2-Dronpa (70.8%
vs. 29.4% *, respectively. * = p <0.05, Fisher’s exact test).
A
)
A)
94
Figure 2.23) Co-localisation between Caveolin-2-Dronpa and NaV1.8. A) Shows a neuron
expressing Caveolin-2-Dronpa. The framed region is magnified to show Caveolin-2-Dronpa
puncta. B) Shows a neuron expressing Caveolin-2-Dronpa. NaV1.8 is visualised by
immunofluorescence. The framed regions are magnified to show Caveolin-2-Dronpa puncta co-
localising (arrow) and not co-localising (dashed arrow) with NaV1.8. C) Show a representative
neuron characterised by a high expression of Caveolin2-Dronpa construct. Scale bars are 20
µm.
B
)
B)
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2.3.11 P11 and lipid rafts in vitro.
P11 is the light chain sub-unit of Annexin II. P11 was discovered in a genetic screening to
indentify novel interactors of NaV1.8 (Malik-Hall et al., 2003). Subsequent studies
demonstrated that P11 binds the N-terminus of NaV1.8 and plays a key role in its trafficking,
since p11 expression is necessary but not sufficient for NaV1.8 functional expression on the cell
membrane. Also, the complex Annexin II-p11 has been reported to partion into lipid rafts
(Oliferenko et al., 1999; Rescher and Gerke, 2004, 2008). Given this evidence, we investigated
its sub-cellular localisation in DRG neurons. By using immunocytochemistry on fixed cells we
found that p11 mirrors NaV1.8 sub-cellular localisation. Indeed, it is expressed on the cell
bodies and along the axons in clusters, where it co-localises with GM1 clusters (Fig. 2.24 A, B,
arrows). This finding indirectly supports NaV1.8 sub-cellular localisation and partition into lipid
rafts, given the evidence that p11 binds to channel and it has the ability to move into lipid
rafts.
A
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Figure 2.24) Co-localisation between p11 and GM1. A) Shows a neuron expressing p11. The
framed area is magnified to show co-localisation between p11 and GM1 (arrows). B) Shows
another example of co-localisation between p11 clusters and GM1 (arrows) along a neurite.
Scale bars are 20 µm.
B)
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2.4 Discussion
2.4.1 NaV1.8 association with lipid rafts: biochemistry techniques.
Lipid rafts were firstly discovered thanks to their biophysical characteristics, which are
different from the characteristics of the bulk membrane. Indeed, they are enriched in
cholesterol, sphingolipids and lipids with saturated fatty acid chains. They exist in a liquid
ordered phase and are resistant to non-ionic detergent lysis at 4˚C. This feature was also
proved to be a valuable property that can be used to separate lipid rafts from the rest of the
membrane. A classic method to isolate lipid rafts is to lyse the tissue/cells of interest at 4˚C, in
a lysis buffer containing a non-ionic detergent. Since lipid rafts are resistant to lysis, during this
process, they will be spared from the detergent action while the bulk membrane will be lysed.
A second step is necessary to biochemically isolate rafts: a centrifugation on a density gradient.
Typically, the membrane lysate, which contains intact rafts associated with raft proteins, and
the lysed bulk membrane are mixed with an agent (e.g. sucrose or Iodixanol) and overlaid with
fractions, containing less amount of the chosen agent. During the centrifugation step, lipid
rafts, due to their low density, will migrate towards the top of the centrifuge tube, while
solubilised lipids and non-raft proteins will remain at the bottom of the tube. A common
strategy to ascertain if a protein partitions into lipid rafts is to test whether it can be recovered
from the low density, buoyant, detergent-resistant membrane fraction. Because the purpose
of the ultracentrifugation on a density gradient is to separate rafts (and rafts associated
proteins) from the rest of the membrane, after the centrifugation step usually the same
volume, rather than the same amount of protein, from the different fractions is subjected to
SDS-PAGE. This allows assessing the relative degree of separation between lipid rafts and
solubilised membranes. The absence of raft markers between the buoyant fraction and the
soluble fraction provides the evidence that rafts were efficiently separated.
In our experiments we have found that in DRGs, sciatic nerve and DRG neurons in vitro, lipid
raft can be efficiently isolated from the rest of the membrane. The detergent of choice in our
case was Triton X-100. Many different detergents have been reported in literature to extract
lipid rafts, including CHAPS, Brij96, Brij98, and Lubrol WX (Pike, 2004). We choose Triton X-100
because this detergent, compared to the others listed before, has the highest detergent power
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and is the most stringent (Chamberlain, 2004; Schuck et al., 2003). It is also the most
commonly used detergent in biochemical preparations of membrane rafts (Besshoh et al.,
2007; Bruses et al., 2001; Davies et al., 2006; Martens et al., 2001; Morenilla-Palao et al., 2009;
Simons and Ikonen, 1997). The potential inconvenient, by using less harsh detergents, is to
only partially digest the cell membrane. In this scenario, non-raft portions of the membrane
could be under digested, contaminate the raft fraction and lead to misinterpretation of the
results.
We have used different markers to define the raft and non raft fractions of the cell. Transferrin
receptor is a recognised marker of the soluble portion of the membrane and does not display
raft properties (Harder et al., 1998). On the other hand, lipid rafts can be identified by protein
and lipid markers. We exploited the known association of Flotillin-1 with rafts (Langhorst et al.,
2005) and the high abundance of GM1 (Brown, 1998; Parton, 1994) in these domains to define
lipid rafts in our biochemical preparations. Since the association of a protein with the
detergent resistant portion of the membrane is proved to be a very powerful indication of raft
association, we looked whether NaV1.8 co-migrates with Flotillin-1 and/or GM1. We efficiently
separated rafts from different sources: DRG cell bodies and sciatic nerve ex vivo and DRG
neurons in vitro. In DRG cell bodies and sciatic nerve we found similar pattern of raft
extraction. In both tissues, Transferrin receptor was retained in the bottom fractions, which
indicates that the detergent effectively solubilised the non-raft portion of the membrane.
Therefore we defined the fractions containing Transferrin receptor as non-lipid rafts. The
partition of GM1, which is highly enriched in lipid rafts, in the top fractions, suggests that in
our preparation lipid rafts are efficiently extracted and separated from the soluble portion of
the tissues. Flotillin-1 profiles also supported this. In fact, Flotillin-1 showed both in DRG cell
bodies and in the sciatic nerve samples, to be associated with two pools; one is floating in the
top layers and the second one, separated from the top one, associated to the non-raft portion
of the membrane. The existence of these two pools could reflect either Flotillin-1 physiological
trafficking between the membrane and the intracellular compartments or an over-digestion
due to the detergent. Flotillin-1 is known to exist in two pools: one on the membrane, fully raft
associated, and one retained in the intracellular compartments (Langhorst et al., 2005). During
the detergent extraction, only the pool of Flotillin-1 associated with rafts is spared from lysis,
while the intracellular pool, not associated with rafts is subjected to detergent mediated
degradation. For this reason, only the raft associated Flotillin-1 will float with rafts and will be
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recovered from the top layers of the density gradient. On the other hand, the intracellular
pool, not raft associated, will be restricted to the soluble fraction. Alternatively, the soluble
pool of Flotillin-1 could arise from an excessive lysis of the membrane, which could impair raft
integrity, and Flotillin-1 migration towards the top of the gradient. This hypothesis is not likely
since GM1 is highly enriched in the top fractions. If over digestion occurred, we would have
expected also an enrichment of GM1 in the bottom fractions. Therefore, in our preparations
we can conclude that the floating detergent resistant membranes are bona fide lipid rafts and
that the soluble fraction is not contaminated with over-digested lipid rafts.
In DRGs and sciatic nerve we found a different pattern of association of NaV1.8 with lipid rafts.
Interestingly, at the level of the cell bodies the great majority of NaV1.8 is in the soluble
fraction (non-raft). At the level of the sciatic nerve, we found a completely opposite scenario:
all NaV1.8 is raft associated. DRGs contain the cell bodies of sensory neurons, glial cells, and
short axonal processes which arise from the cell bodies. It is known that NaV1.8 at the level of
DRG is selectively expressed in the neuronal population, and more specifically, mostly in the
small diameter, unmyelinated, nociceptors (Djouhri et al., 2003a). Also, the great majority of
NaV1.8 is retained intracellularly (Zhang et al., 2008) and it is not functional in terms of cell
excitability. The biological meaning of this intracellular retention is not fully understood. One
possibility is that a reservoir of the channel is stored internally in the ER, ready to be trafficked
to the membrane, upon excitatory stimuli. In fact, inflammatory compounds determine a rapid
increase of TTX-r currents mediated by NaV1.8, which is consistent with a rapid traffic of the
channel rather than an increase in the transcription rate, which could account for increased
TTX-r currents at later stages (Liu et al., 2010). NaV1.8 association with the soluble fraction in
DRG neurons that we have reported perfectly matches the known evidence that this channel is
mostly retained in the ER. In fact, during raft extraction, the bulk plasma-membrane and the
ER, which devoid of rafts (Simons and Ikonen, 1997), are lysed. In this condition, NaV1.8 not
associated with rafts, will not float to the top of the density gradient and will be recovered
from the soluble fraction. By extending the exposure time of our blot, we found that a minor
proportion of the channel is indeed associated with rafts. This pool can be of different origins;
a potential source could be from the minority of the channel which is inserted into the
membrane, and be raft associated. Another source may be the pool of channels which is
trafficked to the axons and exposed onto the membrane where it underlies sodium currents
during action potential propagation. The other source we used to investigate NaV1.8-raft
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association was the sciatic nerve and we found that NaV1.8 is fully raft associated in this tissue.
Sciatic nerve is a spinal nerve which contains efferent axons of motor-neurons and afferent
axons of sensory neurons, plus Schwann cells which contribute to the myelination of the fibres.
In this tissue NaV1.8 is expressed along the axons of unmyelinated DRG neurons where it
contributes to the propagation of action potentials, originated in the peripheral tissues,
towards the spinal cord by encoding TTX-r currents (Jeftinija, 1994b; Quasthoff et al., 1995).
Also, NaV1.8 must be inserted in the membrane to be able to underlie sodium currents and
evoke action potentials (Okuse et al., 2002; Renganathan et al., 2001). Hence, it is assumed
that functional NaV1.8 is localised on the plasma-membrane of axons in vivo. It is worth to
mention that sciatic nerve may also contain intracellular vesicles, which traffic the channel
towards its final destination. The biosynthesis of lipid rafts is still unknown and it is
hypothesised the intracellular rafts may exist in the late trans-Golgi network apparatus (van
Meer and Sprong, 2004), where both cholesterol and sphingolipids are present (Ikonen, 2001;
van Meer et al., 2008). Given this evidence, a fraction of raft associated NaV1.8 from this
source cannot be excluded a priori. Nevertheless, it is important to stress that our result
clearly shows that in the sciatic nerve total NaV1.8 is associated with lipid rafts. This means that
the functional, membrane bound, NaV1.8 pool which mediates action potentials is localised on
membrane rafts and is laterally excluded from the non-lipid raft, bulk portion, of the plasma-
membrane. Interestingly, we found NaV1.8 to be present in different sizes. NaV1.8 predicted
size (as calculated by using the algorithm at http://expasy.org/tools/pi_tool.html) is 220 kDa,
which could considerably vary due to glycosylation states (Goldin et al., 2000; Schmidt and
Catterall, 1987; Yu and Catterall, 2003). In our preparation, we found NaV1.8 as three different
sizes: 201 kDa, 222 kDa and 247 kDa. The heaviest form could arise from a highly glycosylated
form or from the splicing variant that has been reported to have a duplication of exons 12-14
(Akopian et al., 1999a), while the lowest molecular weight could represent one of NaV1.8
shorter isoforms. In fact, one isoform has been reported to lack a portion of the first
intracellular loop, which could account for the reduced apparent molecular weight (Dr. K.
Okuse, personal communication). Also, we recovered NaV1.8 from lipid rafts being associated
with two different fractions (lane 2 and 3 in Fig. 2.7). One hypothesis to explain the different
motility of the channel is to consider raft heterogeneity. Rafts do share the same biophysical
characteristics, nevertheless they can display subtle differences in terms of density (and when
subjected to centrifugation they float to different position (Roper et al., 2000; Schuck et al.,
2003), protein markers (e.g. planar vs. caveola-type) and detergent extraction (Pike, 2004). In
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our hands, NaV1.8 recovered from lanes 2 and 3 could account for pools of the channel
associated with rafts that are both extracted by Triton X-100 but characterised by slightly
different density, which leads to a different migration pattern. In this scenario, the highly
glycosylated form of NaV1.8 would associate with the denser rafts while the lower molecular
weight forms with the lower density rafts. A study supporting a correlation between
glycosylation state and raft trafficking has already been reported. This report focused on
TrpM8, a cation channel expressed in DRG neurons which transduces cold stimuli into cell
depolarisation that, in turn, triggers action potentials. TrpM8, similarly to NaV1.8, is a highly
glycosylated protein. TrpM8 associates with rafts and it has been found that its glycosylation
pattern correlates with the extent of raft trafficking. In particular, the highly glycosylated form
is raft associated while the low glycosylation form tends to partition into the soluble fraction
(Morenilla-Palao et al., 2009). Furthermore other studies have also identified glycosylation as a
targeting signal determining the raft association of membrane proteins (Alfalah et al., 1999;
Scheiffele et al., 1995). In conclusion, from fresh tissues we found that NaV1.8 raft association
is different in DRGs and sciatic nerve. In DRGs cell bodies the majority of NaV1.8 is non-raft
associated (most likely to be retained intracellularly) and along the axons in the sciatic nerve it
is trafficked to lipid rafts. Also, different isoforms/glycosylation pattern could correlate to the
targeting of these forms to different rafts.
We have also analysed NaV1.8 raft association in DRG neurons in culture. Once plated, DRG
neurons display features that they express in vivo. For this reason they are commonly
exploited as a model to investigate DRG protein function (Gold et al., 1996a; Malin et al.,
2007). The advantage of a DRG culture, compared to an ex vivo source, is that the population
of cells is virtually composed only by neuronal cells, as non-neuronal cells are not present due
to the presence of Aphidicolin which inhibits their proliferation. We thought to determine if
rafts could be extracted from DRG neurons in vitro and whether NaV1.8 associates with them.
Our lipid raft preparation, displaying floating fractions enriched in Flotillin-1 and GM1, clearly
demonstrate that DRG neurons do contain raft domains and these can be efficiently extracted.
Interestingly, NaV1.8 is present as two pools; one raft associated and one that is not. This result
can be interpreted considering that, differently from the ex vivo sources where it’s possible to
anatomically separate DRG cell bodies from the axons, in vitro both the neuronal cell bodies
and the axons are present in culture. Given this condition, both intracellular and membrane
bound NaV1.8 is present. Hence, the most likely sources of NaV1.8 are from the ER, which
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appear in the soluble fraction in the biochemical extraction, and from lipid rafts. This latter
pool is likely to be represented by the channels inserted into the membrane along the axons
(see next section of the discussion, 2.4.2). Thus, we have found in vitro a situation that
recapitulates what we have found ex vivo, by using DRGs and sciatic nerve separately: NaV1.8
associates with rafts along the axons and the soluble pool, non raft linked, is likely to be
derived from the intracellular stores of the channel.
2.4.2 NaV1.8 sub-cellular localisation and association with lipid rafts: imaging
techniques.
We explored NaV1.8 sub-cellular localisation and further confirmed its association with lipid
rafts in DRG neurons by using imaging techniques.
Firstly, we investigated NaV1.8 localisation by immunocytochemistry in cultured DRG neurons.
We have found an interesting pattern of localisation of NaV1.8, with a different distribution
between small and large diameter neurons. In particular, in small diameter neurons, which we
identified both by morphology and expression of Peripherin, NaV1.8 was expressed in clusters
along the length of the axons. This distribution was evident for unmyelinated fibres, but not
for large diameter neurons. In fact, these latter cells, which we identified by morphology and
expression of NF200, showed NaV1.8 being either evenly distributed or associated in large
patches along the axons. Interestingly, this dual pattern was already evident after 2 DIV and
conserved up to 4 DIV. This suggests that the clustered distribution of NaV1.8 in small diameter
neurons most likely represents a terminal organization of the channel, already established
after 2DIV, rather than a temporary distribution, due to the channel being trafficked to its final
destination. In this preparation, the localisation of the channel which we identify by
immunocytochemistry cannot be unequivocally determined, since we cannot distinguish
between intracellular and membrane bound channels. DRG neurons, once plated, undergo a
“regeneration” process and extend axons, if growth factors are supplemented (Campenot,
1977). Hence, the distribution of NaV1.8 could also be attributed to a dynamic process that
happens in vitro, which does not occur in adult animals. Strongly supporting the evidence that
NaV1.8 is present in clusters as a terminal organization, we found a clustered appearance of
the channel along the unmyelinated axons in the sciatic nerve in vivo. It is also worth to
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underline that the biochemical sciatic nerve lipid raft preparation showed that all NaV1.8 is raft
associated. Hence, the NaV1.8 channels we found along the axons ex vivo in clusters are most
likely exposed on the membrane. Thus, the clustered appearance along unmyelinated teased
fibres confirms the distribution we found in vitro; this one mirrors a situation which is
established in vivo, rather than being an artifactual localisation, due to regenerative processes
in vitro. The meaning of this clustered distribution is unknown at the moment. The spatial
localisation of ion channels and the electrophysiological properties of the channels themselves
are of paramount importance in shaping the electric excitability of neuronal cells. In fact,
compartmentalisation of ion channels defines the electric properties not only among different
neurons, but also between different regions of the same neuron. The most evident example is
supported by the nodes of Ranvier along the myelinated fibres which guarantee saltatory, high
speed, conduction. In these structures sodium channels are clustered at high density and
potassium channels are spatially segregated, and this contributes to the ability of the nodes to
boost and regenerate action potentials (Kandel et al., 2000). The clustered appearance of
NaV1.8 could have a functional role in terms of action potential propagation along the axons
where this channel is expressed. As discussed before NaV1.8 plays a key role in action potential
generation, by underlying the majority of sodium influx during the rising phase (see section
1.3.1). It is tempting to speculate that in unmyelinated fibres NaV1.8 clusters represent sites on
the membrane where action potential can be actively generated. In the portion of membrane
lacking NaV1.8 the electric signal would spread following passive cable properties, and before
dissipating it could be re-generated at the sites of NaV1.8 clustering. In this hypothetical view,
unmyelinated fibres would generate action potentials only in discrete portions of the
membrane, like myelinated fibres, where action potentials are regenerated only at the nodes
of Ranvier. In unmyelinated fibres we found that the clusters are a few µm apart, differently
from myelinated fibres, where sodium clusters can be separated by hundreds/thousand of µm
(Hille, 2001). It could be hypothesised that the close vicinity of the clusters we have found in
our condition represents a distance short enough for the passively conducted depolarisation to
not be dissipated and to be propagated from cluster to cluster, where it reaches a threshold to
recruit NaV1.8, which actively further depolarises the membrane. Interestingly, classic studies
support a way of action potential conduction in unmyelinated fibres similar to the one that we
hypothesise. In fact, upon demyelination sodium channels redistribute along the unmyelinated
region (England et al., 1990; Meiri et al., 1985; Waxman, 2006a). Electrophysiological analysis
reported that in demyelinated axons (Lysophosphatidyl-choline method) action potential
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conduction is restored before re-myelination occurs. In this condition conduction was found to
be discontinuous and proceeded via “new foci of inward membrane current”. The authors
hypothesise that these foci represent clusters of sodium channels that precede the formation
of nodes of Ranvier and saltatory conduction, and allow action potential conduction in the
absence of myelin (Smith et al., 1982). The biological meaning of clusters could be also
attributed to the fact that clusters of NaV1.8 increase its local concentration, which could be
needed to efficiently generate action potentials. In fact, it is has been demonstrated that high
concentration of sodium channels is needed for an efficient action potential generation. Apart
from the example discussed before about the nodes of Ranvier, where sodium channels are
highly concentrated (> 1200/ µm2) (Poliak and Peles, 2003), sodium channels also cluster at
high concentration in the axonal initial segment (AIS). The AIS is an unmyelinated region of the
axon, which is flanked by the cell body and the myelin wrap of the axon. AIS integrates the
depolarisation propagating from the cell body and triggers an action potential which travels
along the axon and back propagates in the soma (Lai and Jan, 2006). It has been demonstrated
in pyramidal cells that a high concentration of sodium channels (approximately 50 fold greater
than ion channels concentration at the level of the soma and dendrites - most likely NaV1.6) is
needed to generate action potentials (Kole et al., 2008). Another example of clusters of
sodium channel at high density has been reported by Engel et al. Remarkably, this study
demonstrated that in the hippocampal mossy fibre pathway (which connect the dentate gyrus
to the C3 region) sodium channels are at high concentration in the en passant boutons along
the unmyelinated fibres (calculated in 2000 units per bouton). The authors conclude that the
high density of sodium channels is needed to amplify action potential at the pre-synaptic sites
and boost neurotransmitter release. Also, by computation modelling, it has been predicted
that the clusters of sodium channels at the boutons along the axons influence the reliability
and velocity of action potential propagation (Engel and Jonas, 2005). Very interestingly, a
clustered distribution of sodium channels, similar to what we have reported, has also been
described in the unmyelinated axons of animal model Aplysia californica (Johnston et al.,
1996). In this invertebrate the distribution in clusters has been proposed to be more
energetically efficient in terms of cell metabolism and action potential propagation. The
authors predict that by clustering channels along the unmyelinated fibres, fewer channels are
needed to conduct action potentials, compared to a scenario where sodium channels are
evenly distributed. This would imply less channels being transcribed, translated and
transported, with an overall reduction of energetic expenditure. In conclusion, since neuron
105
excitability is dependent on many factors, including ion channel sub-cellular localisation and
local density, NaV1.8 clusters may be at the base of action potential generation and conduction
and be important to shape the excitability of unmyelinated axons of nociceptors.
We next exploited cultured DRG neurons and imaging techniques to further investigate NaV1.8
raft association. Imaging techniques represent complementary methods to study lipid rafts
and raft associated proteins, which support data obtained by conventional biochemistry
techniques. Most of the detailed features of rafts nature have been, in fact, provided by using
these optical methods. FRET allowed the direct visualisation of nano-clusters of GPI-anchored
proteins. FRET is based on the energy transfer between a donor and an acceptor molecule.
Since this phenomenon only occurs in the range of 1-10 nm is suited to study rafts dynamics.
Analysis of these GPI-anchored proteins nano-clusters showed that they are immobile,
cholesterol dependent and that GPI-anchored proteins follow a non random distribution
(Goswami et al., 2008). By using FRET, Silvius et al. showed that at physiological temperature
membrane lipids do partition into Lo and Ld phases (Silvius, 2003). Zacharias et al. showed that
acylated, but not prenylated, GFP and YFP partition and cluster into lipid rafts in live MDCK
cells. Notably, clustering was dependent on cholesterol presence and raft partition correlates
with their extraction from DRMs (Zacharias et al., 2002). FRET was also used to investigate G
proteins association with rafts (Abankwa and Vogel, 2007). In addition, FRET analysis gave us
information about the diffusion kinetics of raft residing proteins. It was found that clustered
Src in rafts are less motile that Src in the non raft portion of the membrane and in the
cytoplasm (Lu et al., 2008). FLIM measures the average time that an electron spends in the
excited state of a fluorochrome before relaxing back to the ground state. By FLIM microscopy
the mechanism behind epidermal growth factor receptor (EGFR) signaling has been unveiled. It
was found that EGFR co-localises at a nano-scale level with ganglioside GM1 (raft marker) but
not with Transferrin receptor (non raft marker). Furthermore, it was found that heterogeneous
resting small rafts are induced to coalesce upon EGF binding to the EGFR, leading to the
formation of a signaling platform (Hofman et al., 2009; Hofman et al., 2008). AFM, which relies
on the “scanning” of a surface with a mechanical probe controlled by a piezo-electric element,
proved to be a valuable tool in studying artificial membranes (Nicolini et al., 2006). Rafts size
has been determined in model membranes to be in the range of 20-100 nm (Yuan et al., 2002).
In FCS microscopy the temporal ﬂuorescence ﬂuctuations, due to diffusion kinetics, of a single
ﬂuorescent molecule are monitored through a small detection volume. FCS was found to be a
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powerful tool to discriminate between diffusion coefficients of raft markers (GM1 ganglioside)
and non raft markers, both in live cells and model membranes. In this study it was found that
cholesterol depletion plus cytoskeletal disruption altered GM1 motility, suggesting the
existence of a raft population stabilized by interaction with intracellular elements (Bacia et al.,
2004). A more recent study monitored rafts in live cells by FCS of raft fluorescent protein
markers (GFP-Thy1, Lck1-12-GFP). It was demonstrated that in live cells rafts exist in the outer
and inner leaflet of the membrane, that they are dependent on cholesterol and sphingolipids
presence and their stability is crucial for Akt recruitment and signaling (Lasserre et al., 2008).
STED allows to excite a small area (smaller than conventional confocal microscopy) and to
lower the resolution limit. STED microscopy allowed single molecule tracking of raft markers
(GM1 and GPI-anchored proteins) as well as non raft markers. The analysis of the traces and
fluctuations in live cells revealed that unlike phosphoglycerolipids, sphingolipids and GPI-
anchored proteins are transiently (10–20 ms) trapped in cholesterol-mediated molecular
complexes, consistent with the idea of small dynamic rafts (Eggeling et al., 2009). Super
resolution microscopy (resolution 3 nm) allowed the direct visualisation of raft enriched nano-
clusters and that the formation of “hot-spots” on the cell surface triggers cell-adhesion. It was
found that in quiescent cells, Integrin LFA-1 and GPI-anchored proteins pre-organize in
separate nano-compartments forming “hot-spots” sites on the cell surface. Activation of LFA-1
by ligand binding drives the formation of larger supramolecular platforms that serve as
nucleation sites for nascent cell adhesion (van Zanten et al., 2009). Fluorescence
photoactivation localisation microscopy (FPLAM) unveiled that raft associated transmembrane
protein haemagglutinin is distributed in nano-cluster (40 nm/> 100 µm diameter) in live cells
(Hess et al., 2007).
We investigated raft NaV1.8 association with a microscopy based technique by visualising GM1
on the neuronal surface with CTB. CTB is a 60 kDa pentameric protein which is implicated in
the pathogenesis of Vibrio Cholerae. CTB, by binding to GM1, allows the internalisation of the
toxin which drives its toxic effects intracellularly by releasing the A sub-unit. Because of the
specificity of the CTB to GM1 (Merritt et al., 1994), and being GM1 highly enriched in lipid
rafts, CTB is used as a common marker to visualise lipid rafts (Bruses et al., 2001; Harder et al.,
1998; Janes et al., 1999; Zhu et al., 2006). The protocol we use to visualise lipid rafts employs
live cells incubated with a biotinylated form of CTB. The toxin itself is visualised by a
fluorescent conjugate of Streptavidin, which binds to the biotin moiety harboured by the toxin.
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Since we use live cells, which are impermeable to Streptavidin, all the GM1 detected with this
method is exposed on the membrane. Small dynamic rafts, which are not stabilised in larger
platforms, are 50-100 nm in diameter. This size, being below the limit of optic detection (200
nm with conventional microscopes) hinders a direct visualisation of the smaller lipid rafts. CTB
is a pentameric protein, which bids to five GM1 molecules (Merritt et al., 1994) and induces
rafts patching (Janes et al., 1999). Streptavidin, which binds to four molecules of biotin, further
enhances the patching process. This method is widely used to induce coalescence between
rafts, and to bring them above the limit of light detection (Hammond et al., 2005; Harder et al.,
1998; Owen et al., 2007). We correlated the immunoreactivity of NaV1.8 to the signal for lipid
rafts in our system. We have found that GM1 is present as puncta on the cell surface, both at
the level of the cell body and along the neurites. Interestingly, the degree of co-localisation
between GM1 and NaV1.8 was very high along the axons, suggesting the clusters of NaV1.8 do
co-localise with rafts in these cell processes. On the contrary, at the level of the cell body this
co-localisation was not as clear as along the axons. This result could contribute to elucidate the
sources of the different pools of NaV1.8 which we identified with biochemistry techniques in
vitro. As we discussed beforehand, it is known that the majority of NaV1.8 is retained
intracellularly at the level of the cell body. We found that at the level of the soma, by imaging,
there wasn’t a clear co-localisation between NaV1.8 and membrane bound GM1. Hence, it is
highly possible that the soluble pool of NaV1.8, extracted with biochemistry techniques, is
derived from the intracellular stores. On the other hand, along the axons, we found co-
localisation between GM1 and NaV1.8. Thus, it is likely that the raft associated pool of the
channel that we extracted with the detergent method is derived from the axonal
compartment. We also found a different pattern of co-localisation between GM1 and NaV1.8 in
small and large diameter neurons. In fact, in large diameter neurons, where NaV1.8 is either
evenly distributed or associated in patches along the axons, the channel and GM1 do not co-
localise. This pool could contribute as a potential source of non-raft associated NaV1.8 which
we detected with biochemistry techniques. This finding also suggests that the process of
NaV1.8 raft targeting is specific for the unmyelinated nociceptors. Rafts play a role in
trafficking, and they have been shown to act as signal to drive channel insertion on the
membrane (Pristera and Okuse, 2011). It is possible that rafts in unmyelinated neurons are
needed for an efficient translocation of NaV1.8 on the membrane. In myelinated neurons a
complex feed-back between neurons and glial cell is at the base of channel clustering at the
nodes of Ranvier or AIS. In unmyelinated neurons, less is known about the mechanisms
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regulating channel trafficking and insertion into the plasma-membrane. Given rafts established
role in trafficking (Echarri et al., 2007; Helms and Zurzolo, 2004; Ikonen, 2001) it is possible to
hypothesise that rafts may play a role in NaV1.8 insertion and/or clustering into the
membrane.
We confirmed NaV1.8 clustered distribution and raft association by using a fluorescent
construct. We tagged the C-terminus of NaV1.8 with DsRed2. The choice to tag the C-terminus
of NaV1.8 is due to the fact that the N-terminus of NaV1.8 is a docking site for p11, a chaperon
protein which promotes NaV1.8 membrane association by directly binding it. We thought that
the addition of a fluorescent tag to this end may have altered the ability of the channel to bind
to p11. In addition, it has already been demonstrated that the fusion of a fluorescent protein
to this end does not alter the NaV1.8 electrophysiological properties (Schofield et al., 2008).
DsRed2 is a new generation red fluorescent proteins which, compared to the wild-type and
first generation of engineered red fluorescent proteins DsRed1, has more advantages.
Compared to DsRed1, DsRed2 has been genetically modified to form a variant which is
brighter, faster maturing (Terskikh et al., 2002) and importantly, less prone to aggregation
(Yanushevich et al., 2002). This construct has been widely used to tag protein of interests
(Maruyama et al., 2004; Traweger et al., 2003; Yamaguchi et al., 2006) and, in neurons, to
analyse trafficking of membrane associated protein (Stan et al., 2010). The major advantages
of this method, compared to antibody based techniques, are that an analysis of live cells and a
direct visualisation of NaV1.8 are possible. Moreover, potential artifacts due to cell fixation are
avoided. A large scale analysis was hindered by the very low transfection efficiency of this
construct by microporation. Primary neurons are very hard cells to transfect in first instance
(Dib-Hajj et al., 2009), and the large size of our construct further complicated its delivery
and/or expression. Nevertheless, in the neurons we managed to transfect we found that
NaV1.8-DsRed2 does cluster and co-localises with GM1 along the axons. This finding confirms
the results we have achieved by using antibody against NaV1.8. It also shows that the addition
of a tag at the C-terminus of NaV1.8 does not alter the gross distribution of the channel.
Given the results showing that NaV1.8 associated with lipid rafts we tested if this association
can be modulated. Our choice was to investigate the potential role of NGF in the association
between rafts and NaV1.8. There are several reasons why we choose NGF. Lipid rafts act as
signaling platform on the neuronal membrane, where they regulate the spatial and temporal
dynamics of different set of proteins. In fact, they can allow molecular interaction and act as
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permissive factors for given pathways, or impede proteins from interacting and therefore act
as an inhibitory signal (Allen et al., 2007). We found that TrkA, NGF receptor, is expressed
along the axons and that NaV1.8 clusters co-localise with TrkA. TrkA, upon binding to NGF,
translocates and is retained into lipid rafts, through the association with Flotillin and CAP (c-Cbl
associated protein), where it initiates intracellular signaling (Limpert et al., 2007). Also, NGF
increases NaV1.8 mediated currents by different routes (Okuse, 2007); in the short term,
through PKCε, by directly phosphorylating the channel (Gold et al., 1998; Khasar et al., 1999) ,
and interestingly in neuronal cells PKC has also been reported to translocate into lipid rafts
upon activation (Botto et al., 2007). In the long term, NGF increases NaV1.8 currents by
augmenting its expression (Fjell et al., 1999a; Okuse, 2007). Given these circumstantial
evidence, we tested if NGF modulates NaV1.8 raft association. We found that the co-
localisation between GM1 and NaV1.8, which is evident in small diameter neurons in control
cells, is impaired in cells not treated with NGF. We investigated long term effects of lack of
NGF. In this experimental model, the lack of association between GM1 and NaV1.8 could be the
results of different causes. NGF is a pleiotropic cytokine, which is fundamental for DRG
neurons survival and to promote neurites extension (Sofroniew et al., 2001). Therefore, many
factors may contribute to mis-colocalisation between Nav1.8 and GM1 in the prolonged
absence of NGF. A direct effect of the lack of NGF in properly trafficking NaV1.8 to lipid rafts
can be hypothesised as well as more generic factors, like decreased expression of NaV1.8,
increased cell apoptosis, cellular stress, lack of an extensive neurite outgrowth. It would be
interesting to test an acute effect of lack of NGF, or the effect of the application of NGF to
short-term deprived neurons, on the association between NaV1.8 and lipid rafts, both by
imaging and biochemical techniques.
We also investigated the sub-cellular localisation of p11. P11 (Annexin II light chain) has been
demonstrated to act as a key role for the functional expression of NaV1.8 into the membrane.
Annexins are a group of proteins which regulate protein trafficking to the membrane in a
calcium dependent fashion. P11 is the only member that has suffered mutations into its
calcium binding site, and exists in a permanent activated states (Gerke and Moss, 2002). P11
binds the N-terminus of NaV1.8 (residues 74-103) (Poon et al., 2004) and is necessary, but not
sufficient, to allow NaV1.8 localisation on the membrane. Moreover, the complex Annexin II-
p11 resides into Triton X-100 resistant membrane (Oliferenko et al., 1999; Rescher and Gerke,
2004). In our system, we found co-localisation of p11 with GM1, suggesting raft association in
110
agreement with other groups’ findings (Oliferenko et al., 1999). Also, p11 displayed a clustered
localisation along the axons in vitro, similar to the distribution of NaV1.8. Given the evidence
that p11 specifically binds to NaV1.8 and it resides in lipid rafts, this result indirectly confirms
the sub-cellular localisation of NaV1.8 and the channel’s raft association in DRG neurons. To
summarise the data discussed so far, we have found that NaV1.8 does associate with lipid rafts
in vitro, and this was confirmed both with biochemical techniques and by imaging.
One pitfall of biochemical extraction is that this is not the best method to ascertain which type
of raft the proteins of interest is targeted to. Lipid rafts can be distinguished by morphology
and protein content, but since the lipid content is very similar, detergent extraction and
density gradient does not unequivocally distinguish between planar and caveola-type lipid
rafts. For this purpose, we used imaging techniques to explore this point. At the time of
performing the experiment, valid antibodies for immunocytochemistry for Flotillin-1 and
Caveolin-2 were not available. For this reason, we cloned these two proteins with a fluorescent
tag, to visualise them in DRG neurons and to correlate their localisation with endogenous
NaV1.8. We used Flotillin-1 as a marker of planar lipid rafts and Caveolin-2 as a marker of
caveola-type lipid rafts, given the established roles of these proteins as markers of the
respective raft types. In neuronal cells the expression of Flotillins has been extensively
documented. In fact, Flotillin-1 has been found in several tissues, including brain (Kokubo et
al., 2003), hippocampal (Swanwick et al., 2010b) and DRG neurons (Lang et al., 1998).
Expression of Caveolins has also been showed to exist in DRG neurons (Galbiati et al., 1998),
hippocampal neurons (Bu et al., 2003) and cortical neurons (Takemoto-Kimura et al., 2007);
nevertheless reports argue against the existence of caveolae and Caveolins in neuronal cells
(Lang et al., 1998; Scherer et al., 1997). The tag of choice was fluorescent protein Dronpa. This
construct is a modified form of GFP, which exhibits useful features. It is more than two-fold
brighter than GFP (Chapman et al., 2005) and has the remarkable property to undergo rounds
of photoactivation/deactivation (Ando et al., 2004; Habuchi et al., 2005; Wilmann et al., 2006).
We tagged the C-terminus of Flotillin-1 and Caveolin-2 and found different localisation pattern:
evenly distributed with brighter puncta and distributed in discrete puncta, respectively.
Fluorescent forms of these proteins have already been described. In particular, in hippocampal
neurons, an EGFP C-terminus fusion of Flotillin-1 tag appears distributed in puncta at the cell
surface with a lower fluorescence signal between the puncta (Swanwick et al., 2010a). We
have found a very similar distribution, with the difference that in our hands the fluorescence
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between the puncta was higher compared to the reported Flotillin-1-EGFP construct. Possible
explanation of this discrepancy could be attributed to the different cellular background which
could partly affect Flotillin-1 trafficking, different fluorescent tag (Dronpa vs. EGFP) and
imaging apparatus. The nature of the brightest puncta cannot be described with certainty by
our data. Given the existence of a heterogeneous population of rafts (small, highly dynamic vs.
large, stable) (Simons and Gerl, 2010; Simons and Ikonen, 1997) it is tempting to speculate that
the brightest puncta of Flotillin-1-Dronpa are associated with large and stable raft platforms
which serve as hubs on the membrane regulating trafficking and cell signaling (Lingwood and
Simons, 2010; Simons and Gerl, 2010). A fluorescent form of Caveolin-2 has not been reported
in neuronal cells. We have found that this construct localises in discrete clusters. We have
correlated the localisation of Flotlillin1-Dronpa and Caveolin-2-Dronpa with endogenous
NaV1.8 and found that NaV1.8 preferentially associated with Flotillin-1-Dronpa, suggesting that
planar lipid rafts are the micro domains that NaV1.8 is targeted to in DRG neurons.
In conclusion, we have found that NaV1.8 partitions into lipid rafts along the sciatic nerve ex
vivo, while at the level of the DRG cell bodies it is mostly associated with non-raft membranes.
In cultured DRG neurons it is associated both with lipid raft domains and non raft portions of
the cells. More specifically, it co-localises along the axons with raft marker GM1 and
preferentially targets planar lipid rafts. We have also shown that NaV1.8 is distributed in
clusters along the axons of nociceptors ex vivo and in vitro.
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Chapter 3: Investigation of the functional
meaning of the association between
NaV1.8 and lipid rafts in DRG neurons
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3.1 Introduction
3.1.1 Synopsis.
In the previous chapter we demonstrated that NaV1.8 is trafficked to lipid rafts. In this chapter
we shall investigate the biological relevance of NaV1.8 raft association by interfering with raft
stability. Methods to disrupt the association between rafts and proteins of interest will be
introduced. We shall also describe and discuss the functional assays (mechanical and chemical
stimulation of DRG neurons to evoke action potentials) that we have exploited to test the
functional meaning of the association between NaV1.8 and lipid rafts in nociceptors.
3.1.2 Methods to disrupt lipid rafts.
The strategy to unravel the biological meaning of the association between a certain protein
and lipid rafts is to disrupt such association and to test the activity of the protein of interest.
Several ways have been described to manipulate lipid rafts stability. These methods interfere
with rafts by changing different aspects of their nature. Cholesterol depletion, inhibition of
cholesterol synthesis, sphingolipids down-regulation and lipid phase change have been
described. The most common method is to deplete the cell from membrane cholesterol.
Indeed, raft stability is dependent on this sterol and its depletion leads to raft disruption.
Cholesterol is a hydrophobic molecule and cyclic oligosaccharides are used to remove it from
the membranes. The most common is Methyl-β-cyclodextrin (MBCD). MBCD is a seven 7-P (1-
4)-glucopyranose unit, toroid shaped, oligosaccharide. The external surface renders MBCD
hydrophilic while the interior surface is hydrophobic. This internal cavity has the ability to
encapsulate hydrophobic molecules and allow them to become soluble in a water aqueous
environment (Brewster, 1990). MBCD shows high affinity for cholesterol compared to other
lipids and is the most effective, between cyclodextrins, in binding cholesterol (Christian et al.,
1997; Yancey et al., 1996). When applied to the cells, MBCD promotes cholesterol depletion
from the cell surface, by binding to it (Christian et al., 1997; Klein et al., 1995; Pottosin et al.,
2007). This effect has been demonstrated to occur because MBCD substantially decrease the
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activation energy for cholesterol efflux from the hydrophobic plasma membrane (Yancey et al.,
1996). MBCD mediated cholesterol depletion leads to rafts disruption and represent the
standard method to assess raft proteins function (Dart, 2010; Davies et al., 2006; Eshcol et al.,
2008; Hartmann et al., 2009; Hering et al., 2003; Limpert et al., 2007; Morenilla-Palao et al.,
2009; Oldfield et al., 2009; Simons and Toomre, 2000; Zhu et al., 2006). Consistent with the
importance of cholesterol for the integrity of rafts, other methods have been used to reduce
its amount on the membrane. Statins are small inhibitors of 3-hydroxy-3-methyl-glutaryl-CoA
reductase (HMG-CoA), an enzyme involved in cholesterol and isoprenoids biosynthesis (Endo,
1992). Treatment with Fluvastatin disrupts lipid rafts and impairs FcγR signaling in
macrophage, which is at the base of the inflammatory response (Hillyard et al., 2004). It has
also been documented that rafts can be destroyed with Simvastatin and that this treatment
reduces the serotonin evoked currents mediated by raft associated 5-HT3 receptor
(Nothdurfter et al., 2010). Another valid approach that leads to raft disruption is to decrease
the amount of sphingolipids. This has been achieved both by using enzymes that digest
sphingolipids and by knocking down enzymes involved in their synthesis. Sphingomyelin
synthase (SMSase) is the last enzyme involved in sphingomyelin synthesis. Inhibition (with
potassium tricyclodecan-9-yl-xanthogenate) or siRNA mediated knock-down of SMSase
determine a robust decrease of sphingomyelin on the plasma membrane and within lipid rafts
(Li et al., 2007). With a complementary approach, it was found that sphingomyelin degradation
(with Sphingomyelinase treatment) affected raft associated protein NKCC1 activity (Hartmann
et al., 2009). The common feature of the strategies presented above is that they target the
amount of certain lipids on the membrane to impair raft stability. A recent method to disrupt
lipid raft has been reported and is based on the perturbation of the Lo lipid phase of rafts,
rather than on the depletion of cholesterol or sphingolipids. This strategy relies on the delivery
of 7-ketocholesterol (7KC) to the cell membrane. 7KC is an analogue of cholesterol, produced
by the non-enzymatic oxidation of cholesterol and is abundant in the arterioschlerotic plaques
(Jessup et al., 2002). 7KC differs from cholesterol only for a ketone group which protrudes
perpendicularly from the sterol plane. 7KC intracellular trafficking is identical to cholesterol
(Gaus et al., 2004). It has been demonstrated that 7KC incorporation into the plasma
membrane decrease lipid order. Indeed, the ketone group limits  the  depth  of  7KC  insertion
into  the  membrane  and  its interaction with phospholipids acyl chains. This results in 7KC
being orientated with the two polar moieties of the oxysterol near the membrane-water
interface. Importantly, the alignment of the sterol ring of 7KC with trans-configured saturated
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acyl chains of sphingoglycolipids is impaired and this leads to decreased formation of ordered
membrane domains (Massey and Pownall, 2005). Remarkably, it has been shown that 7KC
preferentially partition into lipid rafts and does not alter non-raft portion of the membrane
(Gaus et al., 2004). With this method Rentero et al. showed that 7KC, in T-cells during the
development of the immunological synapse, decreased lipid order at the activation site and
prevented raft platform formation. 7KC delivery to T-cells also determined less efficient
signaling at the cell membrane, resulting in compromised downstream activation responses
(Rentero et al., 2008).
3.1.3 Mechano-sensitivity.
DRG neurons have the ability to detect mechanical stimuli, ranging from innocuous light touch
to painful stimuli. DRG neurons are heterogeneous (see section 1.1.2) and mechanical stimuli
recruit different cell types. Anatomically, C- and Aδ neurons terminate in the epidermis as free
nerve ending, or associated with hairs as in the case of some Aδ neurons (D-hair). On the
contrary, Aβ neurons terminate deeper in the skin (deep layer of epidermis/dermis) and their
endings are encapsulated in highly specialised structure such as Pacinian corpuscle (detecting
rapid vibration), Meissner’s corpuscle (detecting low frequency vibration) (Kandel et al., 2000)
and Merkel’s discs (detecting sustained light touch/pressure (Halata et al., 2003). C- and Aδ
neurons, as discussed in Chapter 1 (see section 1.1.2), detect high threshold mechanical stimuli
(noxious touch). Also, Aδ and Aβ neurons are thought to substantially contribute to the
mechanical hyperalgesia and allodynia present in chronic pain conditions (Wall and Melzack,
2005). The different afferents can be classified according to their electrophysiological features
and activity upon presentation of the stimulus. In fact, sub-groups of Aβ neurons have been
found to be rapidly adapting or slowly adapting. The former, which includes D-hair, Pacinian
and Meissner’s corpuscles, fires at high frequency (proportional to the stimulus intensity) upon
the presentation and withdrawal of the stimulus and adapts rapidly. The latter, such as Merkel
discs, fires for the duration of the stimulus with little adaptation (Halata et al., 2003). The
polymodal nature of nociceptors (C-, Aδ neurons) complicates the classification of these
neurons, in terms of mechano-sensation. In fact, rapidly, slowly and intermediate adapting
neurons have been described. Furthermore, there are mechano-sensitive C-nociceptors that
also respond to thermal stimuli and/or chemical stimuli (Lewin and Moshourab, 2004).
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Amongst the senses, touch is the least understood. The molecular identity of the mechano-
transducers is unknown to date (Ingber, 2006). The general assumption is that the molecule/s
gated by touch is a non-specific cation channel which is gated by mechanical stimulation (e.g.
touch, stretch). To date, there are few ion channels which have received attention from the
scientific community: Degenerin/Epithelial sodium channels (DEG/ENaC), Transient Receptor
Potential (Trp) channels and two-pore potassium (KCNK) channels (Nicolson, 2005; Tsunozaki
and Bautista, 2009). C. elegans DEG/ENaC channels MEC-4 and MEC-10 associate in a macro
molecular complex including integral membrane MEC2. It has been found that this complex
transduces light touch in this animal model (Chalfie, 2009). Based on this assumption,
mammalian homologue acid sensitive ion channels (ASICs) were proposed to act as mechano-
transducers. ASICSs are thought to form hetero-oligomers complexes with other accessory
proteins (Lingueglia, 2007). In mice, deletion of ASICs did not reveal profound effect on
mechano-sensitivity (Drew et al., 2004). On the other hand, more profound effects are
revealed in Aβ and Aδ, but not C neurons, when accessory protein SLP3 (mammalian
homologue of MEC2) is missing (Wetzel et al., 2007). Studies on Trp channel led to mixed
results (Christensen and Corey, 2007). A recent study using single-ﬁber recordings in a skin-
nerve preparation showed that Trpa1 KO animals have reduced responses to mechanical
stimuli in C-ﬁbers and slowly adapting Aβ ﬁbers, but have increased responses in rapidly
adapting Aβ ﬁbers (Kwan et al., 2009). On the other hand, KO mice do not show significant
differences in terms of behaviour (Bautista et al., 2006). Trpv4 has been linked to mechanical
hyperalgesia (Chen et al., 2007), but its involvement as a first mediator is still uncharacterised.
The current view on Trp channels is that they are likely to contribute the excitability of
mechano-sensitive neurons, rather than directly transducing mechanical stimuli (Chalfie,
2009). Potassium channels of the KCNK family have been linked to mechano-sensation. TREK-1
and TRAAK are mechano and temperature sensitive channels expressed in DRGs and KO mice
show impairments in mechanical and thermal sensitivity (Noel et al., 2009). It is yet to be
determined if these channels are directly gated by mechanical stimuli or contribute to the
excitability of DRG neurons towards mechanical stimulation.
The gating mode of mechano-sensitive channels is also not fully characterised. Indeed,
multiple models have been proposed, such as channels that open upon membrane stretch, or
channels that are indirectly opened and the gating mode depends on molecular bridges
between the channel and the membrane/cytoskeleton/extracellular matrix (tether model)
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(Christensen and Corey, 2007). To date, the unequivocal identification of mechanical
transducers has not yet been achieved (Chalfie, 2009; Drew, 2009; Drew et al., 2007).
The ability of DRG neurons to retain the competence to respond to mechanical stimuli in vitro
has given the scientific community a model to operate with, in order to find and characterise
the molecular nature of touch sensation (Eilers and Schumacher, 2005). It has been described
in literature that stimulation of DRG neurons evokes action potentials. These studies have
been traditionally performed with electrophysiological techniques, which have allowed the
quantitative analysis of several cellular electric parameters upon mechanical stimulation (e.g.
nature and kinetics of inward currents, currents-voltage relations for mechanically activated
currents). Concomitant with the development of microscopy and ion-sensitive dyes, live cell
imaging (particularly Calcium imaging) has determined a valuable input into the field of
mechanosensation. This method provides a rapid set-up and read-out of mechanostimulation
assays. It allows qualitative and quantitative (upon calibration) information about Calcium ions
during the experiment. In addition, imaging techniques combined with ion-indicators permit
the visualisation of ions dynamics in real time within different compartments of the same cell,
giving useful spatial information. An early report describing DRG mechanic stimulation dates
back to 1999, when McCarter et al. showed that the mechanic stimulation of the DRG neuron
cell bodies, but not sympathetic ganglia neurons, determine an inward current which
depolarises the membrane and triggers firing of action potentials. The nature of the inward
current has been further investigated and has been found that the transient mechanically
evoked current in DRG neurons is mediated by large pore mechanically gated channels, non
selective for cations (McCarter et al., 1999). Inward currents have been classified according to
their kinetics into two broad categories, rapidly and slowly adapting. This difference has been
shown to rely on the type of dynamic stimulus applied and it can be further influenced by
other factors like kinetics of decay, ion channel cohort expression, and properties of the
mechano-transducers themselves (Rugiero et al., 2010). The analysis of axon evoked
depolarisations has been recently carried out, both with electrophysiological and imaging
tools. It has been demonstrated that mechanical stimulation of the axons of cultured DRG
neurons evokes action potentials at the level of the cell soma. Interestingly, neurite
stimulation evoked rapidly and slowly adapting currents. A proportion of rapidly adapting and
most of slowly adapting neurons were identified, by the presence of TTX-r currents and soma
size, as nociceptors (Hu and Lewin, 2006). Calcium imaging has also been employed to study
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mechanostimulation in vitro. By monitoring cell excitability with Fura-2, a ratiometric calcium
indicator, it was found that stimulation of the cell bodies determines an increase of
intracellular calcium. Depletion of extracellular calcium abolished the peak response (without
altering the resting calcium concentration), and TTX had no effect on the calcium increase. The
increase of calcium was also proposed to be directly mediated by mechano-sensors which are
La3+-insensitive, Gd3+-sensitive and amiloride-sensitive (Gschossmann et al., 2000). Axon
mechanostimulation in vitro has been also carried out in combination with calcium imaging. It
was found that it evoked an increase of fluorescence (e.g. intracellular calcium) which
propagated away from the point of stimulation (Sanchez et al., 2007). More recently it has
been clearly demonstrated that axons of nociceptors, when stimulated with a static force,
generate TTX-r action potentials that propagate to the soma. Soma activation was monitored
with Fura-2 upon axonal stimulation and it was described that neurite stimulation evoked
depolarisations at the level of the cell bodies which correlated with an increase of intracellular
calcium (Usoskin et al., 2010).
In conclusion, DRG neurons elicit inward currents and generate action potentials upon
mechanical stimulation of the cell bodies (Gschossmann et al., 2000; McCarter et al., 1999) or
the neurites (Hu and Lewin, 2006; Sanchez et al., 2007). Nociceptors, which express NaV1.8
(Djouhri et al., 2003a) and are high-threshold mechanoreceptors in vivo (Wall and Melzack,
2005), also respond to mechanic stimuli in vitro (Drew et al., 2007; Drew et al., 2002). Because
NaV1.8 mediates action potential generation in nociceptors, mechanostimulation based assay
can give insights into NaV1.8 functions. These features make DRG neurons, and nociceptors,
also good candidates for the study of mechano-sensation.
3.1.4 Chemical stimulation.
Nociceptors have the ability to fire action potential upon chemical stimulation. This process is
at the base of nociception triggered by endogenous molecules, released upon cellular stress
(e.g. injury, metabolic imbalance, cell death), or by irritant exogenous compounds. Several
compounds have been described to excite and/or sensitise these cells, including anandamide,
ATP, Bradykinin, Histamine, Serotonin (Basbaum et al., 2009; Okuse, 2007), capsaicin (hot chilli
peppers) (Caterina et al., 1997), allicin (garlic), isothiocyanate compounds (wasabi, mustard,
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horseradish), Acrolein (tear gas, vehicle exhaust) (Bautista et al., 2006; Jordt et al., 2004) and
menthol (peppermint) (Bautista et al., 2007). These compounds, when they bind to their
receptors, elicit an inward depolarising current which brings the membrane potential close to
the activation threshold of VGSCs. If the depolarisation is strong enough, VGSCs are engaged
and action potentials are generated (Kandel et al., 2000).  In this section, the receptors
recruited by capsaicin, Bradykinin and ATP (compounds that we have used to chemically
stimulate DRG neurons for the purpose of this thesis) will be described.
TrpV1 is a member of the Transient Receptor Potential (Trp) channels family (Venkatachalam
and Montell, 2007) and is the receptor for anandamide (vasodilation mediator in inflammatory
condition) (Zygmunt et al., 1999) and capsaicin. TrpV1 is also gated by noxious temperature
(higher than 43°C) and low pH enhances TrpV1 currents (Caterina et al., 1997). TrpV1 putative
structure comprises six transmembrane segments with intracellular N- and C-terminuses which
form a 95 kDa ion channel. TrpV1 is a non-selective cation channel with high permeability for
Calcium (Caterina et al., 1997) expressed by nociceptive neurons (mostly C fibres) in both the
IB4 positive and IB4 negative sub-populations (Caterina et al., 1997; Guo et al., 1999; Hwang et
al., 2005). TrpV1, apart from being implicated in the transduction of acute noxious stimuli (e.g.
high temperature) plays a role in hyperalgesic conditions (Caterina et al., 2000).  Indeed, TrpV1
represent the convergent target of several intracellular pathways which result in its
sensitisation and/or increased trafficking to the membrane. These effects determine an
increased excitability of nociceptors endings. It has been found that PLC (Rohacs et al., 2008),
Src kinase (downstream of NGF-TrkA pathway) (Zhang et al., 2005), PKCε (Numazaki et al.,
2002) and CamKII (Jung et al., 2004) positively modulate TrpV1 currents. Capsaicin is routinely
used as an activator of nociceptors, as its application and binding to TrpV1 elicits robust action
potential generation (Urban and Dray, 1993) which result in pain sensation, if it is applied to
the skin (Schmelz et al., 2000).
Bradykinin binds to GPCRs receptor B1 and B2. B2 is constitutively expressed (Wang et al.,
2006) and B1 is expressed after injury and release of inflammatory compounds (e.g. GDNF)
(Lee et al., 2002; Vellani et al., 2004). Bradykinin plays a role in inflammation states and is
formed from kininogen precursors following the activation of plasma or tissue kallikrein
enzymes by patho-physiological stimuli, such as inflammation and tissue damage (Calixto et al.,
2000). Bradykinin receptors are expressed in nociceptors and application of this compound
results in an evoked pain sensation (Beck and Handwerker, 1974). Bradykinin exerts its effect
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in pain pathways through parallel mechanisms: direct activation and sensitisation of
nociceptors. Bradykinin binding leads to the activation of PLCβ and PLA2. PLCβ determines the
synthesis of diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) from
phosphatidylinositol 4,5-bisphosphate (PIP2). In turn, DAG activates PKC which gates sodium
and calcium channels that depolarise the neuron and trigger action potentials (Burgess et al.,
1989; Jeftinija, 1994a). On the other hand, PLA2 mediates the synthesis of arachidonic acid,
which is converted into pro-inflammatory agent PGE2. PGE2 sensitise nociceptors by binding
to EP2 receptor and by activating PKA mediated intracellular pathways (Wang et al., 2006). In
addition, Bradykinin sensitises other proteins involved in nociception. Indeed, TrpV1 is
tonically inhibited by PIP2. Activation of PLCβdegrades PIP2 which results in TrpV1 sensitisation
(Chuang et al., 2001). Activation of PKC also results in phosphorylation and enhancements of
currents mediated by TrpV1 (Premkumar and Ahern, 2000) and NaV1.8 (Gold et al., 1998;
Khasar et al., 1999; Okuse, 2007).
ATP binds to P2X3 receptor, a member of the P2X protein family. P2X is a group of nucleotide
gated channels comprising seven proteins (P2X1-7); each protein is thought to comprise two
transmembrane segments, with a long extracellular domain, and to form homo-hetero-
oligomers (North, 2002). P2X3 is the only member of the P2X family which is exclusively
expressed in DRG neurons. It has been found that P2X3 is mostly expressed in IB4 positive, non
peptidergic nociceptors, and to a lesser extent in IB4 negative nociceptors (Ruan et al., 2004;
Vulchanova et al., 1998). ATP is released by necrotic/apoptotic cells after trauma, during
metabolic imbalances and inflammatory states (Cook and McCleskey, 2002). ATP is a pro-
nociceptive compound and elicits a sensation of pain if applied to the skin (Bleehen and Keele,
1977). It excites nociceptors by binding to P2X3; upon binding a conformational change opens
the channel and allows an influx of Calcium ions into the cells, which depolarize the neurons
and trigger action potentials (Bouvier et al., 1991; Gu and MacDermott, 1997). Similarly to the
other chemical transducers, P2X3 is the target of intracellular pathways and contributes to
peripheral sensitisation. For example, Bradykinin and Substance P increase P2X3 mediated
currents and this is has been hypothesised to occur through a PKC dependent pathway
(Paukert et al., 2001). Also, intrathecal delivery of NGF and GDNF to primary afferents has
been shown to up-regulate P2X3 levels in nociceptors (Ramer et al., 2001).
The common characteristic of the aforementioned receptors is that they are expressed in
nociceptors, which also express NaV1.8 (Djouhri et al., 2003a). Therefore the chemical
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stimulation of DRG neurons with capsaicin, ATP and Bradykinin provides a tool to stimulate
this class of neurons and investigate NaV1.8 mediated action potentials.
3.1.5 Aims.
The studies presented in this chapter were aimed at disrupting lipid rafts and interfering with
the association between them and NaV1.8. The methods employed to test the effective
disruption were both biochemical and optical. To assess the biological meaning of the
association of NaV1.8 with rafts we aimed to develop functional assays (mechano- and
chemical stimulation of DRG neurons) and utilised them to investigate NaV1.8 function.
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3.2 Materials and Methods
3.2.1 Sterol complexes preparation.
7-ketocholesterol (7KC) and cholesterol were complexed with Methyl-β-cyclodextrin (MBCD)
(Sigma) as previously described in literature (Klein et al., 1995; Rentero et al., 2008). Sterols
(Sigma) were dissolved in 96% Ethanol (EtOH) to a final concentration of 15 mg/ml. Methyl-β-
cyclodextrin (MBCD) was dissolved in sterile water to a final concentration of 50 mg/ml. 400 μl
of 50 mg/ml MBCD was heated to 80°C and 4x10 μl of 15 mg/ml sterols added every 5’. This
preparation led to stock sterols solutions (3.4 mM 7KC, 3.5 mM cholesterol). The compounds
were prepared fresh on the day of the experiment.
3.2.2 Lipid raft disruption.
DRG neurons were washed three times with pre-warmed DMEM and incubated with 10 mM
MBCD or 50 μM 7KC, diluted in DMEM for 30’ at 37°C. Control cells were either incubated in
DMEM only or with 50 μM cholesterol diluted in DMEM for 30’ at 37°C. After treatment, cells
were washed three times with pre-warmed DMEM and processed for subsequent applications.
For live cell imaging experiments, cells were firstly loaded with the fluorescent dye (see section
3.2.4) and then rafts were depleted.
3.2.3 Di-4-ANEPPDHQ staining and visualisation.
Di-4-ANEPPDHQ (Invitrogen) was dissolved in 96% EtOH to a final concentration of 0.2 mM and
stored at 4°C in the dark. DRG neurons were treated with 7KC, cholesterol and MBCD as
described above. After the different treatments cells were washed three times with Normal
solution. Normal solution composition was: 140 mM NaCl, 5 mM KCl, 1.8 mM CaCl2, 2 mM
MgCl2, 10 mM D-Glucose, 10 mM HEPES, pH 7.4. Solution was sterilised by filtering it through a
0.20 μm filter. All compounds were cell culture grade from Sigma. After washes the cells were
incubated with 4 μM di-4-ANEPPDHQ diluted in Normal solution for 10’ at 37°C in the dark.
Cells were imaged under a Leica SP5 inverted confocal microscope with a 20x air objective. The
dye was excited with a 476 nm Argon laser line. Emission spectra were constructed by
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performing a λ scan. λ scan records a series of individual images within a user-defined
wavelength  range; each image will be detected at a specific emission wavelength. This can be
used to measure the emission spectrum a fluorescent molecule in the sample. In more details,
the fluorescence intensity was recorded across the visible spectrum in the range 510-690 nm
with 19 readings (each reading detected the fluorescence intensity in a window of 9.5 nm). To
build the emission spectra at the end of the scan the fluorescence intensities were
automatically plotted against the respective range of the spectrum they were recorded from.
3.2.4 Fluo-4 AM loading and imaging.
Membrane permeable calcium fluorescent indicator Fluo-4 AM (Molecular probes; Invitrogen)
was reconstituted in dimethyl sulfoxide to a final concentration of 4 mM and stored at -20°C.
DRG neurons were washed three times with Normal solution and incubated with 4 μM Fluo-4
AM diluted in Normal solution for 30’ at R.T. in the dark. After three washes in Normal solution
cells were left 30’ at R.T. for the de-esterification step. Following three washes neurons were
imaged on a Leica SP5 inverted confocal microscope equipped with a temperature controlled
chamber. The microscope is suited for live cell imaging and fast recording, thanks to the
presence of a Leica TCS Resonant Scanning head. The cells were imaged at 37°C in Normal
solution. Fluo-4 was excited with a 488 nm Argon laser line set at 15% of the laser’s maximum
power. Emitted fluorescence was detected in the range 500-570 nm. Gain and offset values of
the photomultipliers were set by using the “Smart gain/offset” tool in combination with the
“Saturation Pseudocolor” mode. To allow fast recording (approximately one frame every 130
msec) the following settings were selected: Scan-mode = xyt; Visible shutter = 1; Frame
accumulation/average = 1; Line average = 2; Resolution = 8 bits; CCD camera frequency = 8000
Hz; Image dimension = 512 x 512 pixels. Files were recorded as TIFF images. Post acquisition
processing was performed with LAS AF Lite software. Pictures are presented either in green
hue or in pseudocolor (GlowDark look-up-table).
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3.2.5 Viability assay.
DRG neurons were treated with 7KC, cholesterol and MBCD as described above. After the
treatments DRG neurons were washed with DMEM and incubated with 1 μg/ml Propidium
Iodide diluted in DMEM for 15’ at R.T. After washes cells were fixed with 4% PFA for 10’ at R.T.
and nuclei counterstained with Hoechst 33342 (see section 2.2.6).
3.2.6 Mechano-stimulation.
DRG neurons were prepared as described in Chapter 2 (see section 2.2.3). Five thousand
neurons were plated on 35 mm borosilicate glass-bottom dishes (MatTek) coated with poly-L-
lysine (Sigma) and Laminin (Invitrogen). Two days after plating cells were loaded with Fluo 4-
AM and treated with different compounds (7KC, cholesterol, MBCD). Mechano-stimulation
was performed under a Leica SP5 inverted confocal microscope equipped with micro-
manipulator Inject Man N1 2 (Eppendorf). The motorised head of the micro-manipulator was
set at 45° against the main surface of the culture wells. Mechano-stimulation of the neurons
was achieved by using a fine glass tip with an outer diameter 1.0 µm (Femtotip; Eppendorf).
The glass tip was moved to the focal plane of DRG neurons by using the “coarse mode” control
and mechano-stimulation performed by using the analogic “fine mode” control (0-5 µm/sec).
When axonal stimulation was needed fields of view comprising the axon and the cell body it
arises from were chosen. Cells were imaged with a 63x water objective and Calcium dynamics
were recorded by visualising Fluo-4 fluorescence over the course of mechano-stimulation by
recording 9 frames per second (111 msec between every frame). Different electronic
magnification values were used between different neurons. Every frame has been acquired
with 2 lines average and pinhole aperture was set at the maximum value (5.4 Airy Units,
minimal confocality). All the experiments were performed in Normal solution in a controlled
temperature incubator set at 37°C. Quantification of the fluorescence intensities was
performed by using Leica SP lite software.
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3.2.7 Campenot set-up and chemical stimulation.
Campenot chambers were custom designed and fabricated with TeflonTM (Tyler Research
Corporation). TeflonTM is an inert substance which is routinely used to set-up
compartmentalised cultures (Campenot and Martin, 2001). The chambers (Fig. 3.1) were
cleaned with a mild detergent, rinsed, soaked in 70% EtOH for 5’, washed in distilled water and
autoclaved before every use. Dividers were stored in sterile conditions till the day of use. The
chambers were set-up the day before plating the neurons. 35 mm plastic dishes (BD Falcon)
were scratched with a pin-rake (Tyler Research Corporation) in the middle portion. The length
between each incision measured 300 µm. The scratched region was coated with 0.1 mg/ml
poly-L-lysine for 2 hours, washed three times with distilled water and left to dry. The middle
portion of the scratched region was overlaid with 30 µl of 1% Methylcellulose (Sigma), 10
µg/ml Laminin (Invitrogen), 50 ng/ml NGF (Peprotech) diluted in DMEM with antibiotics, in
order to wet the region where axons will cross under the divider. The bottom surface of the
TeflonTM dividers was greased with autoclaved high-vacuum grease (Dow Corning) by using a
syringe (Tyler Research Corporation) fitted with a blunt 23G needle. Particular care was taken
in laying the grease with a continuous single movement. The greased side of the dividers was
gently moved on top of the scratched region of the plastic dishes. The dividers were sealed to
the plastic dishes by turning upside-down the dish-chamber complex and by applying gentle
pressure to the plastic dishes with a fine forceps. These procedures were performed under a
stereo-microscope in sterile conditions. The assembled Campenot chambers were left 2 hours
at 37°C to equilibrate. 200 µl of DMEM was applied to the side chambers and left over-night at
37°C to test for leakage. The following day the leaky chambers were discarded. Chambers were
washed three times with pre-warmed DMEM, and coated with 10 µg/ml Laminin (Invitrogen).
DRG neurons were prepared as described in Chapter 2 (section 2.2.3) and 50,000 neurons
were plated in the smallest chamber (soma chamber; A in Fig. 3.1) in DMEM without NGF and
supplemented with 10% FBS, antibiotics, 10 µM Aphidicolin. Axonal outgrowth was promoted
by NGF diluted in 10% FBS DMEM with antibiotics and 10 µM Aphidicolin. The day of plating 50
ng/ml NGF was added to the middle chamber (B in Fig. 3.1), and NGF was maintained in this
chamber until the axons grew in proximity of the wall between the middle chamber and the
side chamber (C in Fig. 3.1), furthest from the soma chamber. When axons started growing
beneath this wall, the furthest chamber from the soma was supplemented with 50 ng/ml of
NGF and the middle chamber was shifted to 25 ng/ml. Axon outgrowth was checked daily and
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media changed every two days. The soma chamber was always left without NGF. Media was
changed every two days. Experiments were carried out 14 days after plating, when extensive
neurite outgrowth in the furthest chamber was obtained.
Figure 3.1) Specifications of the Campenot chamber used for the compartmentalised DRG
culture. A=soma chamber, where DRG neurons were plated, B=middle chamber, C=furthest
chamber from soma chamber (side chamber).
The day of the experiment DRG neurons where loaded with Fluo 4-AM. If lipid raft disruption
was needed, this was carried out only in the middle chamber (B in Fig. 3.1). For imaging
purposes the chambers were filled with 150 µl of Normal solution and axon endings in
chamber C where chemically stimulated with 10 µM Capsaicin (Fluka), 10 µM Bradykinin
(Sigma) and 300 µM ATP (Sigma) diluted in Normal solution. Cell bodies were visualised with a
10x air objective on a Leica SP5 confocal microscope equipped with a heated chamber
maintained at 37°C. Fluo-4 fluorescence intensity was recorded with the same settings used
for the mechano-stimulation assay, with the difference that the pinhole aperture was set at
7.4 Airy Units (minimal confocality).
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3.2.8 Statistical analysis.
Data were computed and analysed with OriginPro 8.5 software (Originlab Corporation). For
multiple comparisons between groups one-way ANOVA (di-4-ANEPPDHQ calculated maximum
emission of the spectra; viability assay) was used. Fisher’s exact test was used for categorical
data (Mechanostimulation assays). Non parametrical Mann-Whitney test was used for
comparison between individual groups (Speed of conduction; chemical stimulation in the
Campenot set-up). Data are expressed as mean ± SEM unless stated otherwise. P value < 0.05
was considered statistically significant. Power analysis of the collected data was computed and
shown when applicable.
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3.3 Results
Investigation of the disruption of the association between NaV1.8 and lipid rafts.
We have demonstrated in the previous chapter that NaV1.8 associates with lipid rafts in vitro.
We extended this finding in order to understand if the association between NaV1.8 and lipid
rafts has got a functional meaning. The next section will focus on the results about lipid raft
disruption and on the consequences of this process on NaV1.8-raft association. The second
section will describe the effort we made to develop assays to investigate NaV1.8 role in action
potential conduction and how this role is affected by disrupting NaV1.8-raft association.
3.3.1 Lipid raft disruption: biochemical evidence.
We used different agents to disrupt lipid rafts in vitro. The agents of choice were 7-
ketocholesterol (7KC) at a concentration of 50 µM and Methyl-β-cyclodextrin (MBCD) at a
concentration of 10 mM. Control cells were left untreated (CTR). We have investigated the
effect of the different compounds on lipid rafts stability, by detergent extraction and gradient
ultracentrifugation. Lipid raft stability is dependent on cholesterol, which allows the tight
packing of the saturated fatty acid chains (Simons and Vaz, 2004). A common method to
disrupt lipid raft is to deplete cholesterol from the cell membrane by using MBCD. We also
used 7KC to interfere with the lipid phase of lipid rafts, in an attempt to interfere with their
stability. The hypothesis was that, by interfering with cholesterol content and with the physical
lipid phase of rafts, the stability of these micro-domains would be affected and this, in turn,
would impair their ability to be resistant to non-ionic detergent at 4°C. We treated 15000 DRG
neurons after 2DIV with the different compounds for 30’ at 37°C and extracted lipid rafts. We
used Flotillin-1 as the protein marker of lipid rafts in the different conditions. We found that 10
mM MBCD, and 50 µM 7KC negatively affected raft stability. In fact, upon detergent
extraction, Flotillin-1 profiles between 7KC, MBCD and CTR were different. In CTR condition
(Fig. 3.2 A, B) the majority of Flotillin-1 is retrieved from the top fractions (lane 2 and 3). In 7KC
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treated neurons Flotillin-1 displayed a reduced amount on the top fractions (lane 2 7KC vs.
lane 2 CTR) and a tailing effect towards the bottom fractions. In MBCD treated samples, lipid
raft disruption was even more evident, with Flotillin-1 being recovered only from the bottom
fractions (lanes 7, 8 and 9) (Fig. 3.2 A, B).
Figure 3.2) Lipid raft disruption in cultured DRG neurons. A) DRG neurons have been treated
with 7KC and MBCD to disrupt lipid raft. CTR (as in Fig. 2.8 of Chapter 2, section 2.3.3) is shown
here to ease the comparison between the different conditions. Fractions from a density
gradient were analysed by western blotting for Flotillin-1 to test the effect of MBCD and 7KC
on lipid rafts stability. Different fractions are labelled from 1 to 9, with 1 being the top fraction
and 9 the bottom fraction. M is the protein ladder. B) Shows the bands intesity plotted against
the fraction number.
A
)
B
)
A)
B)
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We next probed these samples for NaV1.8, to ascertain its partitioning upon raft depletion.
Remarkably we found that, compared to CTR sample, all NaV1.8 is recovered from the bottom,
non raft, fractions. In fact, the lipid raft associated pool (lane 2 in CTR) is absent in both 7KC
and MBCD treated samples (Fig. 3.3A, B). This result indicates that treatments with MBCD and
7KC led to the dissociation of NaV1.8 from lipid rafts.
Figure 3.3) 7KC and MBCD impair NaV1.8-raft association. A) DRG neurons have been treated
with 7KC and MBCD to disrupt lipid raft. CTR (as in Fig. 2.9 of Chapter 2, section 2.3.3) is shown
here to ease the comparison between the different conditions. Fractions from a density
gradient were analysed by western blotting for NaV1.8 to test the effect of MBCD and 7KC on
its association with lipid rafts. Different fractions are labelled from 1 to 9, with 1 being the top
fraction and 9 the bottom fraction. M is the protein ladder. B) Shows the bands intesity plotted
against the fraction number.
A
)
B
)
A)
B)
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3.3.2 Lipid raft disruption: imaging evidence.
We also employed imaging techniques to monitor 7KC and MBCD mediated lipid rafts
disruption. We exploited the remarkable feature of fluorescent dye di-4-ANEPPDHQ to act as a
sensor for the membrane lipid phase (Jin et al., 2005). It displays a blue-shift of the emission
spectrum in the liquid ordered phase (raft-like) compared to liquid disordered phase (non raft)
(Jin et al., 2006). We treated cells with 50 µM 7KC and 10mM MBCD to disrupt lipid rafts;
Control cells were either treated with 50 µM cholesterol (CHOL) or left untreated (CTR). To
determine the effect of the compounds on the lipid phase we constructed the emission
spectra of di-4-ANEPPDHQ by performing a λ scan. Since MBCD and 7KC, in different ways,
disrupt lipid rafts we hypothesised that the emission of di-4-ANEPPDHQ would be red-shifted
compared to controls samples, because of a reduced liquid ordered phase (reflecting a
decreased amount of liquid ordered lipid raft microdomains). Fig. 3.4 A shows representative
live neurons treated with the different compounds, and stained with di-4-ANEPPDHQ. The dye,
as expected, clearly shows a membrane localisation. Cell morphology (highlighted both by the
fluorescent dye and DiC imaging – in the insets) is not altered by the different treatments, as
cell bodies and axons do not show structural abnormalities. The results of λ scans are
summarised in Fig. 3.4 B. The normalised spectra are constructed by reading fluorescence
intensity from 510 nm to 690 nm (each data point is presented as the mean fluorescence
intensity of at least eleven neurons ± SEM). CTR and CHOL treated samples show completely
overlapping spectra, suggesting that CHOL treatmeant does not alter the phase of the
membrane. On the contrary, 7KC and MBCD both determine a red-shift of the spectra,
compared to CTR and CHOL treated samples (Calculated emission maxima, presented as mean
emission maxima ± SEM: CTR= 590 ± 0 nm; CHOL= 590 ± 0 nm; 7KC= 596 ± 1.8 nm *, #; MBCD=
596 ± 1.6 nm *, #; *=p < 0.01 vs CTR, #=p < 0.01 vs CHOL. One-way ANOVA, followed by Tukey’s
post-hoc tests. Calculated power=0.99). Also, MBCD treatment determines a less steep
shoulder of the spectra at wavelenghts higher than 600 nm, compared to the other
treatments. This result clearly indicates that 7KC and MBCD, alter the lipid phase of the
neurons, shifting it to a less ordered phase, consistent with raft disruption.
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Figure 3.4) Lipid raft disruption detected by using lipid phase probe di-4-ANEPPDHQ. A) DRG
neurons have been treated with 7KC and MBCD to disrupt lipid raft. CHOL and CTR were
treated with cholesterol and left untreated, respectively. The images show representative live
A
)
B
)
A)
B)
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neurons stained with di-4-ANEPPDHQ after the treatments. B) The graph shows the normalised
spectra of di-4-ANEPPDHQ emitted fluorescence in the different conditions.
3.3.3 Lipid raft disruption and NaV1.8 sub-cellular localisation.
We sought to investigate if lipid raft disruption had an effect on NaV1.8 sub-cellular
localisation. In particular, we focused on the clustered appearance of NaV1.8 along the neurites
of cultured DRG neurons, which we discussed in the Chapter 2. After 2DIV we treated neurons
with 50 µM 7KC, 10 mM MBCD, and 50 µM CHOL for 30’ at 37°C. CTR cells were left untreated.
After the treatments cells were washed, fixed and processed for immunofluorescence. We
found that the different treatments did not induce macroscopic alteration in NaV1.8
distribution. In fact, regardless of the treatments, NaV1.8 clusters were evident along the axons
(Fig. 3.5, arrows), suggesting that raft integrity is not needed for the stability of the clusters.
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Figure 3.5) Lipid raft disruption does not alter NaV1.8 clustered distribution along the axons.
Images show immunofluoresce for NaV1.8 after lipid raft disruption. Arrows indicate clusters
along the axons of neurons. Cell bodies are identified by nuclear stain Hoechst. Scale bars are
20 µm.
3.3.4 Lipid raft disruption and GM1 sub-cellular localisation.
We previously reported that GM1, when detected with biotinylated CTB and fluorescent
Streptavidin, appears to be present in puncta on the cell surface (Chapter 2, section 2.3.6).
Given its role as a lipid raft marker we also investigated GM1 localisation on neurons upon lipid
raft disruption. We treated cells with 50 µM 7KC, 10 mM MBCD, and 50 µM CHOL for 30’ at
37°C. CTR cells were left untreated. After the treatments cells were washed and probed for
GM1. We have found that, similarly to what we found for NaV1.8, lipid raft disruption did not
abolish the punctuated appearance of GM1 on the neuronal surface (Fig. 3.6). Thus raft
depletion does not alter the punctuated distribution of GM1 along the axons
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Figure 3.6) Lipid raft disruption does not alter GM1 clustered distribution on the cell surface.
Images show GM1 localised on DRG neurons after lipid raft disruption. The framed areas are
magnified to highlight GM1 puncta along the axons. Scale bars are 20 µm.
3.3.5 Lipid raft disruption and Flotillin-1-Dronpa sub-cellular localisation.
We also investigated the localisation of raft protein marker Flotillin-1 after lipid raft disruption.
We have previously reported that, in our hands, the construct Flotillin-1-Dronpa when
expressed in DRG neurons tends to be evenly distributed with puncta of higher fluorescence
along the axons (Chapter 2, section 2.3.10). We have delivered the construct to DRG neurons
and after 2DIV we treated the cells with 50 µM 7KC, 10 mM MBCD, and 50 µM CHOL for 30’ at
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37°C. CTR cells were left untreated. After the treatments cells were washed and fixed. We have
not found obvious changes in Flotillin-1-Dronpa localisation after the different treatments.
Indeed, in control condition, similarly to what we have described before, Flotillin-1-Dronpa was
evenly distributed with brighter puncta along the axons. 7KC, MBCD and CHOL treated cells
were still characterised by the appearance of brighter puncta of the construct along the
neurites (Fig. 3.7).
Figure 3.7) Lipid raft disruption does not alter Flotillin-1-Dronpa ability to cluster. Images
show Flotillin-1-Dronpa after lipid raft disruption. Cell bodies are identified by nuclear stain
Hoechst. Framed area are magnified to show the brigher puncta of the construct. Scale bars
are 20 µm.
3.3.6 Viability assay.
To determine if the agents we used to disrupt lipid rafts cause cell death (apoptosis and/or
necrosis) we performed a viability assay. We treated the cells for 30’ at 37°C with the different
compounds, washed them and incubated them for 30’ at 37°C. After this incubation period we
incubated the neurons with Propidium Iodide (PI) to identify dead cells. We counterstained the
cells with nuclear dye Hoechst and counted the dead cells upon the different treatments (Fig.
3.8 A). We found that the different treatments did not induce cell death at this time point,
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compared to CTR cells (% of PI positive nuclei ± SEM; CTR= 4.6 % ± 0.5, CHOL= 4.8 % ± 1.1,
7KC= 3.9 % ± 0.5, MBCD= 5.3 % ± 0.7; No statistically significant difference between the
different treatments and CTR; n=3; p > 0.1, One-way ANOVA, followed by Tukey’s post-hoc
tests. Calculated power=0.11) (Fig. 3.8 B).
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Figure 3.8) Cell viability assay. A) DRG neurons have been treated with 7KC and MBCD to
disrupt lipid raft. CTR and CHOL are control treatments. Nuclei were stained with Hoechst and
dead cells labelled with PI (arrows). The insets show high magnification of nuclei positive for PI
staining. B) The graph shows quantification of the amount of dead cells per treatment. Values
are presented as percentage ± SEM.
Investigation of the functional meaning of the association between NaV1.8 and lipid rafts.
In the previous sections we have demonstrated that 7KC and MBCD interfere with the lipid
phase of DRG neurons, and they disrupt the association of NaV1.8 with lipid rafts. Importantly,
under these conditions the totality of NaV1.8 is present in the soluble, non raft, fraction of the
membrane. At the same time, the clustered appearance of NaV1.8, Flotillin-1-Dronpa and GM1
(protein and lipid marker of lipid rafts, respectively) was not impaired by raft disruption
treatments. To ascertain if NaV1.8 raft association is functionally relevant we have developed
two assays to determine the potential importance of such association. Since a comprehensive
amount of literature demonstrated that NaV1.8 plays a key role in action potential generation
(Akopian et al., 1999b; Renganathan et al., 2001) and propagation in nociceptors (Brock et al.,
1998; Djouhri et al., 2003a; Jeftinija, 1994a, b; Quasthoff et al., 1995; Steffens et al., 2001) we
have studied the functional meaning of NaV1.8-raft association in action potential propagation
B
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in DRG neurons. The next sections will describe how we developed assays to generate action
potential in DRG neurons, by mechanical and chemical means, and how action potential
propagation is affected in neurons where NaV1.8 does not associate with lipid rafts.
3.3.7 Mechano-stimulation based assay in vitro.
We developed an assay based on mechano-stimulation to study action potential propagation.
DRG sensory neurons are mechano-sensitive in vivo (Kandel et al., 2000; Tsunozaki and
Bautista, 2009) and retain the property to trigger action potential, in response to mechanical
stimuli, in vitro (Cheng et al., 2010; Cho et al., 2002; Drew et al., 2007; Hu and Lewin, 2006;
McCarter et al., 1999). We exploited this ability to study action potential propagation in
cultured DRG neurons. We plated DRG neurons and after 2DIV we loaded them with Fluo-4, a
calcium indicator (Gee et al., 2000; Paredes et al., 2008). We mechanically probed the neurites
of the cells in order to evoke action potentials and we recorded subsequent changes in Fluo-4
signals. We found that when the glass probe contacts the neurite of a responsive neuron an
increase of Fluo-4 fluorescence can be detected. In particular, the increase of fluorescence is
propagated from the point of contact in an antidromic and orthodromic fashion towards the
end of the neurite and the cell body, respectively. When the wave of fluorescence reaches the
cell body, this responds with a sharp increase of fluorescence (Fig. 3.9). Also, repetitive
stimulation evokes multiple responses. Fig. 3.10 clearly shows how multiple mechanic stimuli,
along the axon of a neuron, determine related increases of fluorescence at the level of the cell
body. In this neuron the neurite was stimulated for the first time at 29.2 µm from the cell body
and the second and third stimuli were delivered at 10.8 µm from the soma. For this particular
neuron we found that the second and third stimulation evoked greater responses than the first
one.
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Figure 3.9) Mechanostimulation of DRG neurons in vitro. The figure shows a representative
neuron loaded with Fluo-4 responding to a mechanical stimulus. A) Shows the Fluo-4
fluorescence and DiC image of a DRG neuron. The glass probe is visible in the DiC image, at the
moment of contact with neurite (arrow) which projects from the cell body. B) Shows the Fluo-4
fluorescence in pseudo-color, associated with different time points during the recording. C)
The graph shows the recorded fluorescence intensity of different region of interests (ROIs),
visible in A. The arrow indicates the time point when the cell has been stimulated; cardinal
numbers refer to the time points which the images in B are associated to. Scale bar is 10 µm.
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Figure 3.10) Multiple mechanostimulation of DRG neurons in vitro. The figure shows a
representative neuron loaded with Fluo-4 responding to multiple mechanical stimulus. A)
Shows the Fluo-4 fluorescence and DiC image of a DRG neuron. The glass probe is visible in the
DiC image, at the moments of contact with neurite (arrows) which projects from the cell body.
B) Shows the Fluo-4 fluorescence in pseudo-color, associated with different time points during
the recording. C) The graph shows the recorded fluorescence intensity of the ROI, visible in A.
The arrows indicate the time point when the cell has been stimulated; cardinal numbers refer
to the time points which the images in B are associated to. Scale bar is 10 µm.
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3.3.8 Mechano-stimulation in vitro in the absence of extracellular Calcium or Sodium
ions.
Axon stimulation in vitro evokes cell depolarisation (Cheng et al., 2010; Hu and Lewin, 2006;
Lin et al., 2009). To understand the nature of cell depolarisation associated with the increase
of Fluo-4 we have carried out the mechano-stimulation in Calcium or Sodium free conditions.
We investigated soma responsiveness upon mechanical stimulation of the neurite in medium
devoid of Calcium and in the presence of 2mM EGTA. When calcium was omitted from the
medium we did not detect any Fluo-4 fluorescence increase at the level of the cell bodies (n=8)
(Fig. 3.11 A, B). This result shows that extracellular calcium is needed to evoke Fluo-4 changes
in fluorescence, and rules out involvement of intracellular calcium stores.
Figure 3.11) Mechanostimulation in vitro in Calcium free condition. The figure shows a
representative neuron loaded with Fluo-4 not responding to a mechanical stimulus. A) Shows
A
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the Fluo-4 fluorescence and DiC image of a DRG neuron. The glass probe is visible in the DiC
image, at the moment of contact with neurite (arrow) which projects from the cell body. B)
The graph shows the recorded fluorescence intensity of the ROI visible in A. The arrow
indicates the time point when the cell has been stimulated. Scale bar is 10 µm.
We repeated the experiment in the presence of Calcium and absence of Sodium. In this
condition, we replaced extracellular NaCl with an equimolar amount of Choline chloride to
maintain the right osmolarity (Fitzgerald et al., 1999) and presence of positive charges in the
medium. Importantly, in this condition we did not detect any soma response upon mechanic
stimulation of the axons (n=15) (Fig. 3.12 A, B). This result indicates that sodium ions are
necessary for the propagation of the depolarisation from the axon towards the cell body and
that calcium ions alone are not sufficient for the propagation of the depolarisation.
Occasionally we detected, after the axonal stimulation, an increase at the level of the cell body
characterised by a very slow onset (20 secs) (Fig. 3.12 C, D).
Figure 3.12) Mechanostimulation in vitro in Sodium free condition. A) Shows the Fluo-4
fluorescence and DiC image of a DRG neuron not responding to a mechanical stimulus. The
glass probe is visible in the DiC image, at the moments of contact with neurite (arrow) which
projects from the cell body. B) The graph shows the recorded fluorescence intensity of the ROI
visible in A. The arrow indicates the time point when the cell has been stimulated. C) Shows
A
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the Fluo-4 fluorescence and DiC image of a DRG neuron responding to a mechanical stimulus
with a slow onset of fluorescence increase. The glass probe is visible in the DiC image, at the
moments of contact with neurite (arrow) which projects from the cell body. D) The graph
shows the recorded fluorescence intensity of the ROI visible in C. The arrow indicates the time
point when the cell has been stimulated (Neuron stimulated at 11.2 sec and maximum
fluorescence intensity was recorded at 32.7 secs). Scale bar are 10 µm.
3.3.9 Axonal Mechano-stimulation: effect of Lidocaine, Tetrodotoxin and lipid raft
disruption.
We used the mechano-stimulation based assay to study action potential propagation in
different conditions. In fact, we tested the effect of lipid raft disruption, a scenario where we
demonstrated NaV1.8 shifts to the soluble fraction, on action potential propagation. We also
further characterised the nature of the propagating depolarisation from the axon to the cell
body, by performing the experiment in the presence of Lidocaine or TTX. For this series of
experiments we probed axons originating from small diameter neurons (Diameter < 25 µm),
most likely to be nociceptive, at a mean distance of 19.8 ± 7.6 µm (mean distance ± SD;
n=188). We probed the cell three times and for our analysis we defined a neuron as
“responsive” if the axonal stimulation evoked a soma response after one of these three
stimulations. In case of multiple responses only the first stimulation was included in the
analysis, to minimise the effect of sensitisation/desensitisation. Also, the increase of
fluorescence at the level of the cell body to be classified as “response” had to be higher than
10% (threshold set arbitrarily), compared to baseline fluorescence, and to reach the maximum
level within 20 seconds. In case the neurite was displaced during the stimulation and the cell
was responsive, the time point considered as “contact” was the time point at which the
neurite showed the maximum displacement. Cells that showed swelling or rupture of the
axons were discarded from the analysis. Given this criteria we found that in the presence of
Lidocaine (used concentrations: 10 mM (Gu and MacDermott, 1997) and 500 µM (Chevrier et
al., 2004) the percentage of responsive cells dropped significantly compared to control cells (%
of responsive cells; CTR=50.9%, Lidocaine 10 mM=12.5% *, Lidocaine 500 µM=0% *; *= p<0.05
vs CTR. Fisher’s exact test. Table 3.1). These data clearly indicates that voltage gated sodium
channels are needed for the propagation of the evoked depolarisation towards the cell body
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and for the response of this one. Also, the presence of 250 nM TTX did not affect the cell
responsiveness, suggesting that TTX-r VGSC channels are sufficient to propagate and
depolarise the cell soma (% of responsive cells; CTR=50.9%, TTX 250 nM=50%; Table 3.1). We
also determined the effect of lipid raft disruption on action potential propagation. We
performed the mechano-stimulation in Normal solution (see materials and methods for its
composition; section 3.2.3) after lipid raft disruption. We treated the cells with 50 µM 7KC and
10 mM MBCD to disrupt lipid rafts, CHOL cells were treated with 50 µM cholesterol and CTR
cells left untreated. Under this conditions we found that cholesterol treated cells were as
responsive as control cells. Remarkably, upon lipid raft disruption and NaV1.8 shift to the
soluble fraction of the cell membrane, we found a significant decrease in the number of soma
able to respond to the mechanical stimulation of the axon (% of responsive cells; CTR=50.9%,
CHOL 50 µM=54.2%, 7KC 50 µM=27.8% *, MBCD 10 mM=27.8% *; *= p<0.05 vs CTR. Fisher’s
exact test. Table 3.1).
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Table 3.1. Effect of different treatments on cell responsiveness, upon axonal stimulation.
Table summarises the results of axonal mecho-stimulation of DRG neurons in vitro.
Percentages of neuronal cell bodies responsive to mechanical stimulation of the axon, in the
different conditions, are listed. *= p<0.05 vs CTR. Fisher’s exact test.
The mechano-stimulation based assay allowed us to calculate the time between the
mechanostimulation and the soma response. Since also the time at which the cell soma starts
responding is known, we calculated the mean speed of conduction of the depolarisation,
between the point of stimulation on the axon and the cell body. We found that, compared to
control condition, the mean speed of conduction upon lipid raft disruption was significantly
lower. Cholesterol treatments had no effect (Mean speed (in µm/sec) ± SEM: CTR = 20.8 ± 2.1,
n=28; CHOL = 19.1 ± 3.4, n=13; 7KC = 12.3 ± 2.2 *, n=10; MBCD= 12.4 ± 2.6 *, n=10; *= p<0.05
vs CTR., Mann-Whitney U Test. Calculated power value for the paired  couples are: CTR vs.
CHOL = 0.15, CTR vs. 7KC = 0.99, CTR vs. MBCD = 0.99 ) (Fig. 3.13).
Treatment Total number of
screened neurons
Responsive
neurons
% Responsive of
responsive neurons
CTR 55 28 50.9
Lidocaine 10 mM 16 2 12.5 *
Lidocaine 500 µM 13 0 0 *
TTX 250 nM 8 4 50.0
CHOL 50 µM 24 13 54.2
7KC 50 µM 36 10 27.8 *
MBCD 10mM 36 10 27.8 *
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Figure 3.13) Lipid raft disruption determines a reduction in the speed of conduction. The
graph shows quantification of the speed of conduction in the different treatments. Values are
presented as percentage ± SEM. *= p < 0.05 vs. CTR, Mann-Whitney U test.
* *
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3.3.10 Soma Mechano-stimulation: effect of lipid raft disruption.
We also directly probed the cell body of DRG neurons in the different conditions to test 1) the
mechanosensitivity of the soma and 2) the effect of lipid raft disruption on mechano-
transduction. We found that cell bodies of DRG neurons were mechano-sensitive, and upon
stimulation an increase of fluorescence was evoked. Fig.3.14 shows a representative response
of a DRG cell body responding to mechano-stimulation.
Figure 3.14) Mechanical stimulation of the cell soma of DRG neurons in vitro. The figure
shows a representative neuron loaded with Fluo-4 responding to a mechanical stimulus
delivered to the soma. A) Shows the Fluo-4 fluorescence and DiC image of a DRG neuron. The
glass probe is visible in the DiC image, at the moment of contact with the soma (arrow) B)
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Shows the Fluo-4 fluorescence in pseudo-color, associated with different time points during
the recording. C) The graph shows the recorded fluorescence intensity of different region of
interests (ROIs), visible in A. Note that increase of fluorescence was evident also along the
axon (ROI 2). The arrow indicates the time point when the cell has been stimulated; cardinal
numbers refer to the time points which the images in B are associated to. Scale bar is 10 µm.
Differently from what we found upon axonal stimulation, when we disrupted lipid rafts the cell
response was not altered following this method of stimulation (Table 3.2)
Table 3.2. Effect of different treatments on cell responsiveness, upon soma mechanical
stimulation. Table summarises the results of soma mecho-stimulation of DRG neurons in vitro.
Percentages of neuronal cell bodies responsive to mechanical stimulation of the soma, in the
different conditions, are listed.  p > 0.5 vs. CTR. Fisher’s exact test.
Treatment n Responsive % Responsive Cell
CTR 33 20 60.6
CHOL 50 µM 18 11 61.1
7KC 50 µM 33 21 63.6
MBCD 10mM 38 26 68.4
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3.3.11 Chemical-stimulation based assay in vitro: DRG neuron culture in Campenot
chambers.
We further investigated action potential propagation along the axons of DRG neurons in
control and raft depleted conditions by exploiting the properties of Campenot chambers,
which allow a compartmentalisation of different parts of the neurons.
We first developed a culture system where DRG neurons can be functionally segregated in
different compartments. We used a Campenot chamber (for details of the dimensions see
materials and methods; section 3.2.7) with three separate chambers. The protocol we used to
set the culture chamber is known to segregate the different compartments (Campenot, 1977).
Nevertheless, we wanted to confirm that in our hands the technique is efficient. We set a
chamber and imaged the side chamber when a fluorescent dye was present in the middle
chamber. The images in Fig. 3.15 show that no leakage occurred between the chambers.
Figure 3.15) No leakage occurs between the chambers. We filled the middle chamber with 1%
Texas Red in normal solution, and kept the side chambers filled with normal solution. After 5’
and 30’ we monitored the side chamber and no leak of Texas Red from the middle chamber
was detected.
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Once DRG neurons were plated, neurite outgrowth was promoted by creating a density
gradient of NGF across the chambers (see section 3.2.7). At the day of the experiments, DRG
cell bodies (Fig. 3.16, arrow heads) were confined in the Soma chamber and projected axons,
through the Mid-chamber, to the furthest chamber (Axon chamber) (Fig. 3.16)
Figure 3.16) DRG neurons cultured in Campenot chamber. The composite image shows an
immunofluoresence for neuronal marker III β-Tubulin (βTub). Cell bodies (arrow heads) are
restricted in the Soma chamber. Bundles of axons projects through the Mid-chamber to
furthest Axon chamber. Note that axons beneath the walls are not visible because, during
immunostaining, the walls prevented antibody binding. Scale bar is 100 µm.
3.3.12 Chemical stimulation of DRG neurons in Campenot chambers.
We tested the excitability of axons to chemical stimulation. We also ascertained if the axonal
stimulation is strong enough to depolarise the axons to an extent that is sufficient to evoke
depolarisations that travel towards the cell bodies. We loaded the cells (all compartments)
with Fluo-4 and stimulated only the axons by applying a chemical mix to the Axon chamber
(furthest chamber from Soma chamber, see also Fig 3.16). We used a cocktail composed of
Capsaicin 10 µM, ATP 300 µM and Bradykinin 10 µM (CAB). These chemicals were used
because DRG neurons have been shown to be excited by these agents and to respond by
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triggering action potentials (see Introduction; section 3.1.4). When axons were subjected to
CAB application they displayed a rapid increase of Fluo-4 fluorescence (stimulation and
visualisation of the same chamber: Axon chamber; see Fig. 3.16), clearly showing that the
axons in the Axon chamber can be efficiently excited with these chemicals (Fig. 3.17).
Figure 3.17) Chemical stimulation of DRG neurons: axonal stimulation and axonal recording.
The figure shows axons in the Axon chamber loaded with Fluo-4 and responding to a chemical
stimulus (CAB). A) Shows the Fluo-4 fluorescence and DiC image of a the axons. B) Shows the
Fluo-4 fluorescence in pseudo-color, associated with different time points during the
recording. C) The graph shows the recorded fluorescence intensity of different ROIs, visible in
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A. The arrow indicates the time point when the cell has been stimulated; cardinal numbers
refer to the time points which the images in B are associated to. Scale bar is 100 µm.
Most importantly, for the purpose of our experiment, we found that axonal stimulation carried
out in the Axon chamber is able to elicit a Calcium influx that travels through the Mid-chamber
and invades the cell bodies in the Soma chamber. In fact, CAB application only in the Axon
chamber elicited a fluorescence increase at the level of the cell bodies in the Soma chamber.
Application of vehicle did not elicit any response (Fig. 3.18).
Figure 3.18) Chemical stimulation of DRG neurons: axonal stimulation and soma recording.
The figure shows the effect, at the level of the cell bodies, of axonal chemical stimulation. A)
Shows the Fluo-4 fluorescence and DiC image of the cell bodies (Soma chamber, arrow heads)
and axons projecting to the Axon chamber, through the Mid-chamber. B) The graph shows the
recorded fluorescence intensity of different cell bodies visible in A (Soma chamber, arrow
heads). Each data point is the mean fluorescence intensity ± SEM of different cell bodies
(n=58). Images in pseudo-color represent the Soma chamber Fluo-4 fluorescence. The black
arrow indicates the time point when Vehicle has been applied. Red arrow indicates when the
B
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axons have been stimulated with CAB; cardinal numbers refer to the time points which the
images in pseudo-color are associated to. Scale bar is 100 µm.
3.3.13 Chemical stimulation of DRG neurons in Campenot chambers: Sodium free
condition and effect of TTX.
We have investigated the nature of the propagating depolarisation by substituting NaCl in the
Mid-chamber only with equimolar Choline chloride. In this set-up, since the chambers do not
allow mixing of the media, the Axon chamber, which is stimulated by CAB, and the cell bodies
are in the presence of extracellular sodium. When CAB is applied to the axonal terminals, in
the absence of sodium in the Mid-chamber, we found that no cell responded with an increase
of fluorescence (0% responsive cells; experiment performed in triplicate). This data clearly
shows that sodium ions are needed in the Mid-chamber for the propagation of the action
potentials towards the cell bodies. Moreover, when Choline chloride is replaced with NaCl in
the Mid-chamber, cell body responsiveness was restored and the CAB stimulation at the level
of the axons determined an increase of fluorescence in the Soma chamber. In fact, the same
cells which do not respond in the absence of sodium (Fig. 3.19 A, B) became responsive with
the presence of sodium in the Mid-chamber, upon chemical stimulation.
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Figure 3.19) Chemical stimulation of DRG neurons: Sodium free condition. The figure shows
the effect, at the level of the cell bodies, of axonal chemical stimulation in the absence
(Sodium free) and presence (Normal solution) of NaCl. A) Shows the Fluo-4 fluorescence and
DiC image of the cell bodies (Soma chamber). C) The graphs show the recorded fluorescence
intensity of different cell bodies visible in B. The black arrow indicates the time point when
CAB has been applied. Scale bar is 100 µm.
We have also investigated the contribution of TTX-r currents in the propagation of action
potential. For this purpose we have added 250 nM TTX to the Mid-chamber only. This
concentration is known to completely block all TTX-s channels. NaV1.8, being TTX-r, is spared
from blockage at this concentration (Akopian et al., 1996; Akopian et al., 1999b; Renganathan
et al., 2001; Sivilotti et al., 1997). In this condition, the TTX-s channels in the axonal
compartment (where stimulation is carried out) and in the soma compartment are not
blocked. We have found that the blockage of TTX-s currents does not impair action potential
propagation. In fact, compared to CTR condition, the same number of cells responded to
chemical stimulation (mean percentage of responsive neurons in TTX treated samples,
expressed as % of CTR ± SEM; CTR = 100% ± 35.9, TTX = 109% ± 12.1; n=3; p=1, Mann-Whitney
test. Calculated power = 0.08) (Fig. 3.20). This result shows that the majority of sodium
currents encoding the propagation of the action potential are indeed mediated by TTX-r
channels.
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Figure 3.20) TTX-r VGSC mediate action potential propagation from the axon terminals to the
cell bodies. The graph shows the quantification, at the level of the cell bodies, of axonal
chemical stimulation in the presence of TTX in the Mid-chamber.
3.3.14 Chemical stimulation of DRG neurons in Campenot chambers: lipid raft
disruption.
Having demostrated that action potential propagation is mostly mediated by TTX-r currents
(e.g. NaV1.8) we investigated the effect of lipid raft disruption and NaV1.8 shift to the soluble
fraction on the propagation of action potentials. For this purpose we have disrupted lipid rafts
with 7KC or MBCD in the Mid-chamber only and applied CAB to the axonal terminals (Axon
chamber) and recorded fluorescence intensity at the level of the cell body (Soma chamber). It
is worth to stress the fact that axon terminals and cell bodies are unaffected from lipid raft
disruption and the shift of NaV1.8 to the soluble fraction only occurs in the Mid-chamber.
Control cells were either left untreated or treated with cholesterol. Upon CAB application we
have quantified the number of cells responsive to the chemical stimulation. Cells that showed
an increase of fluorescence were classified as responsive. In particular, the increase of
fluorescence had to be higher than 3%, compared to baseline. This value was chosen as it
represents at least three times the increase that occured in few cells in CTR condition after
vehicle application (1% increase in 1 out of 58 cells). Also, the increase of fluoresence had to
show a transient profile to be classified as positive. Cells with fluorescence oscillation before
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the chemical stimulation were not included in the analysis. Fig. 3.21 shows representative
increases of fluorescence that occured in cells bodies upon CAB stimulation of the axons.
Figure 3.21) Representative profiles of DRG neurons responding to axonal stimulation. The
figure shows cell bodies in the Soma chamber loaded with Fluo-4 responding to a chemical
stimulus (CAB). A) Shows the Fluo-4 fluorescence and DiC image of the cell bodies. B) Shows
the Fluo-4 fluorescence in pseudo-color, associated with different time points during the
recording. Arrow head indicates a cell body wich responded to the chemical stimulation. C)
B
)B)
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The graph shows the recorded fluorescence intensity of different ROIs, visible in A. The arrow
indicates the time point when the axons have been stimulated; cardinal numbers refer to the
time points which the images in B are associated to. Scale bar is 100 µm.
Importantly, the different treatements did not alter the morphology of axons in the Mid-
chamber (Fig. 3.22).
Figure 3.22) Treatments did not alter the morphology of  neurites in the Mid-chamber. The
figure shows neurites in the Mid-chamber loaded with Fluo-4, after the treatments. Scale bar is
100 µm.
In Table 3.3 we list the raw data relative to the chemical stimulation in Campenot chamber.
We found variability across different experiments in terms of absolute number of responsive
neurons, together with a consistant decrease in the percentage of neurons responding to
chemical stimulation upon raft depletion. Because of this reason in Table 3.4 we show the
percentage change of cells responding to the chemical stimulation compared to control cells,
for ease of comparison between the different groups. We found that 7KC and MBCD
treatments significantly decreased the percentage of cells responding to the chemical
stimulation. On the other hand, cholesterol treatment did not cause any effect on action
potential conduction.
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Table 3.3. Campenot set-up raw data. Table lists the percentage and the absolute number of
neurons responding to the axonal chemical stimulation (responsive neurons / total neurons
per field of view).
Experiment
number
CTR Treatment CHOL Treatment
1 20.7% (17/82) 28.3% (19/67)
2 7.7% (8/104) 2.7% (3/109)
3 3.5% (3/86) 4.8% (5/105)
Experiment
number
CTR Treatment 7KC Treatment
1 4.9% (3/61) 0% (0/58)
2 5% (3/59) 2.1% (1/46)
3 2.5% (2/81) -
4 1.9% (3/158) 0% (0/160)
5 3.5% (2/57) 2.2% (1/44)
6 10.5% (6/57) 2.2 % (1/44)
7 20.7% (17/82) 14.1% (13/92)
Experiment
number
CTR Treatment MBCD Treatment
1 98.3% (57/58) 4.5% (3/66)
2 - 20% (20/100)
3 46.6% (14/30) 5.5% (4/72)
4 5.8% (1/17) -
5 5.7% (3/52) -
6 1.9% (3/158) 1.0% (2/184)
7 18% (6/33) 8.7% (5/57)
8 10.5% (6/57) -
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Table 3.4. Lipid raft disruption impairs action potential propagation in DRG neurons. Table
shows the percentage of neurons responding to the axonal chemical stimulation after the
different treatments. Data are presented as means of responsive neurons expressed as % of
CTR ± SEM. *=p < 0.05 vs CTR, Mann-Whitney test. Calculated power value is shown In
brachets for each paired couple.
CTR Treatment CHOL Treatment
100 % ± 48.7 112 % ± 77.3 (0.05)
CTR Treatment 7KC Treatment
100 % ± 7.7 34.5 % ± 12.8 * (0.99)
CTR Treatment MBCD Treatment
100 % ± 27.1 34.4 % ± 10.8 * (0.89)
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3.4 Discussion
Investigation of the disruption of the association between NaV1.8 and lipid rafts.
We have demonstrated in the previous chapter that NaV1.8 associates with lipid rafts in vivo
and in vitro. We further explored this finding by investigating the functional meaning of this
association. The strategy that we pursued was to disrupt lipid rafts and to test how NaV1.8
partitions. A functional assay was also needed to determine how NaV1.8 function changes after
lipid rafts disruption, to unmask the potential physiological meaning of NaV1.8-raft association.
The first section of the discussion will analyse the results regarding the disruption of rafts and
the effect on NaV1.8 obtained by biochemical and imaging techniques. The second part of the
discussion will focus on the development of functional assays and on the effect of lipid raft
disruption, and NaV1.8 shift to the soluble portion of the membrane, on action potential
propagation.
3.4.1 Lipid raft disruption: biochemical and imaging techniques.
We have disrupted lipid rafts by using two complementary approaches, which interfere with
different aspects of lipid raft nature: MBCD treatment and 7KC delivery. MBCD is the most
common agent used to disrupt lipid rafts (Simons and Toomre, 2000). Lipid rafts are highly
enriched in cholesterol, and its presence is necessary for raft stability (Pike, 2003). MBCD is a
cyclic oligosaccharide which binds to sterols. If added to the media it depletes cholesterol from
the cell membrane and leads to raft disruption (Dart, 2010). On the other hand, 7KC
represents a novel tool to disrupt lipid rafts. 7KC is an analogue of cholesterol which, if present
on the membrane, impedes the tight packing of the saturated fatty acid chains. This physical
alteration perturbs lipid raft stability by decreasing the lipid order (Owen and Gaus, 2010;
Rentero et al., 2008) (for a detailed description of these compounds and mode of action see
the introduction; section 3.1.2). We have first tested the effects of these compounds on raft
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integrity in vitro by monitoring the flotation pattern of Flotillin-1, a protein raft marker. In fact,
upon MBCD treatment or 7KC delivery two different scenarios can be predicted. In MBCD
treated cells cholesterol is removed from the membrane and rafts, by lacking its constituent,
are not present, or reduced, on the cell surface. In 7KC treated samples, on the other hand,
cholesterol is still present in rafts, but the inclusion of 7KC decreases the lipid order. Hence,
both treatments induce fundamental changes in rafts’ physical properties. Since lipid rafts are
resistant to non-ionic detergents thanks to their physical properties any alteration of these
should be reflected in their ability to resist non-ionic detergent lysis. These consequences can
be monitored by analysing the floatation pattern of raft associated proteins. In fact, if rafts
ability to resist lysis is affected they will be lysed with the rest of the membrane. Consequently
raft proteins, since they do not associate with rafts anymore, lose their floating properties in a
density gradient. In our conditions, both agents proved to impair raft stability. Indeed,
compared to control condition, in 7KC and MBCD treated samples, Flotillin-1 is also recovered
from the soluble fractions. This effect was more prominent for MBCD, where no Flotillin-1 was
associated with floating fractions, compared to the tailing effect present in 7KC treated
samples, where Flotillin-1 was distributed across the gradient. From this result we can
conclude that both MBCD and 7KC impaired raft stability. These data confirmed two lipid rafts
hallmarks in our system: they are dependent on cholesterol and on a lipid ordered phase. We
also found that MBCD proved to be a stronger agent than 7KC. The effect could be attributed
to the different modes of action of the compounds. It is possible that the effect of MBCD,
which results in stripping of cholesterol from the membrane, has a more profound effect on
raft stability, compared to the effect of 7KC, which impairs the ability of rafts to be detergent
resistant by decreasing their lipid order and not by removing cholesterol from the cell surface.
In summary, we have demonstrated that MBCD and 7KC disrupt lipid rafts.
We asked what the effect of these treatments would be on NaV1.8 buoyancy. Since we found
that NaV1.8 associates with rafts in vitro we would expect an alteration of its floating pattern,
upon raft disruption. We found that both MBCD and 7KC treatments had the same effect on
NaV1.8. NaV1.8 was found to be associated only with the soluble portion of the membrane and
the raft pool of NaV1.8 was completely absent after the treatments. This result demonstrates
that the floating pool of NaV1.8 is indeed raft associated in DRG neurons and that the methods
we employed to interfere with rafts integrity are useful tools to induce a shift of raft
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associated NaV1.8 to the soluble portion (non-raft) of the membrane. This evidence also opens
the way to the investigation of NaV1.8 properties when it is raft associated and when it is not.
We have further investigated the effect of MBCD and 7KC on the lipid phase of live cell. We
have used a completely different approach: live cell imaging. Noticeably this method does not
involve any detergent extraction and is carried out at physiological temperature. We have
exploited the properties of the environmentally sensitive styryl dye di-4-ANEPPDHQ. Di-4-
ANEPPDHQ is water soluble and shows minimal background fluoresence in water. When it
binds the outer leaflet of the plasmamembrane it becomes fluorescent, and is characterised by
a large Stoke shift. This dye has the interesting property to act as a lipid phase probe. It was
first described to distinguish between liquid ordered and liquid disordered phase in model
membranes. It displays a red-shift of the emission spectra in lipid disordered phase, compared
to lipid ordered phase (Jin et al., 2005). It is worth to underline that this feature is dependent
on the lipid phase itself and not on preferential binding of the dye to certain class of proteins.
Indeed, it has been discovered that di-4-ANEPPDHQ emission and excitation spectra (in both
lipid raft and soluble part of the membrane) are unaffected by the presence of peptides (Dinic
et al., 2011). Also, di-4-ANEPPDHQ emission spectra is dependent on cholesterol content (Jin
et al., 2006). It has been proposed that these properties rely on the effect of the solvent on the
dye’s fluorescence emission. When the dye is buried into the plasmamembrane in a stiff
environment (e.g. lipid raft) it shows a smaller Stoke shift, compared to a more soluble
environment. A stiffer environment limits the dispertion of the energy from the excited dye to
the sourronding lipids, hence more energy is retained by the dye for the emission
phenomenon, which occurs at lower wavelenghts (Jin et al., 2006). Importantly for the
purpose of our discussion, this dye is suitable to image lipid phase in live cells. Di-4-ANEPPDHQ
has been reported as a lipid raft probe in live HeLa cells, Neutrophils and T-cells (Jin et al.,
2006; Owen and Gaus, 2010; Owen et al., 2006; Owen et al., 2007; Owen et al., 2010). We
found that MBCD and 7KC impairs raft stability. We thought that this could correlate to an
altered lipid phase. For this purpose we used di-4-ANEPPDHQ to stain live DRG neurons after
lipid raft disruption. We found that both 7KC and MBCD determined a red shift of the dye’s
spectra. Cholesterol treatment did not influence the lipid phase, as the related spectrum
completely overlapped to the spectrum of untreated cells. This demonstrates that, in our
model, the concentration of cholesterol we used was below the needed concentration to
induce cholesterol-insertion dependent modification of the membrane, which is in accordance
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with published findings (Rentero et al., 2008). When cholesterol homeostasis is studied,
usually, much higher concentration are needed to detect physiological differences (Lundbaek
et al., 2004). Our data perfectly match with the expected outcome of 7KC and MBCD
treatments. In fact, regardless of the mode of action, both compounds interfere with lipid
rafts; impairment of tight lipid packing (7KC action) and loss of rafts (MBCD action) action
should correlate with a decrease of lipid order and we found that di-4-ANEPPDHQ emission
spectra shifted to redder wavelenghts compared to control cells upon both treatments. Hence,
the dye’s spectrum shift is consistant with an increase of membrane disorder in DRG neurons
and it confirms that 7KC and MBCD impairs lipid rafts in our model. Interestingly, we also
found that the spectra of 7KC and MBCD treated cells was different at longer wavelenghts (e.g.
7KC was narrower). This effect is consistant with the dye’s properties. Indeed, it has been
reported that an increase of cholesterol concentration determine a narrowing of the emitted
spectrum, or in other words the decrease of cholesterol results in a broader emission spectrum
(Jin et al., 2006). The difference between 7KC and MBCD spectrum could be due to the fact
that, even though both treatments increase lipid disorder and both spectra are red-shifted
compared to control and cholesterol samples, in MBCD treated samples membrane cholesterol
is depleted and this is mirrored in a less steep shoulder of the spectrum, compared to 7KC
(where cholesterol content is unaffected).
In conclusion, we have used to two different methods to disrupt lipid ratfs and two
complementary techniques to confirm and assess the degree of disruption. The data combined
from biochemistry and imaging approaches demonstrate that 7KC and MBCD determine a loss
of lipid order on the membrane and lead to lipid rafts disruption. Importantly, in these
conditions, NaV1.8 is present in the soluble part of the membrane and the cells completely
devoid of raft associated NaV1.8.
By imaging techniques we have also investigated the sub-cellular localisation of raft markers
and NaV1.8. We reported (see Chapter 2; Results section) that GM1, Flotillin-1-Dronpa and
NaV1.8 display a characteristic clustered distribution along the axons of neurites. Since one of
lipid rafts role is to act as platforms to stabilise protein complexes on the membrane (Dart,
2010; Hering et al., 2003; Zhu et al., 2006) we hypothesised that raft disruption would lead to a
dispersion of the clusters into an even distribution. For example, it was reported that AchR
clusters at the post-synaptic site in neuromuscular junctions are stabilised by cholesterol, and
its depletion via MBCD lead to a disassembly of the clusters. In more details, it was found that
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rafts allowed SRC-Family protein tyrosine Kinases (SKFs) to act in the stabilisation of AchR
clusters by phosphorylating AchR and by maintaining their association with the cytoskeleton
(Willmann et al., 2006). MBCD also disrupts the clustered distribution of AchR in the somatic
spines of ciliary neurons. It was found that raft integrity was necessary to maintain the clusters
at the cell surface (Bruses et al., 2001). We found that regardless of the treatments, GM1,
Flotillin-1-Dronpa and NaV1.8 clusters were still present on the membrane. GM1 visualisation
(as we discussed before, see discussion Chapter 2) depends on the patching mediated by CTB
binding to GM1 and Streptavidin binding to CTB. Upon lipid raft disruption, changes at the
molecular level may occur and alter GM1 distribution, which we cannot detect at a single
molecule level because of the intrinsic limit of light microscopy. Hence, the clustering activity
of CTB-Streptavidin method that we use to visualise raft components could mask the effect of
raft disruption on GM1 sub-cellular localisation, by bridging molecules of  GM1 that are not
associated in rafts anymore. Distribution of Flotillin-1 is affected when rafts are disrupted, as
we demonstrated by biochemistry techniques. Nevertheless, when we employed imaging
method to detect its sub-cellular localisation we did not detect any gross change. For this
purpose it would be interesting to employ microscopy techniques which overcome the limit of
optical resolution, like FRET, PALM, SEM and single molecule tracking to understand what the
local effect of raft disruption is at a molecular level. NaV1.8 clusters were also apparent after
lipid raft disruption, suggesting that the clustered appearance may not be dependent on raft
integrity. Our data suggests that NaV1.8 clusters represent a terminal organization of the
channel (see data from ex vivo samples; section 2.3.5). It is known that sodium channels
interact with membrane (e.g. VGSC β subunit, Contactin), and intracellular proteins (e.g.
Ankyrin) that stabilise the channels on the membrane, by bridging it either directly or
indirectly to the cytoskeleton (Cusdin et al., 2008; Lai and Jan, 2006; Poliak and Peles, 2003).
Specifically for NaV1.8 it has been reported that Contactin regulates NaV1.8 expression and
currents along the axons (Rush et al., 2005). Also, NaV1.8 has a conserved Ankyrin binding
motif (VPIAEGESD) which may mediate a direct association of the channel, via its intracellular
loop, with the cytoskeleton (Lemaillet et al., 2003). It could be hypothesised that lipid rafts role
is not to maintain NaV1.8 clusters, and upon raft disruption NaV1.8 localisation is retained by its
association with intracellular proteins. It is worth to highlight that our experimental set-up was
aimed to analyse potentially short term effects of raft disruption on NaV1.8 localisation. It
would be interesting to assess NaV1.8 localisation at later time points after lipid raft disruption.
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We have demonstrated that 7KC and MBCD disrupt lipid rafts. We have tested if these
treatments had an acute toxic effect on DRG neurons. For this purpose we used Propidium
Iodide to stain DNA. Propidium Iodide is a fluorescence intercalating agent that increases its
fluorescence 30 folds when it binds DNA. Since it is membrane impermeable it can only bind
the nuclei of neurons with a compromised cell membrane. In our hands we found that lipid
raft disruption did not induce any toxic effect resulting in membrane disruption. This data
further supports that 7KC and MBCD short term effects on raft integrity and lipid phase of the
cell membrane are specific and not due to pleiotropic toxic effects.
3.4.2 Lipid raft disruption: functional assays.
We demonstrated that NaV1.8 associates with lipid rafts in DRG neurons and that upon
treatments with 7KC and MBCD it shifts to the soluble portion of the membrane. NaV1.8
mediates the majority of sodium influx during action potentials (Renganathan et al., 2001). It
also encodes TTX-r currents which are able to propagate along unmyelinated fibres. In fact,
classic studies pointed at NaV1.8 as a key player in action potential propagation in
unmyelinated fibres. The first evidence that NaV1.8 supports action potential propagation in C-
fibres came from studies performed in the early nineties. Jeftinija showed that in a spinal cord-
dorsal root ganglion preparation, application of high concentration potassium to DRG (cell
bodies, dorsal root and peripheral processes) evoked action potentials that propagated to the
spinal cord where they triggered excitation of dorsal horn neurons. Inhibition of TTX-s channels
blocked action potential propagation in large fibres, but it did not affect the propagation in
unmyelinated nociceptors. This indicates that NaV1.8 is sufficient to mediate the propagation
of action potentials in slowly conducting fibres (Jeftinija, 1994b). The same author later
described a similar finding by using Bradykinin, a pro-inflammatory peptide, as the excitation
agent. It was found that the stimulatory effect of Bradykinin (depolarisation and firing of action
potentials) on DRG neurons was TTX resistant. In the presence of TTX, application of
Bradykinin to DRG neurons still evoked excitatory action potentials in dorsal horn neurons.
Bradykinin also potentiated the postsynaptic potentials recorded in the dorsal horn, induced
by electrical stimulation of TTX-resistant afferent fibres. This finding further demonstrates that
TTX-r currents are able to mediate propagation of action potentials from DRG neurons to the
spinal cord (Jeftinija, 1994a). Furthermore, conduction of TTX-r action potentials has been
167
described in unmyelinated C-fibres from human sural nerve (Quasthoff et al., 1995). NaV1.8 is
expressed in the unmyelinated fibres in cornea, which originate from the trigeminal ganglia,
where it encodes TTX-r currents (Black and Waxman, 2002). In these fibres TTX-r action
potential propagation has also been shown. In fact ongoing electric activity, mechano, thermal
and chemical stimuli evoke action potentials in the cornea, and these are conducted in the
presence of TTX (Brock et al., 1998). Moreover TTX-r action potential propagation has been
described to occur in C fibres along the dorsal roots (Steffens et al., 2001).
All these data collectively show that NaV1.8, which mediates TTX-r currents, is sufficient to
mediate in certain conditions action potential propagation. Given these evidence, in order to
test if NaV1.8-raft association is physiologically relevant, we decided to investigate action
potential propagation in small diameter neurons (e.g. nociceptors) in control conditions and in
neurons where, upon lipid raft disruption, NaV1.8 is only associated with the soluble fraction of
the membrane. We developed two assays to generate and propagate action potentials: direct
mechano-stimulation and chemical stimulation of DRG neurons in vitro.
3.4.3 Mechano-stimulation based assay.
Our aim is to study the effect of lipid raft disruption on NaV1.8 functions. We used in first
instance, for this purpose, voltage sensitive dyes and a sodium sensitive dye, whose
fluorescence is dependent on the membrane voltage and intracellular sodium concentration,
respectively. Both methods proved to be hindered by technical limits (data not shown). For
this reason we have investigated action potential propagation upon mechanical stimulation of
the axons, by using Fluo-4, a calcium sensitive dye. Nociceptors, which express NaV1.8 (Djouhri
et al., 2003a), respond to high-threshold mechanic stimulation in vivo (Wall and Melzack,
2005) and maintain this ability when cultured. Nociceptors, following a direct mechanic
stimulation of the cell bodies (Gschossmann et al., 2000; McCarter and Levine, 2006; McCarter
et al., 1999) or the neurites (Hu and Lewin, 2006), encode inward currents and generate action
potentials. Similarly to what we have reported, mechanical stimulation of the axons also
evokes a propagating wave of Fluo-4 fluorescence from the point of stimulation (Sanchez et
al., 2007). In agreement with data in literature we have found that a direct mechanical
stimulation of the axons of DRG neurons in vitro evokes an increase of calcium at the level of
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the cells body, showing that the focal stimulus on the periphery evokes an excitation event
that is propagated to the cell body. In our system we have further investigated the nature of
such excitation and correlated it to the function of NaV1.8. In agreement with published data
(Gschossmann et al., 2000), we found that in the absence of extracellular calcium no cell body
responded. This implies that the intracellular stores do not participate in the raise of calcium
upon stimulation at the level of the axons and cell bodies. We also performed the experiment
in sodium free conditions. We replaced extracellular sodium with Choline chloride. This
compound is commonly used in electrophysiological experiments and allows maintaining
positive charges and the right osmolarity in the extracellular media in the absence of sodium
(Allard et al., 2006; Fitzgerald et al., 1999). Remarkably we found that in this condition no
peak-like increase of fluorescence was detected at the level of the cell bodies, upon axonal
stimulation. Occasionally we found that stimulation of the axons evoked a slow rise of
fluorescence at the level of the cell bodies. Since calcium free conditions demonstrated that
the intracellular stores are not involved in the propagation of the signal, the extracellular
calcium could be the reason of this slow increase of fluorescence. In literature it has been
reported that voltage gated calcium channels can underlie action potential (Quasthoff et al.,
1995; Renganathan et al., 2001). It is possible that these channels are responsible for this slow
component of the excitation which propagates to the cell bodies. For this reason we only
focused on the fast, sodium dependent, component of the increase of fluorescence at the level
of the cell bodies. The sodium free condition clearly shows that the event of stimulation
evokes a sodium conductance which is responsible for the excitation of the cell bodies. This
strongly points to an involvement of sodium channels in this process. Furthermore, we have
correlated the increase of fluorescence of the cell bodies to voltage gated sodium channels
and NaV1.8 activity. We used Lidocaine, a local anaesthetic, at concentrations which block
voltage gated sodium channels (Chevrier et al., 2004; Gu and MacDermott, 1997), to
investigate the role of this class of protein in action potential propagation. We found that the
blockage of voltage gated sodium channels dramatically decreased the number of cell bodies
responding to the axonal stimulation, demonstrating the these channels are involved in the
propagation of the depolarisation to the soma from to the focal contact on the axons. Also,
the pharmacological modulation of mechano-stimulation, together with the evidence that we
were able to repetitively stimulate the same cells, show that we produced mechanically gated
currents as opposed to artifacts (e.g. increase of ionic conductance due to membrane rapture).
NaV1.8 is a TTX-r channel, hence we exploited this feature to analyse its role in action potential
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propagation. In the presence of TTX, at a concentration which blocks all TTX-s channels
(Akopian et al., 1999b; Goldin et al., 2000; Renganathan et al., 2001; Yu and Catterall, 2003),
the axonal stimulation still evoked an increase of fluorescence at the level of the cell body. This
shows that NaV1.8, in our condition, is sufficient to underlie action potential propagation in
DRG neurons. Our combined data demonstrate that mechanical stimulation evokes a
depolarisation at the level of the neurite which propagate away from the point of contact
towards the cell body. The propagation of the excitation relies on the presence of sodium and
more specifically on the activity of voltage gated sodium channels. Most importantly, NaV1.8
alone is sufficient to let the action potentials propagate.
A potential limitation of our set-up is that is not possible to directly correlate the mechano-
stimulation with a stimulus that would produce nociception in vivo. In fact, unmyelinated
fibres in adult animals are surrounded by other cell types/extracellular matrix which could be
physically involved in the propagation of the force from the point of stimulus to the axons. A
direct investigation of mechano-transducers in vivo has been hampered by technical
difficulties; the small size and inaccessibility of unmyelinated mechano-sensitive endings have
avoided a direct analysis of electric properties of such neurons, hence a direct correlation
between pain/mechano sensations in animals and in vitro is not available at the moment.
Nevertheless, mechano-stimulation in vitro has been proposed to potentially correlate to
noxious mechano-sensation (Hu and Lewin, 2006). Drew et al. found that nociceptors
(identified by capsaicin responsiveness) responded to higher level of pressure, compared to
non-nociceptive neurons, which correlates with the finding that in vivo nociceptors have high
threshold of mechanical activation (Drew et al., 2002).  The same group later discovered that a
conopeptide toxin analogue selectively blocked mechanically evoked currents in DRG neurons.
These currents were slowly adapting and associated with small nociceptive sensory neurons
(identified according to capsaicin sensitivity and expression of Peripherin). Interestingly, this
peptide blocked pain behaviour in response to high intensity mechanical stimuli but did not
affect the threshold to low intensity pressure, highlighting a correlation between the currents
evoked in vitro and in vivo and supporting the view that the slowly adapting mechano-sensitive
channels mediate the responses to noxious pressure (Drew et al., 2007). Additional evidence
on the mechanostimulation of nociceptors in vitro has been provided by Di Castro et al. This
group showed that signaling pathways involved in inflammatory pain conditions directly
modulate the mechano-transduction apparatus of sensory neurons. PKC activation (which
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induces mechanical hyperalgesia in vivo) and NGF (which is a pro-nociceptive agent)
administration increased mechano activated currents. It was found that PKC mediates
insertion of mechano-transducers into the membrane, while NGF increases their transcription
rate (Di Castro et al., 2006). Moreover, ATP and UTP sensitise nociceptors through P2Y2
receptors and determine potentiation of mechanically activated currents in vitro via a Gq
protein dependent pathway (Lechner and Lewin, 2009). In addition, it has been reported that
DRG neurons express a channel (whose molecular identity is unknown) which is gated by a
high pressure mechanical stimulus in vitro. This channel is only present in small diameter
neurons and its current is modulated by pro-inflammatory agent PGE2 (Cho et al., 2002). Even
if ultimately it cannot be ascertained if our mechanical stimulation in vitro mirrors nociception
in vivo, it must be stressed that with our model we developed an assay to study action
potential propagation, mediated by NaV1.8, in small diameter sensory neurons, which are likely
to be nociceptive (Djouhri et al., 2003a).
We used this set-up to study NaV1.8 function in control samples, where the channel associates
with lipid rafts and in samples where, upon raft disruption, it is associated only with the non-
raft (soluble portion) of the membrane. Remarkably, in raft depleted neurons we have found a
drastic reduction of cell bodies responding to propagating action potentials and the neurons
which still responded showed slower action potential propagation. These data shows how the
association between NaV1.8 and rafts correlates with proper action potential conduction and
disruption of such association has a detrimental effect in action potential propagation. In fact
less cells bodies, compared to control, respond to the propagating depolarisation. The speed
of conduction is also lowered in raft depleted cells. There are several determinants of speed of
conduction including membrane resistance (Rm), fibre thickness, temperature, magnitude and
kinetics of the active sodium currents (Hille, 2001). It would be interesting to assess the
passive properties of the membrane to determine if these parameters are affected, and if they
are, to which extent by raft depletion. On the other hand, it is known that rafts exert an
influence on fundamental properties of proteins, and their disruption could lead to altered
activity of the NaV1.8. Supporting the idea that impaired electrophysiological properties could
alter speed of conduction, it is demonstrated that modification in the inactivation kinetics
decrease the speed of conduction along the axons of unmyelinated fibre (De Col et al., 2008).
In our experimental model we were interested in an acute perturbation of lipid rafts. It would
be interesting also to gather information about the re-constitution of rafts upon their
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depletion. It could be possible to deliver cholesterol after MBCD treatment to replenish its
content, or allow the cells to recover after the lipid phase change and test if the raft depletion
has a chronic or transient effect. It must be underlined that with the mechano-stimulation set-
up we cannot exclude a priori that the mechano-transducer(s) itself is located in lipid rafts and
that raft disruption alters mechano-transduction. Since the molecular identity of mechano-
transducers is unknown we could not test if they partition into rafts by biochemical and
imaging method. In addition, the lack of a valid positive control for mechano-stimulation does
not rule out the possibility that the decrease in responsiveness of neurons upon raft depletion
may be due to pleiotropic effects of the raft depleting agents, rather than a direct effect on the
propagation of the depolarisation. Because of these reasons we exploited our functional assay
and have investigated mechano-stimulation of the cell bodies directly, a method of stimulation
which does not involve propagation of action potential. We found that raft disruption does not
alter cell responsiveness. We can hypothesis that the increase of intracellular calcium can be
originated by a direct flux from the extracellular media through mechano-transducers only
(Gschossmann et al., 2000). Alternatively, even though several lines of evidence argue against
this hypothesis (Gschossmann et al., 2000; Sharma et al., 1995), both mechano-transducers
and calcium specific channels (e.g. voltage gated calcium channels), which are activated in
response to the cell depolarisation, contribute to calcium influx. In our hands, direct
stimulation of the cell bodies demonstrates that both mechano-transducers and/or other
calcium channels potentially involved in calcium influx are not affected by raft disruption. This
demonstrates that upon raft depletion the mechano-transduction mechanism and output
measurement is not impaired. We cannot be sure if NaV1.8 participates in cell responsiveness
upon direct soma stimulation. We can hypothesise a scenario where calcium influx is
independent of voltage gated ion channels and one where they are involved. If the latter case
is true we did not find any difference in cell response upon raft disruption, indicating that this
method of stimulation is not affected from the association of VGSC and NaV1.8 with rafts.
Interestingly, we have found that at the level of the cells bodies NaV1.8 and GM1 (a marker of
rafts) did not co-localise (see chapter 2, Fig. 2.15; section 2.3.6). It is tempting to speculate
that, in the hypothetical scenario where NaV1.8 does indirectly contribute to soma stimulation
mediated calcium influx, raft disruption does not impair its activity since at the level of the cell
body NaV1.8 is not associated with rafts in the first instance.
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The data gathered from the mechano-stimulation based assay highlights that raft disruption
and parallel NaV1.8 shift to the soluble portion, do not lead to pleiotropic effects and
specifically accounts for impairment in action potential conduction. This data strongly points to
a biological and physiological importance of NaV1.8-raft association.
3.4.4 Chemical stimulation based assay.
We explored action potential propagation also with Campenot chambers and chemical
stimulation. The great advantage of this method is that it is possible to segregate different
parts of DRG neurons in vitro. Campenot chambers are named after the author who first
developed this method. This set-up was traditionally used in the investigation of the effects of
trophic factors on different compartments of the neurons (e.g. soma vs. axons). By using these
chambers it was demonstrated how NGF promotes axon outgrowth from the cell bodies to the
adjacent chambers (Campenot, 1977). Compartmentalised chambers are also used in the study
of protein trafficking (Cui et al., 2007; Ure and Campenot, 1997), axonal degeneration
(Nikolaev et al., 2009) and viral infection (McGraw and Friedman, 2009). This method, albeit
with differences, was used to study DRG-dorsal horn neurons connectivity. In this model, DRG
cell bodies were forced to project axons in the adjacent chamber, where they formed
functional synapses with dorsal horn neurons. It was shown that electric and chemical
stimulation of the DRG neurons evoked action potential that propagated between the
chambers. Also, as we have demonstrated, TTX-r action potentials propagation was described
to occur in nociceptive neurons (Vikman et al., 2001). By using a three-chamber set-up we
segregated the cell bodies from the conducting portion of the axons and the axonal terminals
that we used to excite the cells. We don’t know the molecular fingerprint of the cells
projecting to the further chambers. However, we exploited the activity of NGF to promote
neurite outgrowth (Campenot, 1977; Petruska and Mendell, 2004; Sofroniew et al., 2001),
therefore the cells projecting neurites are most likely peptidergic nociceptors expressing NGF
receptor TrkA (Averill et al., 1995; Fang et al., 2005). It is well known that the chemicals we
used to excite the axonal terminals are able to depolarise the neuronal membrane of
nociceptors and to trigger action potentials. Capsaicin elicits a noxious sensation of burning
pain when it binds to nociceptors in vivo. Specifically, it binds to TrpV1, a non-selective cation
channel expressed by nociceptors, which is also gated by noxious temperature (Caterina et al.,
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1997). Once gated, TrpV1 depolarises the membrane due to the influx of cations, voltage gated
sodium channels are engaged and action potentials generated. ATP also elicits pain sensation
in vivo (Coutts et al., 1981). It binds to P2X3, a cation channel exclusively expressed in DRG
neurons, and encodes a depolarizing current (Bouvier et al., 1991). Bradykinin is a nonapeptide
with pro-inflammatory activity which binds to receptors B1, B2 and causes sensation of pain.
Its application to nociceptors also evokes depolarising currents (Burgess et al., 1989; Jeftinija,
1994a; Wang et al., 2006) and mediates sensitisation of other pain transductors (Okuse, 2007;
Premkumar and Ahern, 2000). Chemical stimulation excites DRG neurons in vitro and this
activity correlates well with nociception in vivo. In fact, the chemicals described above have all
been shown to bind to nociceptors in adult animals, excite them and elicit pain sensation (Wall
and Melzack, 2005). We have used a cocktail of chemicals in order to maximise the
responsiveness of DRG cell bodies. DRG neurons are a heterogeneous population, and small
fibres can further be classified according to the expression of certain class of proteins (e.g.
peptidergic vs. not peptidergic). NaV1.8 is expressed in virtually all nociceptive neurons (both
peptidergic and non peptidergic) (Choi et al., 2007; Djouhri et al., 2003a). We used chemicals
whose receptors are expressed in nociceptors (for details see Introduction; section 3.1.4).
TrpV1 has been shown to be present in nociceptive cells, both peptidergic and non peptidergic,
which encode TTX-r currents (Arbuckle and Docherty, 1995; Hwang et al., 2005; Wood and
Docherty, 1997); P2X3 is present in non peptidergic nociceptors (and to a lesser extent in
peptidergic fibres) (Ruan et al., 2004); Bradykinin receptors, B1 and B2 are also expressed in
nociceptive neurons. B1 has been found in IB4 positive, TrpV1 expressing nociceptors if GDNF
supplemented (Vellani et al., 2004) and B2 in TrkA expressing cells (Lee et al., 2002). We have
demonstrated that chemical stimulation of the axonal terminals triggers calcium influx that
propagates towards the cell bodies. This propagation is sodium dependent, which
demonstrates that sodium channels are necessary. This finding also indirectly shows that
calcium and calcium channels do not play a major role in action potential propagation. In the
presence of TTX only in the middle chamber, the number of cell bodies responding to the
chemical excitation was only slightly reduced (and not to a statistically significant level)
compared to control cells. Importantly, this data confirms that NaV1.8 clearly mediates the
majority of action potentials in the cells responding to the chemical stimulation. If the
population of cells responding to the chemical stimulation was expressing mostly TTX-s
channels, like non-nociceptors which do not express TTX-r channels (Djouhri et al., 2003a; Fang
et al., 2002), TTX would have blocked most of the action potential conduction. The main
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contributor to TTX-s currents in nociceptors is NaV1.7 (Djouhri et al., 2003b). In DRG neurons it
is thought to boost ramp currents and enhance depolarisations which determine recruiting
NaV1.8 (Cummins et al., 1998; Waxman, 2006b). Even though a comprehensive analysis of its
sub-cellular distribution is still missing, reports showed that NaV1.7 is enriched at the axon
terminals where it amplifies cell depolarisations to reach thresholds for action potential firing
(Toledo-Aral et al., 1997; Waxman, 2006b). In our model, the finding the TTX does not impair
action potential propagation supports that NaV1.7 is present at the axon terminals. On the
other hand a report showed that a NaV1.7 blocker does stop action potential propagation in C
fibres. However, it must be noted that the concentration of blocker used for the experiment
was at least 100 times higher than the calculated IC50 and at this concentration blockage of
other channel isoforms could occur (Schmalhofer et al., 2008). It is also worth noting that
NaV1.9, the other TTX-r channel expressed by nociceptors, is mainly expressed in peptidergic
neurons which do not express TrkA (Fang et al., 2006). Since we used NGF to promote the axon
outgrowth of TrkA positive neurons the expression of this channel in our system is likely to be
minimal. NaV1.9 is also characterised by extra-slow kinetics and is thought to underlie a
persistent current which contributes to set the resting membrane potential rather than to
evoke transient currents and action potential generation (like NaV1.8) (Dib-Hajj et al., 2002;
Priest et al., 2005; Waxman, 2006b). Moreover, in our set-up we used NGF but not GDNF as
trophic factors and the presence of GDNF has been reported to be crucial for the expression of
NaV1.9 in vitro (Fjell et al., 1999a). In conclusion, the Campenot set-up allows us to investigate
NaV1.8 mediated action potential conduction, and most importantly to interfere with the
association between NaV1.8 and lipid rafts only in specific region of the cells. Because we
sought to investigate action potential propagation we interfered with rafts stability only in the
middle chamber, which contains the axonal compartment responsible of action potential
propagation. Since Campenot chambers allow growth of axons beneath the septa, yet it stops
media from different chambers to mix, when we disrupted lipid rafts in the middle chamber
we only affected portion of the neurons present in this chamber. On the other hand, the
axonal terminals, which responded to chemical stimulation, and cell bodies, which responded
to the propagated action potentials, were unaffected. Thus, Campenot chambers set-up
represented a valuable tool to interfere, from a spatial point of view, specifically with NaV1.8
raft association. Remarkably, when we disrupted the association of NaV1.8 with rafts in the
middle chamber action potential propagation was negatively affected, as shown by less cell
responsiveness compared to control.
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To summarise the data presented so far we have found that NaV1.8 resides in lipid rafts along
the axons of small diameter neurons, most likely nociceptors. The functional assays that we
have described confirm the existing data showing that NaV1.8 mediates the majority of sodium
influx during action potential (Renganathan et al., 2001) and is able to let propagate TTX-r
currents (Jeftinija, 1994a, b; Quasthoff et al., 1995). They also strongly point to a functional
meaning of the association between NaV1.8 and rafts. In fact our results show impaired action
potential propagation in nociceptors upon raft disruption.
176
Chapter 4: General discussion and
conclusions
177
4.1 Discussion
Meaning of the association between NaV1.8 and lipid rafts: possible explanations.
We have demonstrated that NaV1.8 associates with lipid rafts in small sensory neurons.
Moreover, the disruption of lipid rafts leads to the dissociation of NaV1.8 from these micro-
domains and this is correlated with impaired NaV1.8 mediated action potential propagation in
nociceptors in vitro. These findings strongly suggest that the association between NaV1.8 and
rafts is of fundamental importance for the correct functioning of this channel and for its
involvement in action potential propagation in nociceptors. In the next section we shall discuss
the hypothesis to explain what the physiological base of such association might be.
4.1.1 Lipid rafts are involved in trafficking (exo-endocytosis) and clustering of NaV1.8.
We originally hypothesised that rafts on the membrane acted as platforms necessary for the
maintenance of NaV1.8 clusters on the cell surface. Our experiments in raft depleted samples
showed that clusters of NaV1.8 and raft markers (GM1, Flotillin-1-Dronpa) were still present.
Hence, at least in the short period, lipid rafts are not necessary for the stability of NaV1.8 large
clusters. Nevertheless, this finding does not rule out rafts’ potential involvement in NaV1.8
trafficking to the membrane and/or development of clusters. Lipid rafts have been shown to
act as cues on the membrane where proteins, including ion channels are targeted to (Dart,
2010; Echarri et al., 2007; Martens et al., 2004; Pristera and Okuse, 2011). For example it has
been found that rafts regulate Nicotinic AChR clustering at neuromuscular junctions, by
facilitating the molecular interaction of Nicotinic AchR with Rapsyn and by regulating the
Agrin/MuSK signaling (Zhu et al., 2006). It would be interesting to monitor NaV1.8 forward
trafficking and cluster nucleation in control and raft depleted samples with live cell imaging
(e.g. FRAP, FLIP with NaV1.8-Dronpa; NaV1.8-ACP) to assess the role of rafts in these processes.
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It would be also interesting to clarify p11 role. It is not known if p11 is important for the
trafficking of the channel to the membrane or for its stabilisation on it, but it is a necessary
factor for NaV1.8 presence on the membrane and, notably, it does associate with rafts. It may
be proposed that NaV1.8 targets rafts per se or via the interaction with p11 and/or other
proteins. A direct association of NaV1.8 with rafts may be mediated by cholesterol binding or a
fatty acid modification (palmitoylation, myristoylation). To date, a direct binding of NaV1.8 to
cholesterol has not been described and even though palmitoylation can occur to VGSC
(Schmidt and Catterall, 1987) it has not been reported for NaV1.8. Thus, NaV1.8 could
translocate to rafts per se via still unknown mechanisms but at the moment evidence for this
process are missing. On the other hand, it may be proposed that p11 binds to NaV1.8 in the
exocytosis pathway and promotes its insertion and/or stabilisation onto membrane lipid rafts.
Given these considerations, raft disruption could determine defective NaV1.8
trafficking/retention to the membrane, which would result in reduced sodium currents and
action potential propagation failure in nociceptors. Insights on this process could come from
biochemical raft preparation and imaging study in p11 KO mice, which features less NaV1.8 on
the membrane and reduced TTX-r currents, compared to wild-type animals (Foulkes et al.,
2006).
VGSC beta subunits are known to bind the alpha sub-unit and to regulate its trafficking and
electrophysiological properties (Isom, 2001). It has been found that beta subunits partition
into rafts in mouse adult brain and cortical neurons in vitro (Brackenbury et al., 2008; Wong et
al., 2005). We did not investigate NaV1.8 beta sub-units partition into rafts but their
involvement in NaV1.8 raft association could also be possible, both in terms of forward
trafficking and of stabilisation on the neuronal membrane, similarly to what we have proposed
for p11. The proteins we listed above are obvious interesting targets, because of their known
role in NaV1.8 trafficking and/or association with rafts. NaV1.8 interacts with several proteins
(Malik-Hall et al., 2003) whose function is not fully understood and it would be interesting to
assess their roles in NaV1.8 trafficking/raft association.
Complementary to forward trafficking, lipid rafts have also been shown to regulate
endocytosis of membrane proteins. One potential explanation of action potential conduction
failure in raft depleted samples could be that in the absence of rafts, NaV1.8 is recruited into
endocytotic pathways. This would lead to a reduction of TTX-r currents which may impair the
conductivity along the axons. A similar mechanism has already been described for an ionic
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channel in hippocampal neurons. In fact, lipid raft depletion leads to a reduction of AMPA
receptor molecules on the membrane, both in basal and AMPA stimulated neurons, due to
their recruitment into the endocytotic pathway (Hering et al., 2003).
Another consideration can be raised about raft biosynthesis and NaV1.8 raft association. In
fact, the exact mechanisms of raft synthesis are largely obscure (Munro, 2003). It could be
possible that, as discussed above, rafts are important for NaV1.8 forward trafficking and that
NaV1.8 is targeted to pre-existing lipid rafts; alternatively, lipid rafts could nucleate around
NaV1.8 clusters. Neuronal protein NAP-22 has been described to promote raft formation by
cholesterol binding, in synthetic conditions (Epand et al., 2001).
4.1.2 Lipid rafts directly modulate the electrophysiological properties of NaV1.8.
There is a constantly growing body of evidence which focuses on how lipid rafts directly alter
the fundamental properties of membrane proteins. This implies that lipid rafts not only affect
cell excitability by regulating ion channel trafficking but also by shaping the
electrophysiological properties of the ion channels. Evidence supporting this is numerous and
includes different classes of ion channels. Even though the exact mechanisms are unknown, it
is thought that rafts exert a physical effect on the membrane proteins. Rafts are characterised
by a liquid ordered phase, with different lateral pressure, viscosity and by-layer thickness,
compared to non raft regions of the membrane. All these parameters can influence protein
properties by modulating, for example, folding, kinetics of transition between different
conformational states (e.g. the process open-closed-inactivated) and the stabilisation of
allosteric states (e.g. open vs. closed vs. inactivated). Indeed, whenever a conformational
change occurs (as it is for voltage gated channels when they experience voltage changes across
the membrane) the protein will disturb the neighbouring lipids. Hence, the kinetics of state
transitions or stabilisation into a certain conformation, do not only depends on the intrinsic
properties of the channel but also on the interaction between the protein itself and the lipid
environment (Andersen and Koeppe, 2007; Dart, 2010; Lee, 2004; Lundbaek et al., 2004;
Phillips et al., 2009; Tillman and Cascio, 2003). Dramatic direct alteration of
electrophysiological properties upon raft disruption has been described for ion channels. For
example,  lipid raft disruption, by cholesterol depletion, increases the activity of TrpM8 to
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multiple stimulation, both when menthol and cooling stimuli are applied, suggesting that lipid
rafts have an inhibitory role towards this channel. When the electrophysiological properties of
the channel were examined it resulted that its threshold of activation, in MBCD treated cells,
was lower than control cells (i.e. warmer stimuli were able to gate the channel) and the
voltage dependence of activation shifted to a more negative value. Interestingly the trafficking
of the channel is unaffected in treated cells, suggesting the lipid rafts directly modulate the
gating properties of the channel rather than its amount on the membrane (Morenilla-Palao et
al., 2009). KV2.1 is a voltage gated potassium channel mostly associated with non-caveolae
type lipid rafts. It is expressed in the brain and localises preferentially to the dendritic
compartment of neurons (Lim et al., 2000). The depletion of cholesterol from lipid rafts leads
to altered buoyancy and electrophysiological properties. In fact, Kv2.1 steady state inactivation
curve is shifted towards more hyperpolarised values, while current density and activation
kinetics are unchanged (Martens et al., 2000). Also, modulation of cholesterol content has
been correlated to changes in the shape of action potentials and neuronal firing in
hippocampal neurons (Guo et al., 2008). To date there are a few examples of an effect of
membrane phase/lipids on sodium channel electrophysiological properties. NaV1.4 is a voltage
gated sodium channel expressed in the skeletal muscle. It has been shown that, when
expressed in heterologous system, cholesterol depletion determines a hyperpolarising shift in
the voltage dependence of steady-state inactivation and a decrease of inactivation kinetics of
NaV1.4 (Lundbaek et al., 2004). Interestingly, it has also been conjectured that membrane
lateral lipid pressure influences NaV1.6 properties at the nodes of Ranvier. NaV1.6 transient
current displays irreversible hyperpolarising shifts of steady-state inactivation and of activation
upon membrane trauma, which leads to changes in later membrane pressure (Wang et al.,
2009). All these data support a scenario where rafts depletion may change NaV1.8 intrinsic
electrophysiological properties and this, in turn, affect action potential propagation, like we
proved in our model. Indeed, changes in the voltage dependence of steady-state
activation/inactivation, kinetics of channel opening/closing and conductivity may affect the
overall NaV1.8 mediated sodium conductance and ultimately action potential propagation. We
also found that both methods used to disrupt lipid rafts determined the same output. Since
different tools were employed, it is possible that different mechanisms were involved. In fact,
MBCD could lead to differences due to both depletion of cholesterol and parallel lipid phase
change, while 7KC exerts its effect through lipid order change. This data suggests that a phase
order change is sufficient to drive changes in membrane excitability. If this effect is mediated
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solely by changes of NaV1.8 (e.g. trafficking as previously discussed or electrophysiological
properties) or due to a combination of different factors is not yet known. In fact, with a direct
effect of lipid rafts to NaV1.8 electrophysiological properties we can also consider indirect
effects. We have not investigated, for example, if other sodium channels partition into rafts.
We have demonstrated that TTX-s channels (e.g. NaV1.7 in nociceptors) do not substantially
contribute to action potential propagation in our system. Nevertheless it may be hypothesised
that NaV1.7 partitions in lipid rafts and has an indirect effect on NaV1.8 mediated action
potential propagation. If rafts depletion altered NaV1.7 properties we could speculate that a
defective boost of ramp currents (mediated by this channel) may impair NaV1.8 recruitment,
due to its high threshold of activation (Rush et al., 2006). Also, NaV1.9, even though it is not
involved in action potential generation, contributes to set the resting membrane potential. If
raft disruption altered NaV1.9 gating properties a change in resting membrane potential could
affect NaV1.8 availability to fire action potentials. These examples could be extended to other
class of proteins which contribute to membrane excitability, like Sodium/Potassium ATPase
and leaky potassium channels. For this purpose, a large scale proteomic profiling of the sciatic
nerve/DRG neurons would be helpful to define the raft associated protein population. To
unravel if raft depletion is indeed directly affecting NaV1.8 electrophysiological properties,
electrophysiological techniques would be necessary. Both soma and axonal patching would
reveal if and how rafts affect NaV1.8 properties.
4.1.3 Lipid rafts indirectly modulate the electrophysiological properties of NaV1.8
through signaling protein complexes on the membrane.
Lipid rafts modulate, by segregating or by facilitating the interaction of certain molecules, cell
signaling (Golub et al., 2004; Simons and Toomre, 2000; Tsui-Pierchala et al., 2002). A potential
way rafts could also influence action potential propagation is by indirectly influencing NaV1.8
properties. NaV1.8 currents are modulated by PKA and PKCε (Okuse, 2007). Interestingly, we
have found that NaV1.8 co-localised with TrkA, the NGF receptors which is upstream of PKCε.
Also, in neuronal cells PKC and TrkA have been reported to translocate into lipid rafts upon
activation (Botto et al., 2007; Limpert et al., 2007). In our model, a plausible hypothesis could
be that raft depletion alters the signaling between TrkA, PKCε and NaV1.8 resulting in modified
properties of NaV1.8. Supporting the hypothesis that rafts influence ion channel properties by
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regulating cell signaling, there is the evidence of NaV1.5. NaV1.5 is mainly expressed in the
cardiac tissue, where it triggers action potentials and supports their propagation through the
tissue. NaV1.5 resides in Caveolae-type lipid rafts in cardio myocites. Caveolin-3, a marker of
rafts, is specifically involved in the β-adrenergic stimulation-mediated increase in sodium
currents through the activation of the alpha sub-unit of GS protein (Yarbrough et al., 2002). It
has also been proposed that the association between potassium channel Kv2.1 and rafts
facilitates the interaction between Kv2.1 and signaling molecules known to be enriched in rafts
such as kinases. The altered properties of KV2.1 upon raft disruption may depend on
misregulated signaling between kinases and their effectors (including KV2.1) (Martens et al.,
2000).
In conclusion, we propose that the effect of lipid rafts on NaV1.8, which translates in an
influence on cell excitability and ultimately on action potential propagation, may be mediated
through one or a combination of the mechanisms we have proposed above. In fact, the
complex feed-back between intracellular signaling, gating properties, channel trafficking,
association with other proteins and the known involvement of rafts in these processes suggest
that multiple ways may occur to tune NaV1.8 activity.
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4.2 Conclusions
Since the concept of lipid rafts was proposed, a vast and constantly growing amount of data
has been clearly showing how these domains influence protein properties and cell behaviour.
Traditionally, studies on rafts have been conducted on immune cells. The interest has moved
also into other cell types, and at the moment there is great excitement about the role of these
micro-domains in regulating cell processes in neurons. Recent studies have highlighted how
lipid rafts affect ion channels function in DRG neurons, and how this translates to modulation
of cell excitability (Morenilla-Palao et al., 2009; Vacca et al., 2004). The cohort of ion channels
expressed on the membrane of neuronal cells and their sub-cellular localisation defines the
excitability and firing properties of each cells. The understanding of the detailed mechanisms
shaping cell excitability in nociceptors is of obvious importance, given the role of these cells. In
fact, they represent the first gate in the perception of painful stimuli in normal conditions and
in chronic pain states, where sensitisation and discharge of abnormal ectopic stimuli
contribute to hyperalgesia and allodynia (Wall and Melzack, 2005). The great majority of
studies conducted so far in the molecular and cellular aspects of pain have unveiled the role of
different classes of proteins in cell excitability. Nowadays it is becoming clear that also the
lateral organisation of the membrane, with different rafts and domains, and the selective
partition of classes of proteins between these domains represent a further level of tuning over
protein function and a new field of research.
We focused our study on NaV1.8 and lipid rafts in nociceptors. NaV1.8 is one of the major
determinants of nociceptor excitability. NaV1.8 has been found to play an undisputed role in
nociception, pain pathways, inflammatory pain and in neuropathic conditions, even though in
this latter case there is contrasting evidence. Our main finding was that NaV1.8 is associated
with lipid rafts in vivo along the sciatic nerve and it retains this association in cultured DRG
neurons. Also, we have found a characteristic sub-cellular distribution of NaV1.8. It was found
in clusters, both in vivo and in vitro. Since cell excitability and ultimately action potential
propagation relies on the gating properties of ion channels and their distribution within the
cell, this finding may shed light on the precise mechanisms of action potential propagation in
unmyelinated nociceptors.
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We have also investigated the role of the association between rafts and NaV1.8 in
unmyelinated nociceptors, and this association proved to be of physiological importance: we
have demonstrated that raft disruption results in altered cell excitability. In fact, both
mechanical and chemical stimuli, with the latter known to trigger pain in vivo, evoked action
potentials which failed to propagate along the axons of raft depleted nociceptors. Notably, this
directly correlates with the shift of NaV1.8 from lipid rafts to non-lipid raft compartments. This
finding highlights the importance of rafts in shaping NaV1.8 mediated action potential
propagation. The discovery of NaV1.8 associating with rafts represents a novel insight not only
into the pain field but also in the lipid raft field. Indeed, we are the first group to date to show
that a voltage gated sodium channel segregates into rafts in neuronal cells and that this
correlates with an effect on cell excitability. We have conducted experiments in vitro. The
advantage of this system is that precise control of certain experimental variables is possible.
On the other hand, it would be intriguing to further extend our findings in in vivo models. It
would be interesting to translate our findings to pain models to assess what the role of the
association between rafts and NaV1.8 would be, in terms of action potential propagation, cell
excitability and ultimately pain behaviours in adult animals.
We conclude that the effect of lipid rafts on cell excitability represents a novel aspect to be
considered in the efforts aiming to understand the fundamental properties of nociceptors and
neuronal cells in general. Studies which are being carried out to discover new and effective
drugs to treat pain conditions would potentially benefit from further investigation into the
influence of rafts on neuronal excitability. Indeed, the exact mechanisms of protein behaviour
in its lipid environment could lead to insights which may open new perspectives in the race to
find new targets for effective painkillers.
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